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Abstract
The cornea is the primary refractive element of the eye and is also fundamental to the 
protection of the visual system. Collagen is the major constituent of the cornea, where it is 
organised in a lattice that enables corneal transparency. Proteoglycan macromolecules are 
thought to regulate the diameter and spatial order of collagen fibrils in the cornea, which are 
both pre-requisites for corneal transparency, although the mechanisms by which they 
organise fibrils are not fully elucidated. This investigation examined the morphology, 
morphometry and organisation of proteoglycans three-dimensionally, in both normal and 
genetically altered mouse corneas, to gain a greater understanding of proteoglycan structure- 
function relationships.
In summary, we found that proteoglycans are primarily responsible for the remarkable 
collagen organisation in the mouse cornea, which allows for corneal transparency. The self­
association of proteoglycans into complexes is likely to result in a robust attachment of 
neighbouring fibrils and provides biomechanical strength, whilst sulphation patterns are seen 
to have a direct effect on the aggregation potential of proteoglycans. Removal of 
proteoglycans, particularly lumican, affects the regulation of both fibril size and spatial order, 
both required for corneal transparency.
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Chapter 1 -  Introduction
1.1 Introduction
The cornea forms a transparent, dome-shaped cover of the eye that is optimally designed for 
the focus of entry and refraction of light. It is the principal refractive element of the eye and 
the structural organisation it maintains plays a pivotal role in achieving optical functionality. 
The cornea accounts for approximately 15% of the surface of the human eye's outermost 
layer; the remainder is the white opaque sclera which protects the internal structures of the 
eye, helps to maintain its shape and serves as a portal for the passage of nerves and blood 
vessels in and out of the eye (Oyster, 1999). Collagen is the major constituent of the cornea, 
where it forms fibrils that are highly organised with remarkably uniform diameters and 
regular interfibrillar spacing. The sclera, also made mainly of collagen fibrils, exhibits 
relatively disorganised collagen fibril arrangement, however (Komai and Ushiki, 1991). This 
disparity between collagen fibril organisations in both tissues is believed to be the 
fundamental reason for the observed difference in transparency.
The precise arrangement of collagen fibrils enables the corneal stroma to withstand tensile 
stress, whilst the hydrated gel formed by proteoglycans creates inflation forces that prevent 
the structure from being compressed (Scott, 1995). The interaction between proteoglycans 
and collagen develops and maintains structural integrity whilst enabling the cornea to achieve 
transparency and the refraction of light into the eye. The interwoven collagen fibrils in both 
cornea and sclera tissues also confer rigidity, resistance to penetration and protect the eye’s 
inner layers. Macro-molecular organisation within the cornea is also essential for the correct 
formation of corneal curvature; any dysfunction can lead to disease states such as 
keratoconus and improper imaging by the eye (Meek et al., 2005). The specific collagen 
architecture and the regulation of corneal hydration, particularly in the anterior region, 
contribute to the correct curvature required for the cornea (Muller et al., 2001). This thesis 
aims to further our understanding as to how proteoglycans regulate the intricate collagen 
fibril assembly in the cornea.
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1.2 Corneal Structure
The cornea is attached to the sclera via a transitional region known as the limbus. The limbus, 
centre and periphery of the cornea exhibit varying compositions of collagen and 
proteoglycans (Borcherding et al., 1975) and, as a result, a significant change in interfibrillar 
spacing is noticed from the central corneal region to the limbus (Boote et al., 2003). The 
central 4prepupillary’ area of the cornea is deemed to be the principal optical zone and is 
considered to comprise 70% of the total focusing power of the eye (Waring, 1989). The 
peripheral area surrounding the central zone is less curved however and is a refractive surface 
primarily aiding peripheral vision. Only recently has the composition of the peripheral cornea 
been investigated and it is suggested that peripheral vision plays a far more important role in 
overall vision than was first considered.
The varying collagen composition in the different areas of the cornea is exemplified by the 
absence of the long variant collagen type XII in the limbus that is expressed transiently 
throughout the corneal stroma. Type XII collagen is thought to contribute to the differences 
in the basement membrane zones of the cornea and limbus (Wessel et al., 1997). The limbo- 
scleral region, which is more disorganised in collagen arrangement, is abundant in 
chondroitin sulphate/dermatan sulphate proteoglycans in mammals other than mice, as 
opposed to the greater extent of keratan sulphate proteoglycans witnessed in the central 
cornea, a region which exhibits the highest degree of collagen organisation (Borcherding et 
al., 1975). In terms of collagen direction, fibrils extend from limbus to limbus with a 
preferred alignment in both the vertical and horizontal directions up to within 1mm of the 
limbus. The limbal collagen fibrils adopt a circumferential alignment, which is structurally 
relevant for the mechanical properties of the tissue, including development of correct corneal 
curvature (Aghamohammadzadeh et al., 2004). Meek (2004) illustrated that a significant 
proportion of collagen fibrils that run across the cornea change direction at the limbus, fusing 
with the limbal collagen that is orientated circumferentially.
The difference in proteoglycan and collagen composition is believed to be instrumental in the 
differences in collagen fibril diameter and interfibrillar spacing between the corneal zones
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and also the reason why the central area of the cornea is almost completely transparent 
whereas the sclera and limbus are not.
Superior
Limbus
Peripheral
Cornea
3mm„ 9mm11mm
v
4mm
10mm
Prepupilliar 
; Cornea
_ 12mm
Fig. 1.1 Designation of anterior surface zones in human cornea, representing the different positions of the 
optical zones and positions with altered curvature within the cornea (Adapted from Boote et al., 2003, 
Waring, 1989).
1.3 Corneal Layers
The human cornea is segregated into five different layers that individually play an important 
role in the developing and mature corneal tissue. The largest domain of the cornea, the 
stroma, lies between the epithelium and endothelium and also contains two structurally 
distinct regions known as Bowman’s layer and Descemef s membrane. The epithelium and 
endothelium are layers of cells that constitute the most anterior and posterior parts of the
3
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cornea respectively. Bowman’s layer separates the stroma from the epithelium whereas 
Descemet’s membrane is situated between the stroma and the endothelium.
1.3.1 Epithelium
The epithelium is the outermost layer of the cornea and consists of six to eight layers of cells 
stacked to form a layer approximately 50pm thick in humans. The purpose of the epithelium 
is to protect the cornea from passage of foreign bodies and to extract nutrients or oxygen 
from tears into the eye (Fatt, 1978). It also controls the swelling of the stroma to an extent. 
The epithelium is vital to the development of both Bowman’s layer and the stroma of the 
developing chick cornea, depositing several different collagen types essential for the creation 
of structural integrity (Gordon et al., 1994).
Basal cells reside within the basal lamina of the epithelium; they are recently created cells 
positioned on Bowman’s layer that are transformed in time to become wing cells. Wing cells 
form the next anterior layer of the epithelium. The wing cells, in a process similar to basal 
cell transformation, are pushed up out of the wing cell layer and become squamous cells, 
remaining at the anterior surface until they are shed into the tear film at the cornea’s surface. 
The existence of multiple layers of cells within the epithelium at various stages of 
morphology helps create a barrier to the free movement of water from tears. Compared to the 
endothelium, the epithelium is a highly selective barrier for osmotically active molecules 
(Oyster, 1999).
1.3.2 Bowman’s Layer
Bowman’s layer is situated in-between the epithelial basal lamina and the anterior region of 
the stroma. In humans, it is composed of collagen fibrils approximately 20 -  25nm in 
diameter individually running in varying directions (Komai and Ushiki, 1991). The 
developing comeal epithelium is believed to play a pivotal role in the formation of Bowman’s 
layer; contributing type V collagen fibrils in early chick comeal development (Gordon et al.,
1994). Also, It has been hypothesised that chemotactic influences regulated by cytokines
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from the epithelium are paramount for the normal development and maintenance of 
Bowman’s layer (Wilson and Hong, 2000).
Epithelium
Stroma
3 ______
Bowman's
Layer
Keratocyte Nuclei
Descement's
Membrane
Endothelium
Fig 1.2 Cross-section of mouse corneal tissue illustrating the sub-layers (own image).
The arrangement of collagen within Bowman’s layer differs significantly to that of the 
stroma. Collagen fibrils form relatively disorganised, densely woven felt-like sheets with 
individual fibrils that are comparatively thinner than fibrils of the stroma. There have been 
several attempts to deduce the function of Bowman’s layer, including its potential for serving 
as a comeal ligament that maintains comeal structure, or even as a pathological barrier for 
viruses due to its acellular nature. Although, no evidence has been suggested to support these 
hypotheses and the fact that there are many species devoid of Bowman’s layer indicates a less 
than critical role (Wilson and Hong, 2000).
1.3.3 Stroma
In humans, the comeal stroma accounts for 90% of the overall comeal depth (Oyster, 1999) 
and contains a highly organised network of collagen fibrils stacked into over 200 lamellae. X- 
ray diffraction studies have illustrated that most collagen fibrils in the stroma of the central
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cornea adopt a preferred orientation in the inferior-superior and nasal-temporal directions 
(Aghamohammadzadeh et al., 2004). The stromal lamellae extend from limbus to limbus and 
are arranged at less than 90° to each other in the anterior stroma. However, lamellae in the 
posterior stroma exhibit near orthogonal conformations (Meek et al., 1987). The main 
constituent of the stroma is water, although 71% of dry mass is collagen (Maurice, 1957). 
Type I collagen is present in higher proportions than other collagens, and heterotypic fibrils 
containing both collagen types I and V are predominant (Birk et al., 1988) and are the main 
constituents of the lamellae. The fibrils are embedded in a hydrated gel that is formed by 
proteoglycans, believed to be necessary for the correct arrangement of collagen. The 
proteoglycans are also known to serve other roles within the extracellular matrix due to the 
nature of their dense electrostatic charge and are fundamental to the balance of hydration 
within the corneal tissue.
To a lesser extent, the stroma is comprised of non-fibril forming collagens, insoluble salts and 
keratocytes; the cells responsible for the formation of new collagen and proteoglycans that 
often sit in-between lamellae (Komai and Ushiki, 1991). Keratocytes occupy 3 -  5 % of 
stromal volume (Beuerman and Pedroza, 1996) and their function is to maintain the ordered 
meshwork within the corneal stroma. Experiments with avians showed that comeal collagens 
such as type I, V and VI (Ruggiero et al., 1996, Linsenmayer et al., 1998) are produced by 
keratocytes, illustrating their importance. Also, their nuclei are a source of backscattered light 
in normal human corneas, affecting the light transmission properties of the cornea (Moller- 
Pedersen, 2004). Bowman’s layer and Descemet’s membrane are continuations of the stroma, 
the ends of stromal collagen intertwine within Bowman’s layer and separate the epithelium 
from the anterior stromal region (Oyster, 1999).
Comeal transparency arises from the uniformity of collagen fibril diameters and interfibrillar 
spacing within the stroma, thought to be established by the interrelationships between several 
different types of collagen and specific proteoglycans. The stroma is our primary interest 
within this report as investigation into the association of stromal collagen and the different 
proteoglycans is directly relevant for a greater understanding of the establishment of comeal 
transparency.
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Fig. 1.3 Transmission electron micrograph illustrating the orthogonal arrangem ent of collagen fibrils in 
adjacent lamellae of the mouse corneal stroma. The consistent fibril diameter sizes and regular fibril 
spacing can be seen within the lamellae (own image). Scale b a r  = lOOnm
1.3.4 Descemet's Membrane
D escem ef s membrane is the layer situated between the posterior, mono-layered endothelium 
and the stroma. In humans, it is produced by the endothelium  and may be distinguished at 
four months o f gestation where it progressively thickens with age (Beuerman and Pedroza, 
1996). D escem ef s membrane has been described as a thick basal lamina secreted by the 
endothelium composed o f an anterior banded portion and a posterior non-banded portion 
(Beuerman and Pedroza, 1996). Situated between D escem ef s membrane and the stroma is a 
thin 0.5pm layer o f irregularly arranged collagen fibrils (Komai and Ushiki, 1991).
1.3.5 En doth elium
The endothelial layer is approximately 4-6pm  thick and mediates the transport o f molecules 
and water from the aqueous humor into the stroma. It is a single layer o f approximately
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400,000 cells and is a less effective passive barrier than the epithelium. Executing a 
significant role in ion exchange, endothelial cells are considered the most metabolically 
active within the cornea due to the significant quantities of mitochondria and golgi witnessed 
(Beuerman and Pedroza, 1996). The endothelium is able to pump water out of the cornea in 
cases of increased stromal osmotic pressure and consequently it may control corneal swelling 
(Oyster, 1999).
1.3.6 Mouse Corneal Layers
The murine corneal stroma also exhibits regular interfibrillar spacing and collagen fibrils 
approximately 30-35nm in diameter (Quantock et al., 2001) that are slightly larger than 
human corneal collagen fibrils. Haustein (1983) illustrated that the total thickness of the 
mouse cornea is approximately 90pm, and is mainly constituted of a 25 pm thick epithelium 
and a stroma measuring 60pm in size. This is supported by histological sections which report 
the same thickness (Hayashida et al., 2006). However, recent studies indicate that murine 
corneal thickness may depend on the strain and can range from 89 to 124pm (Lively et al., 
2010). A rudimentary Bowman’s layer can be seen in electron microscopy, which visualises a 
fibrous region posterior to the stroma but underneath the epithelium (Haustein, 1983).
Keratocytes in the mouse corneal stroma can be up to 30pm in diameter, displaying a 
thickness of 0.8-1.6pm. They lie adjacent to the lamella and their long axes are parallel to the 
surface of the cornea. The mouse corneal extra-cellular matrix is composed differently from 
other mammals; the thickness of the cornea is only 80-90pm which is much less than most 
other mammalian species and so the composition reflects this through a variation in 
proteoglycan content (Scott & Bosworth 1990)
1.4 Collagen
The collagen super-family accounts for approximately a quarter of all proteins in humans 
(Marshall et al., 1993) and are major components of tissues as diverse as the cornea, skin, 
cartilage and bone. Collagen is central to the structural integrity of connective tissues and
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plays varying roles within their development and normal physiology. Extracellular matrices 
within connective tissues are composed of a variety of collagens and associated 
polysaccharides secreted locally to form an organised meshwork defining the physical 
characteristics of the respective tissues. The components of connective tissues have evolved 
to withstand the stresses of movement and the maintenance of shape (Scott, 1975). Currently, 
there are 29 known members in vertebrates (Soderhall et al., 2007), encoded by more than 40 
genes, whereby type I is the most understood and predominately exists within most 
connective tissues. The different types of collagen display varying characteristics and 
functionality, although they retain structural homology and may also interact with each other. 
However, some collagen types, such as type XXVII, have functions yet to be elucidated 
(Pace et al., 2003).
Collagens exhibit a characteristic triple-chain helix with non-helical regions in varying 
amounts and sire all common in this respect. Each collagen molecule shares a similar 
structure composed of three polypeptide chains, known as a chains, containing characteristic 
Glycine -  X -  Y repeats. X is commonly proline whereas Y is usually hydroxyproline. The 
individual a chain forms a left-handed helix; the three a chains wind around each other in a 
right-handed super-helix, where glycine, being the smallest amino acid with no side chain, 
plays a pivotal structural role within the core of the super-helix. The requirement of glycine 
in every third position is imperative for the structural integrity of the protein. If glycine is 
displaced by any other larger amino acid there is disruption of the helix (Piez and Reddi, 
1984).
Fibrillar collagen molecules interact and stabilise through intermolecular bonds at their C and 
N terminals and aggregate to form micro-fibrillar structures. The inter-connected collagen 
molecules are known to aggregate in ‘quarter-stagger’ arrays in contact with approximately 
75% of the neighbouring lateral molecule and reach about 300nm long, typically (Scott, 
1988). The periodicity that arises as a result of the stagger gives rise to the characteristic 
collagen negative staining pattern. The cornea’s transparency and mechanical resiliency is a 
result of the formation of an extra-cellular matrix consisting of narrow-diameter, heterotypic 
collagen fibrils displaying a remarkable degree of uniformity in their spatial organisation 
(Maurice, 1957). The fibrils are uniformly thick with an average diameter of 25-35nm in
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humans (Komai and Ushiki, 1991) and have regular interfibrillar spacing of approximately 
55nm (Meek and Leonard, 1993). Within the cornea, collagen forms as sheet-like structures 
known as lamellae, whereby each collagenous lamella is arranged near-orthogonal to its 
neighbour and to the path of light into the cornea (Maurice, 1957).
Fibril forming collagen type I and V are the predominant collagens within the comeal stroma. 
Other collagens, including micro-fibrillar, non-fibril forming and fibril associated collagen 
with interrupted triple helices (FACIT) collagens also pay important roles in the maintenance 
of comeal structure and function.
1.4.1 Collagen Biosynthesis
Collagen a chains are synthesised on membrane bound ribosomes where they are inserted 
into the rough endoplasmic reticulum (RER), primarily forming long proa chains as 
precursors to the a polypeptide chain. The a chain precursors contain signal sequences for 
transport of the nascent polypeptide to the RER which are subject to cleavage during transit, 
along with other amino acids termed propeptides at both the C and N terminus (Alberts et al., 
2002). Different combinations of genes that encode collagen are expressed in different 
tissues. In theory, this could give rise to tens of thousands of different tropocollagen (mature 
collagen form consisting of three a polypeptide chains) molecules but only 29 are currently 
known to be produced. Type I collagen exists as a hetero-trimer containing two proa 1(1) 
chains encoded by the gene COL1A1, and one proa2(I) chain translated from the gene 
COL1A2 (Michelacci, 2003). Type I collagen is the most extensively characterised and exists 
abundantly in most connective tissues. Several tissues, such as tendon, sclera and bone 
contain negligible amounts of any other collagen type (Scott 1988).
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Fig 1.4 Collagen structure. (A) A single collagen a  chain model illustrating the Gly-X-Y repeat. The chain 
is organised as a left-handed helix with glycine positioned every th ird  amino acid. The a chain comprises 
of a series of Gly-X-Y sequences where X is commonly proline and Y is usually hydroxyproline. (B) 
Collagen molecule. The a chains are  arranged to form a triple-stranded right-hand helix. Glycine is 
strategically positioned through the centre of the helix as it is the only amino acid small enough to do so. 
Normally, collagen molecules are 300nm in length (Taken from Alberts et al., 2002).
The proa chains may undergo post-translational modification within the RER which includes 
hydroxylation of lysine and proline residues as well as the glycosylation of the subsequently 
formed hydroxylysine or hydroxyproline (Alberts et al., 2002). However, the post- 
translational modification of proa chains varies in different collagen types. For example, the 
extent of hydroxylation of lyslyl and prolyl within type I and II collagen is more than 75% 
less than that of type IV (Michelacci, 2003). Hydroxylation of specific residues within the 
collagen helix is essential for the formation of inter-chain bonds that confer stability as well 
as potential substrates for glycosylation (Eyre et al., 1984). The hydroxylation of proline at 
position 4 is also a pre-requisite for thermal stability within the helix. Another addition to the
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proa chain within the endoplasmic reticulum is the coalescence of asparagine-linked 
oligosaccharides which are also synthesised on the RER membrane and then processed within 
the golgi apparatus (Clark, 1982).
Once processing of the proa chains has occurred, three a chains align and the globular 
domains fold and stabilise through the formation of disulphide bonds. Subsequently, triple 
helix formation begins from the C-terminal to the N-terminal. Propagation of the triple-helix 
structure requires all the peptide bonds involving prolyl residues to be positioned in the trans 
form (Michelacci, 2003) in order to manufacture the procollagen molecule. Procollagen 
molecules are then subject to translocation into the golgi apparatus and exocytosis into the 
extracellular matrix. Upon expulsion into the ECM, procollagens undergo proteolytic 
cleavage by N and C-proteinases (Alberts et al., 2002). The triple-helical domain left after 
cleavage stabilises by the creation of more intermolecular bonds and becomes tropocollagen.
Tropocollagen molecules form aggregates that lead to the formation of micro-fibrils and 
collagen fibrils, precisely designed and orientated to fulfil their function within the ECM. 
Fibril formation is a non-enzymatic process and the size of aggregation differs in various 
connective tissues. It is thought that, in general, the regulation of collagen fibril diameters 
and the control of the rate of flbrillogenesis is due to the interaction of the collagen fibrils 
with proteoglycans. Control of flbrillogenesis is essential for limiting the diameters of 
collagen fibrils, achieved by the prevention of lateral self-assembly.
Evidence suggests that early fibrils present in developing tissues may be either bi-polar or 
uni-polar (Kadler et al., 1996). The aggregation and size of fibrils is considered to rely on the 
balance of polarities; the presence of anti-parallel fibrils may limit the rate of fusion of 
collagen fibrils (Scott and Parry, 1992). This also suggests that in the presence of parallel 
groups of fibrils, the probability of fusion is higher.
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Fig 1.5 Schematic representation of collagen biosynthesis from translation of the a chain on ribosomes 
and injection into the RER to the subsequent post-translational modification and exocytosis (Taken from 
Lodish et al., 1999).
1.5 Collagen Types in the Cornea
Collagen exists in several different forms including: fibrillar forming, micro-fibrillar, FACIT 
(Fibril Associated Collagen with Interrupted Triple Helices) and non-fibril forming. Each 
form has an integral role in the formation of extracellular matrix structural integrity.
I.5.1 Fibril-forming
Within the corneal stroma, the fibril forming collagen types I and V are abundant, where they 
co-assemble to form heterotypic fibrils that are inextensible; resisting and transmitting tensile 
stress and ultimately defining the maximum size of the tissue (Scott, 1995). Collagen types I,
II, III, V and XI are fibrillar-forming and all of them (excluding XI) may exist in the stroma 
at some stage in development and maturity of the cornea (Michelacci, 2003). Fibril forming 
collagens organize into the characteristic axial periodicity for collagen denoted as the D-
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period (D=67nm). Although, the cornea exhibits a D-periodicity closer to 65nm (Marchini et 
al., 1986). This may have connotations in the ability of collagen fibrils to transmit tensile 
stress. The fibril-forming collagens consist of an uninterrupted triple helical domain attached 
to telopeptides either side, measuring approximately 300nm in length and 1.5nm in diameter.
Type I collagen is the most extensively characterised collagen and is abundant in most 
tissues. Primarily, it withstands tensile stress within the tissues as it is the strongest fibrillar 
forming type whilst it also defines the size and shape of its surroundings. Type I exists as a 
hetero-trimer of two identical a 1(1) and one a2(I) polypeptides. Mutations in genes 
responsible for the creation of type 1 procollagens result in oesteogenesis imperfecta and 
signify collagen type I importance in the structural maintenance of diverse tissues (Prockop 
and Kivirikko, 1995).
Type II consists of three identical polypeptide chains, a l (II), which constitutes the triple helix 
structure. Type II collagen is primarily a cartilage collagen, although it is present in stromal 
development.
Type III has three identical polypeptides, a l (III) that constitute its triple helix. It has been 
found to attach to the stromal lamellae and also with the substratum of the epithelium. 
Collagen type III is believed to be involved with the structural maintenance and function of 
the epithelial tissue (Newsome et al., 1982). It is also considered to play a significant role in 
response to tissue damage, exerting its role in wound healing and inflammation.
Type V collagen co-assembles with type I within the stroma, where the resulting heterotypic 
fibril constitutes most of the collagen within the tissue. It is composed of three different 
polypeptide chains which are al(V), a2(V) and a3(V). Birk (1990) illustrated that, in vitro, 
collagen flbrillogenesis is affected when collagen type V is displaced from the stroma, 
whereby fibril diameters increase; removal of type V collagen has implications in the 
development of heterotypic fibrils with narrow diameters.
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Type XI is formed from al(XI), a2(XI) and a3(XI) polypeptides in a 1:1:1 ratio (Morris and 
Bachinger, 1987). The a3(XI) chain however, is actually transcribed from the COL2A1 gene 
but results from a post-translational modification of an a l (II) polypeptide of collagen type II 
(Wu and Eyre, 1995).
■
1
I Fibril Bowman’s layer; • Fibril-forming; (Michelacci,
Forming Stroma (75% of abundant in cornea 2003, Birk et
collagen content • structural integrity and al., 1986)
in stroma) formation of 
transparency
I I I Fibril Bowman’s layer; • Inflammation (Marshall et
Forming Stroma • wound healing al., 1991,
Michelacci,
2003)
V Fibril Bowman’s layer; • Forms heterotypic (Michelacci,
Forming Stroma (2% of fibrils with type I 2003, Birk et
collagen content • believed to regulate al., 1986)
in the stroma); collagen fibril diameter
Interfibrillar
Matrix
Table 1.1 The distribution of fibril forming collagen types throughout the cornea
1.5.2 FACIT
FACIT (Fibrillar-Associated Collagens with Interrupted Triple-Helices) collagens, as well as 
proteoglycans, are pivotal to the correct orientation of collagen fibrils within the extracellular 
matrix. Collagen types IX, XII, XIV, XVI, XIX, XX and XXI are all part of the FACIT 
collagens group (Gelse et al., 2003). FACITs are not fibril forming collagens, however, they
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are known to co-aggregate with other collagens and extend from their surface, this enables 
collagen fibrils to form interactions with other matrix components or adjacent fibrils 
(Svensson et al., 2001). Each FACIT molecule has domains that lie along the fibril surface 
anchoring them to underlying fibrillar collagens, often by covalent interaction (Wu and Eyre,
1995). FACITs are common in the fact that they all share a non-helical sequence motif that 
interrupts the triple helical domain, as their name suggests.
FACITs are known to associate with the surface of collagen fibrils and alter their interactive 
properties. Type IX collagen is a hetero-trimer of al(IX ), a2(IX) and a3(IX) and co- 
distributes with collagen type II in cartilage (Gelse et al., 2003). Type XII collagen is 
localised within the corneal stroma and Bowman’s layer. By comparison with type IX 
collagens, corneal FACITs XII and XIV may be expected to execute a similar role to type IX 
in cartilage. Therefore, the N-terminal domains of type XII and XIV may extend from the 
surface of collagen fibrils within the corneal stroma interacting with other proteins and 
polymers in the ECM.
1.5.3 Non-fibrillar/Filamentous
Collagen type IV is the most predominant collagen component of basement membranes; they 
form the anchoring plaques and the lamina densa. Type IV collagen molecules exhibit a long 
central collagenous domain with a non-helical domain at the C-terminal end (Linsenmayer et 
al., 1998). Type VIII and X collagens are known as short-chain collagens, existing in 
basement membranes and cartilage respectively.
Micro-fibrillar type VI collagens also exist within the stroma at different levels. Collagen 
type VII, which is also micro-fibrillar, acts as an anchoring fibril between the epithelium and 
its corresponding basement membrane (Linsenmayer et al., 1998). Collagen type XIII, a non- 
fibrillar collagen, has also been found bound to the cell membrane and within the posterior 
two thirds of the corneal stroma (Sandberg-Lall et al., 2000).
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IV Basement
membrane
Descemet’s • Adhesion of Descemet’s (Fitch et al., 1991, 
membrane membrane, stroma and Linsenmayer et al., 
endothelium 1998)
VI Micro­
fibrillar
Stroma • Forms thin filaments with (Zimmermann et al., 
a 1 OOnm periodicity 1986, Linsenmayer 
alongside collagen fibrils et al., 1986,
• Interact with Nakamura et al., 
proteoglycans to stabilise 1997, Nakamura et 
arrangement of collagen al., 1992) 
fibrils.
VIII Short chain Anterior • Flomologous to type X (Sawada et al., 
banded although may have 1990, Gelse et al., 
region of different functions. 2003)
Descemet’s • Assembles as a hexagonal 
membrane lattice in Descemet’s 
membrane
XII FACIT Epithelium- • Involved in fibril (Wessel et al., 1997, 
basement; organisation Akimoto et al., 
Bowman’s • Distribution indicates may 2002) (Kato et al., 
layer, play role in interactions in 2000)
Stroma epithelial and stromal 
tissues
XVII Membrane
intercalated
• Hemidesmosomal (Linsenmayer et al., 
attachment 1998, Gordon et al.,
1997)
Table 1.2 The distribution of non-fibril forming collagen types throughout the cornea.
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1.6 Collagen Flbrillogenesis
Collagen flbrillogenesis encompasses fibril assembly and the subsequent packing of collagen 
molecules according to the requirements of the tissue. Connective tissues are composed of 
various collagen types and the relative amounts of collagen types. How the collagen is 
ordered directly affects the physical properties of the respective tissues. Interestingly, 
collagen molecules incubated in vitro at physiological temperature and pH aggregate 
continuously to form insoluble fibrils of varying lengths and diameters (Kadler et al., 1996). 
Therefore, certain governing factors must exist that contribute to the specific organisation of 
collagen witnessed in the cornea.
Micro-fibrils within tendon are staggered longitudinally with an axial periodicity of 67nm, 
denoted as the D-periodicity, whereas, as mentioned earlier, the cornea exhibits a D- 
periodicity of 65nm (Marchini et al., 1986). The angular tilt patterns are believed to account 
for the noticeable difference in axial periodicity within different tissues (see below); corneal 
micro-fibrils tilt at an angle of 15 degrees (Holmes et al., 2001) whereas highly tensile fibrils 
run straighter at an angle of 5 degrees (Ottani et al., 2001). Fibril assembly in the cornea is 
governed by a multitude of factors that enable the formation of fibrils with regulated 
diameters and distribution. Studies have indicated that the diameter of human corneal 
heterotypic collagen fibrils is approximately 3 lnm and reaches up to 34nm with aging (Meek 
and Leonard, 1993). No evidence suggests that fibril diameters increase with respect to 
stromal depth (Freund et al., 1995).
Corneal collagen mainly consists of heterotypic fibrils that are composed of type I associated 
with type V collagen. The triple-helical domain of type V collagen is enclosed within the 
fibril and the N-terminus is exposed at the surface, protruding outwards through the gap 
regions. A short a helical region at the N-terminal domain acts as a flexible hinge-like region 
which allows the part of the polypeptide to extend from the molecule. This region is 
responsible for the regulation of the assembly of immature fibril intermediates. The N- 
terminal domain alters the cohesion of collagen molecules and lateral growth and therefore, 
inhibits the formation of insoluble fibrils with larger than normal diameters (Birk, 2001).
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Average fibril diameters remain constant across the cornea before increasing at the limbus 
region (Borcherding et al., 1975).
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Fig. 1.6 Axial packing arrangement of triple-helical collagen molecules illustrating the characteristic 
‘quarter-stagger’ and D-periodicity. Gap and overlap regions are  indicated by negative staining, 
whereby staining is left over and therefore darker in regions where collagen presence is to a lesser extent, 
which is known as the ‘gap’ zone (Adapted from Kadler et al., 1996).
The fibrils are hydrated in a manner that results in a lateral distance between collagen 
molecules of 1.8nm (Malik et al., 1992). In the human cornea, collagen fibrils ~ 36nm in 
diameter are organised into micro-fibrils which are tilted by 15° to the fibril axis in a right 
handed helix (Holmes et al., 2001). Due to the 4quarter-staggered’ nature of collagen fibril 
assembly, incomplete overlapping of collagen molecules results in a ‘gap’ zone that is clearly 
evident upon staining of collagen. The ‘gap’ zone is considered to be 0.6D (Meek and 
Quantock, 2001) and is the distance between the amino terminal of one collagen molecule 
and the next amino terminal to extend past it. ‘Overlap’ zones are deemed to be the areas 
where staining does not accumulate in negative staining methods and collagen molecules 
overlap one another. The D-period is further subdivided into 12 bands from al to e2 enabling
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identification of axial position through the length of a collagen fibril (Hodge and Schmitt, 
1960).
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Fig. 1.7 Localisation of collagens type I-VII1 in human cornea. Collagen 1 (blue circle), III (green square), 
V (brown square), and VI (red circle) are present within Bowman’s layer and the stroma with only types 
V, VI being expressed within the interfacial matrix. Both types VI and VII (green circle) are present 
within the basal lamina situated in the sub-epithelium. Type IV collagen is abundant within Descemet’s 
membrane. Type VIII collagen (yellow square is present within the anterior banded region (ABR) of 
Descemet’s membrane. BMC -  Basement membrane complex; ABR -  Anterior Banded Region; PNBR; 
Posterior near-banded region (Adapted from Marshall et al., 1993)
Picture: http://education.vetmed.vt.edu/Curriculum/VM8054/EYE/CRNEADGM.JPG)
As stated previously, collagen fibrils are also considered to be directional because the 
collagen molecules that make up fibrils are orientated parallel to one another (Scott and 
Parry, 1992), although collagen molecules are also known to exists in anti-parallel 
conformations. Wess et al (1998) proposed that type I collagen fibrils are formed by five left- 
handed micro-fibrils. Micro-fibrils are considered to be interconnected covalently through
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telopeptides at gap-overlap regions. It is also suggested that collagen fibrils are modular 
structures as opposed to the initial idea that they existed as quasi-crystalline aggregates (Scott 
and Parry, 1992). The regular appearance of proteoglycans that exist associated with collagen 
fibrils gives weight to the suggestion of a modular nature. Orgel (2006) studied the micro­
fibrillar structure of type I collagen postulating that collagen molecules form a super twisted 
(discontinuous) right handed micro-fibril connecting with other close micro-fibrils. The result 
of this relationship is the crystallographic super-lattice formed by quasi-hexagonally packed 
collagen molecules.
1.7 Corneal Lamellae
The constituent collagen element is unique within the cornea when compared to other 
connective tissues; it allows the dual functionality of protecting the eye’s inner layers as well 
as the focusing of light into the eye. In 1938, Kokott first postulated that collagen fibrils 
within the deep layers of the corneal stroma run circumferentially and that there was no 
preferential alignment of collagen within the anterior stroma.
Collagenous lamellae within the corneal stroma are indeed orientated differently in the 
anterior and posterior regions. Lamellae situated adjacently are positioned at varying angles 
to each other, except in the posterior region, where lamellae may be positioned orthogonally 
and a more tilted conformation is witnessed. This is illustrated by the total scattering cross- 
section of each region, where values for the posterior region were lower than the anterior 
portion, depicting a higher degree of order in the posterior stroma (Freund et al., 1995). 
Lamellae situated towards the anterior are thinner and exhibit a flat appearance (approx. 
30pm wide an 1.2pm thick) when compared with the broader and thicker posterior lamellae 
(200pm wide and 2.5pm thick) (Komai and Ushiki, 1991).
Within the anterior stroma, lamellae appear to run in random directions and display a high 
degree of irregularity in their interweaving. There is an evident anterior to posterior lamellae 
interweave within the anterior stroma believed to help aid corneal curvature (Muller et al., 
2001) and confers stability along with Bowman’s layer (Bron, 2001). Central lamellae are
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found to cross irregularly, forming interwoven networks. Posteriorly positioned lamellae run 
parallel to the corneal surface and are largely uninterrupted structures that extend from one 
region of the limbus to the other, which is believed to compound additional strength. The 
posterior region is hydrated to a greater extent at physiological conditions (Turss et al., 1970) 
and exhibits a lower refractive index (1.373) than the anterior stroma (1.380) (Patel et al., 
1995). The hydration properties are, in part, a result of the glycosaminoglycan constituent of 
each region within the stroma. Due to keratan sulphate’s greater affinity to water than 
Chondroitin sulphate, the posterior region, with a larger KS:CS ratio than the anterior stroma, 
exhibits a higher degree of hydration. This is also furthered by the proximity of the posterior 
stroma to the 'leaky' endothelium. Therefore, stromal swelling tendencies increase with 
respect to stromal depth (Castoro et al., 1988).
Fig 1.8 Scanning electron micrograph (SEIM) of corneal lamellae in the mid-stroma region. The 
arrangem ent of the collagenous lamellae is depicted running at varying angles whilst also interweaving in 
some areas (short arrow). The angles between lamellae may be calculated by measuring the angle 
between the longitudinal axes of adjacent lamellae (large arrows). (Taken from IMeek and Fullwood, 
2001) Scale bar - 10pm
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1.8 Proteoglycans
Proteoglycans are fundamental to the composition of the extracellular matrix in connective 
tissues, playing key roles in the maintenance of tissue shape and definition. Known for a 
variety of diverse biological functions; within the cornea they are compression-resistant, 
soluble polymers that interact with collagen and are primarily involved with the regulation of 
collagen fibril diameters and interfibrillar spacing (Scott, 1975). Ultimately, they are 
responsible for the uniform organisation of collagen fibrils through regulation of 
flbrillogenesis as well as the hydration of the corneal stroma (Hedbys, 1961). Proteoglycans 
swell in water occupying large volumes that press against the networking collagens and, in 
turn, resist compressive forces that would reduce the size of the tissue. This osmotic swelling 
mechanism is likely to play a key role in their regulatory functions, as discussed later. 
Proteoglycan diversity is reflected by the varying proteoglycan composition of tissues; 
tendon is designed to resist or transmit most types of tensile stress and therefore is more 
fibrillar in content, whereas cartilage, which is more elastic in nature, contains a considerably 
larger amount of soluble polymers than tendon (Scott, 1991). According to this concept, the 
cornea can be expected to also have a high degree of proteoglycan content when compared to 
tendon, which is indeed the case. Deficiency of proteoglycans has been shown to result in the 
aggregation of collagen fibrils and consequently corneal opacity (Hassell et al., 1980), 
depicting the necessity of proteoglycan presence in the maintenance of corneal transparency.
There are two major components of proteoglycans - a protein core covalently attached to one 
or more polysaccharide glycosaminoglycan side-chain(s). Within the corneal stroma, two 
major classes of proteoglycan exist according to their glycosaminoglycan component; keratan 
sulphate or a hybrid of chondroitin sulphate/dermatan sulphate (Iozzo, 1999). 
Glycosaminoglycans are negatively charged at physiological pH due to the high level of 
sulphation and confer this charge to the proteoglycan molecule, which stimulates interaction 
with counter-ions and other glycosaminoglycan chains. The electrostatic forces that exist due 
to the charge density of glycosaminoglycans enables the binding of cationic staining solutions 
such as Cupromeronic blue or Cuprolinic blue, which allows us to visualise proteoglycans 
under an electron microscope as electron-dense filamentous structures (Scott, 1980).
23
Chapter 1 - Introduction
Proteoglycans can contain as much as 95% carbohydrate by weight, reaching 3xl06 Da in the 
case of the cartilage proteoglycan aggrecan (Alberts et al., 2002). However, within the cornea 
there exists a subsection of the family of proteoglycans known as the small leucine rich 
proteoglycans (SLRPs) that are considerably smaller than cartilage proteoglycans because of 
the respective glycosaminoglycan components, such as decorin, which has only a single 
glycosaminoglycan chain. SLRP protein constituents inhibit collagen flbrillogenesis in order 
to control the fibril diameter whereas the glycosaminoglycan chain extends to form 
interfibrillar bridges responsible for the development of regular fibril spacing. 
Proteodermatan and proteokeratan sulphate proteins exhibit horseshoe conformations, 
purposefully designed to aid interactions with collagen fibrils (Scott, 1996)
Fig 1.9 Transmission electron micrograph of mouse corneal stroma stained with Cupromeronic blue. 
Proteoglycan structures appear as electron-dense filaments and are  found to be regularly associated with 
fibrils (short arrows) longitudinally, as well as appear ing  to be large, elongated structures running across 
several fibrils (long arrows). The large proteoglycan structures are  illustrated as circular in transverse 
sections (arrow heads), reaching 20nm in diameter. Bar -  250nm (Taken from Young et al., 2005)
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1.9 Glycosaminoglycans
Glycosaminoglycans are linear chains of repeating disaccharides. One of the sugars is an 
amino sugar whereas the second sugar is an uronic acid or galactose and either may be 
sulphated. Carboxyl (COO') and sulphate ester (SCV) groups are present on specific sites of a 
glycosaminoglycan chain and confer a highly negative charge. The negative charges that 
exist through varying degrees of sulphation enable proteoglycans to interact with other 
molecules and other glycosaminoglycans. Anionic glycosaminoglycans are rigid chains that 
should display mutual repulsion, however they are known to aggregate (Fransson, 1976). 
They also attract counter-ions such as Na+ which induces osmotic swelling or turgor. 
Glycosaminoglycans fill a large amount of space and exhibit strong swelling pressure at 
relatively low concentrations, forming hydrated gels that suck water into the matrix (Scott, 
1995).
Keratan sulphate and chondroitin sulphate/dermatan sulphate are the predominant 
glycosaminoglycan chains that associate with SLRPs in the cornea (Iozzo, 1999) and attach 
to specific axial sites along collagen fibrils {see 1.12). The subsequent hydrophilic property 
of glycosaminoglycans enables them to orientate into extended structures, although, it has 
been elucidated that glycosaminoglycans are in fact amphiphilic structures capable of 
hydrophobic interaction and hydrogen bonding. It is these interactions that enable the 
glycosaminoglycans to counteract the strong expected mutual repulsion and associate to form 
interfibrillar bridges (Scott, 2001).
1.9.1 Keratan Sulphate
Keratan sulphate is a sulphated glycosaminoglycan chain, first isolated by Karl Meyer (1953) 
in bovine cornea, that consists of the amino sugar N-acetylglucosamine (GlcNAc) and 
galactose repeated as disaccharide units. The glycosaminoglycan chain of keratan sulphate 
can contain a combination of non-sulphated, mono-sulphated and di-sulphated disaccharide 
units (Varki and Cummings, 2008). Keratan sulphate occurs as two different forms dependant 
on the linkage to its respective protein core. N-linked keratan sulphate molecules are termed 
keratan sulphate class I, whereas class II is defined as those linked to proteins through O-
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linkage at Ser/Thr residues (Funderburgh, 2000). N-linked keratan sulphate exists primarily 
in the cornea and is therefore defined as corneal keratan sulphate. There is more than ten 
times the amount of keratan sulphate in cornea than in cartilage (Funderburgh et al., 1987). 
The principal glycosaminoglycan within the mammalian corneal stroma, keratan sulphate, is 
found attached to three different SLRPs; lumican, keratocan and mimecan (Funderburgh, 
2000).
Keratan sulphate associated proteoglycans are known to attach at bands ‘a’ and ‘c’ of 
collagen fibrils (Meek et al., 1986) and the cornea is the only tissue known to have 
proteoglycan attachment sites at these loci (Scott, 1995). The sclera exhibits lower 
concentrations of keratan sulphate proteoglycans than the cornea and due to the differing 
fibril diameters inherent in each tissue, it is subsequently believed that keratan sulphate 
proteoglycans play important roles in the regulation of collagen fibril diameter (Borcherding 
et al., 1975), allowing light to be refracted through the cornea with minimal scattering (Varki 
and Cummings, 2008). This is evident when there is a failure to synthesize a mature keratan 
sulphate proteoglycan, which results in corneal opacity and even blindness (Hassell et al., 
1980).
1.9.1.1 Keratan Sulphate Biosynthesis
Production of the keratan sulphate glycosaminoglycan chain occurs within the golgi 
apparatus and is subject to processing by glycosyltransferases and sulphotransferases. These 
two families of enzymes are responsible for chain elongation and the transfer of sulphate 
esters to the immature glycosaminoglycan, where upon maturation the keratan sulphate 
proteoglycan is secreted into the extracellular matrix. Elongation of the keratan sulphate 
chain is carried out by action of glycosyltransferases that alternately add galactose and 
GlcNAc to the elongating polymer (Funderburgh, 2000). The elongation of the immature 
glycosaminoglycan is processed by enzymes of two glycosyltransferase families, Bl,3-N- 
acetylglucosaminyltransferase (B3Gnt) and B 1,4-galactosyltransferase (B4GalT). When 
genes encoding B3GnT and B4GalT7 were suppressed in cultured human corneal cells, levels 
of sulphated keratan sulphate decreased, illustrating that these enzymes are necessary for 
elongation and the synthesis of normal keratan sulphate (Kitayama et al., 2007).
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The enzymes responsible for the sulphation of the keratan sulphate glycosaminoglycan are 
keratan sulphate galactose 6-0 sulphotransferase (KSG6ST) and comeal N- 
acetylglucosamine 6-0 sulphotransferase (CGn6ST). CGn6ST only transfers sulphate to the 
non-reducing terminal GlcNAc but does not sulphate internal GlcNAc, suggesting that 
sulphation and elongation occur simultaneously (Kitayama et al., 2007).
Keratan Sulphate
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Fig 1.10 Structure of the main corneal stromal glycosaminoglycans. The glycosaminoglycan-protein 
linkage region is depicted as well as the main disaccharide sugars. Gal-Galactose; Fuc-Fructose; Man- 
IMannose; Xyl-Xylose; GluA-p-D-glucuronic acid; IduA-a-L-iduronic acid; GalNAc-N- 
acteylgalactosamine; GalNAc4S-N-aeetylgalactosamine 4-sulphate; GlcNAc-N-acetylglucosamine; 
GlcNAc6s-N-acetylglucosamine 6-sulphate; Asp-Asparagine; Ser-Serine (Adapted from Michelacci, 
2003).
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1.9.2 Chondroitin Sulphate /Dermatan Sulphate
Chondroitin sulphate/dermatan sulphate (CS/DS) glycosaminoglycans contain N- 
acetylgalactosamine as its hexosamine constituent, with D-glucuronic and/or L-iduronic acid 
as its uronic acid within the repeating disaccharide. However, chondroitin sulphate contains 
no L-iduronic acid, which is commonly part of dermatan sulphate’s disaccharide unit (Scott, 
1988). Dermatan sulphate is a derivative of chondroitin sulphate, as it is formed by the 
epimerization of glucuronate C-5 upon creation of the glycan chain (Scott, 1988). Decorin is 
the main proteoglycan composed of hybrid CS/DS glycosaminoglycan chains; it is also the 
smallest proteoglycan with only one associated glycosaminoglycan chain.
thChondroitin sulphate was first isolated in the late 19 century and has been found to be a 
major component of cartilage as well as the corneal stroma. CS/DS is found to be less 
abundant within the human cornea than keratan sulphate glycosaminoglycans, comprising 
20% of the total corneal glycosaminoglycan content (Scott and Bosworth, 1990). However, 
the opposite is true for the murine cornea; only 18% of total glycosaminoglycan content is 
keratan sulphate (Scott and Bosworth, 1990). Chondroitin sulphate exhibits a variable 
sulphation pattern whereby the fourth and sixth residue within the galactosamine unit may be 
sulphated in the cornea (Scott and Bosworth, 1990). Dermatan sulphate may be sulphated at 
the second and fourth position of its galactosamine unit (Scott and Bosworth, 1990) and was 
originally considered to be a form of chondroitin sulphate and is often termed chondroitin 
sulphate B.
1.9.2.1 Chondroitin Sulphate/Dermatan Sulphate Biosynthesis
CS/DS chains are attached to serine residues within core proteins through xylose. 
Xylotransferase (isoforms XT1 + XT2) utilises UDP-xylose as a donor to initiate the 
formation of the glycosaminoglycan chain (Varki and Cummings, 2008). Upon addition of 
xylose, a tetrasaccharide forms via the addition of two galactose subunits catalyzed by 
members of the glucuronosyltransferase family of enzymes. At this point in biosynthesis, the 
addition of a 1-4 GlcNAc initiates the formation of Heparan sulphate or the addition Bl- 
4GlcNAc begins development of the chondroitin sulphate chain. The sulphation of galactose 
is limited to chondroitin sulphate chains, however. Polymerisation of the chondroitin sulphate
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chain is catalysed with chondroitin synthases that exhibit both Bl-3 glucuronosyltransferase 
and Bl-4 N-acetylgalactosaminyltransferase activities. The elongation of the polymer in 
chondroitin sulphate also requires the action of chondroitin polymerising factor, a protein that 
does not act independently but collaborates with the polymerases that transfer subunits. 
Sulphation occurs via the action of multiple sulphotransferases, conferring sulphation at 4-0 
and 6-0 positions on N-acteylgalactosamine residues. Further enzymatic processing exists for 
the epimerisation of glucuronic acid to iduronic acid for dermatan sulphate production (Varki 
and Cummings, 2008).
1.10 SLRPs
The small leucine rich proteoglycan (SLRP) super-family consists of proteins within a range 
of diverse biological locations that are related both structurally and functionally. All SLRPs 
have one domain that is formed from the presence of tandem leucine rich repeats which 
adopts a curved solenoid fold (Hocking et al., 1998). The leucine rich repeat motifs within 
SLRPs are flanked on either side by cysteine-rich clusters, the presence of which are an 
integral part of the leucine rich repeat domain (Kobe and Kajava, 2001). Distribution of 
leucine rich repeat sequences within the protein structure and in different species illustrates 
the diversification of their roles, and this apparent retention throughout evolution indicates 
that the sequence provides an ideal conformation for binding to other proteins (Hocking et al.,
1998).
SLRPs are classified into five distinct families according to protein and genetic homology 
and also the positioning of the N-terminal Cys-rich clusters (Iozzo and Schaefer, 2008). All 
SLRPs exhibit homologous sequences throughout their central domain of approx 10 fold 
repeats of a series of 24-amino acid leucine rich repeats (Iozzo, 1999). Leucine rich regions 
fold the protein into a series of beta-sheets forming a 3-D arch shape conformation that 
enables glycosaminoglycans to extend from the concave side of the arch (Iozzo, 1999). This 
conformation allows corneal proteoglycans to have bi-antennary functionality, attaching to 
collagen fibrils whilst protruding glycosaminoglycans that form interfibrillar bridges. The 
SLRPs are known to play a significant role in modulating collagen fibril diameter. Lumican 
and decorin have been show to inhibit the lateral aggregation of collagen fibrils (Rada et al.,
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1993). Furthermore, studies indicate that the regulation of collagen flbrillogenesis is specific 
for certain proteoglycans. This is highlighted by the fact that biglycan and aggrecan display 
no effect on the rate of formation of collagen type I and II fibrils in vitro (Vogel et al., 1984).
SLRPs contain four regions that exhibit similar motifs in all members of the super-family 
(Iozzo, 1999). In the prototypic SLRP decorin, domain I consists of a signal peptide and 
propeptide; domain II comprises of four evenly spaced cysteine residues and the 
glycosaminoglycan attachment site; domain III, which contains the tandem LRR repeats and 
domain IV, a C-terminal domain of approx. 50 amino acids containing two conserved 
cysteine residues. The function of the propeptide is unidentified but the signal peptide 
dictates transit of the nascent peptide to the rough endoplasmic reticulum.
The crystal structure of a leucine rich repeat protein, pancreatic ribonuclease inhibitor, 
illustrated the nature of the repeats in the tertiary structure (Kobe and Deisenhofer, 1993). It 
is described as the characteristic leucine repeat fold. The significant number of tandem 
leucine rich repeat sequences in SLRPs forces the two parallel lines of a helices and beta- 
sheets into a curved shape homologous to the ribonuclease inhibitor (Kobe and Deisenhofer, 
1993). The horseshoe conformation of SLRPs enables the attachment of SLRPs to collagen, 
as the diameter of space inside the horseshoe configuration (approx 2nm) is larger than the 
diameters of collagen micro-fibrils at (1.5nm) (Scott, 1996).
Corneal SLRPs have bi-functional character whereby the protein core binds the collagen 
fibrils at strategic areas and the attached glycosaminoglycan chain extends to regulate 
interfibrillar spacing. Each corneal SLRP has a unique core protein although they share 35% 
amino acid homology (Funderburgh et al., 1991).
1.11 Corneal Proteoglycans
The proteoglycans that exist within the cornea are all members of the SLRP super-family. 
The presence of the proteoglycans, differentiated by their glycosaminoglycan chain, varies
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with respect to their position within the cornea. The proteoglycan differences co-ordinate the 
varying organisation of collagen that can be found from the centre of the cornea to the sclera. 
Specific interactions with respective fibrils hold down glycosaminoglycans but they orientate 
and maintain fibril organisation by forming interfibrillar bridges (Scott, 2001).
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Fig. 1.11 Classification of SLRPs and consensus sequences of cysteine rich clusters (Taken from Iozzo and 
Schaefer, 2008).
1.11.1 Lumican
Lumican is a keratan sulphate proteoglycan and a member of the SLRP super-family. 
Originally isolated from a cDNA clone encoding chick cornea proteoglycan (Blochberger et 
al., 1992), lumican is similar to the other SLRPs; it contains the characteristic four domains 
and has a molecular weight of approximately 40kDa. Lumican plays an important role in the 
maintenance of comeal stroma architecture; lumican-null mouse corneas appear bright in 
confocal microscopy due to an increase in backscattered light, indicative of collagen fibril 
assembly disorder (Chakravarti et al., 2000). Lumican-deficient mice also displayed larger 
fibril diameters in the posterior of the stroma than that of wild type mice. In addition to the 
significant amount of large fibril diameters, lumican-null mice also exhibited irregular
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interfibrillar spacing resulting from a disruption in lamellar organisation and abnormal fibril 
packing (Chakravarti et al., 2000).
Electron microscopy examination of fibrils formed in vitro illustrates that, in the presence of 
lumican, fibrils display markedly thinner diameters than those left to aggregate independently 
(Rada et al., 1993). Rada (1993) also showed that collagen fibrils in the presence of purified 
lumican core protein were much thinner than those exposed to the proteoglycan form of 
lumican. This may indicate a role of keratan sulphate in limiting the interaction of lumican 
core protein with collagen fibrils -  a possible mechanism tailored to implement precise fibril 
diameter. From these findings, it is evident that lumican is a potent modulator of collagen 
flbrillogenesis. Interestingly, lumican knockout mice exhibit the most severe phenotype out 
of all keratan sulphate proteoglycan knockout mice. Age-related corneal opacity, 
disorganised collagen architecture and a thinner corneal stroma are all the result of lumican- 
null mice (Chakravarti et al., 1998).
Studies of keratocan-null mice and lumican-null mice indicate that lumican most likely 
prevents lateral fusion of collagen fibrils (Meek et al., 2003, Chakravarti et al., 1998). This is 
based on the fact that Keratocan deficient mice exhibit no large and irregularly shaped fibrils 
that are witnessed in lumican-null mice (Liu et al., 2003). It has also been postulated that 
lumican may in fact regulate the synthesis of keratocan. The modulation of keratocan has 
been measured via introsomal injection of a lumican mini-gene into the stroma of lumican- 
null mice (Carlson et al., 2005). SiRNA knockdown of lumican in vitro reduced keratocan, 
whereas increased keratocan translation was detected after insertion of a lumican mini-gene 
in vivo (Carlson et al., 2005). This evidence helps towards the understanding of why lumican- 
null mice display hazy corneas whilst keratocan-null mice retain corneal transparency.
Lumican, as well as keratocan, have sulphotyrosine residues situated at the N-terminal end of 
the core proteins (Funderburgh et al., 1995). Kao (2002) suggested that the sulphation of the 
tyrosine residues may affect interactions with cationic domains of extracellular matrix or cell 
surface proteins. In embryonic chick corneas, transparency increases in respect to the 
accumulation of lumican (Comuet et al., 1994) and exerts its function early in collagen
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flbrillogenesis (Ezura et al., 2000). It is clearly evident from current studies that the presence 
of lumican is imperative for the normal control of collagen flbrillogenesis within the cornea.
1.11.2 Keratocan
Keratocan is a 38kDa proteoglycan that is associated with 4-5 keratan sulphate 
glycosaminoglycan chains (Michelacci, 2003). Also part of the SLRP family, it is one of the 
major components of the corneal extracellular matrix. Keratocan exists abundantly within the 
cornea, expressed by keratocytes, but it is also found in skin and cartilage to a lesser extent. It 
is only subject to sulphation within the cornea, however. It has been postulated that keratocan 
and lumican display similar three-dimensional structures, also similar in arrangement to that 
of the porcine ribonuclease inhibitor (Dunlevy et al., 1998).
Keratocan-null mice exhibit clear corneas at early development compared to the hazy corneas 
that are seen from lumican null mice at the same stage (Kao and Liu, 2002). They display a 
thin corneal stroma at this stage, however. Later in development, collagen fibril spacing 
becomes abnormal when compared to that of wild type mice. However, fibrils appear to 
remain circular (Kao and Liu, 2002). Also, the expression of keratocan is specific to the adult 
comeal stroma in mice (Liu et al., 2003). In humans, mutations to the gene encoding 
keratocan results in the formation of cornea plana and ultimately, decreased vision acuity 
when comeal curvature is flattened and the refractive properties are altered (Pellegata et al., 
2000). Investigations into the elucidation of keratocan’s role suggest that along with other 
keratan sulphate proteoglycans it is a potent modulator of collagen fibrillogenesis.
1.11.3 Mimecan
Mimecan is a 25kDa keratan sulphate proteoglycan that is transcribed from the same gene 
that encodes osteoglycin and is synthesised via proteolytic splicing and/or mRNA alternative 
splicing (Funderburgh et al., 1997). Similar to keratocan, it is only sulphated within the 
cornea and is expressed to a lesser extent in other tissues. Mimecan contains a lower 
incidence of the tandem leucine repeat motifs, only six compared with the ten of the other
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comeal SLRPs (Iozzo, 1997), and belongs to SLRP class III (Iozzo and Schaefer, 2008). On 
comparison with lumican and keratocan, a high level of sequence identity is not noticed. 
Structural domains within all three proteins are conserved, whereby each protein has one or 
more tyrosine residues situated next to acidic amino acids at their N-terminus (Funderburgh 
et al., 1997).
Collagen fibrils within the comeal stroma of mimecan-null mice are of a normal diameter and 
have regular interfibrillar spacing on average (Beecher et al., 2005). This evidence suggests 
that mimecan plays a role of lesser significance in the regulation of collagen flbrillogenesis 
than other keratan sulphate proteoglycans. However, Tasheva (2002) demonstrates that 
mimecan may modulate collagen flbrillogenesis and that in its absence, collagen fibril 
diameters increases in both skin and the cornea.
1.11.4 Decorin
Decorin was initially cloned from a human fibroblast cell line (Krusius and Ruoslahti, 1986) 
but has since been discovered localised in many other connective tissues. Like other SLRPs, 
it is a low molecular weight proteoglycan that contains a leucine rich 45kDa protein core and 
has a single glycosaminoglycan chain consisting of either chondroitin or dermatan sulphates. 
Decorin, unlike keratan sulphate proteoglycans, binds to the ‘d’ and ‘e’ loci of collagen fibrils 
(Scott, 1990) and was termed decorin due to its ability to 'decorate' collagen fibrils. It has 
been deduced that the sixth leucine motif within decorin is the major collagen type I binding 
site (Kresse et al., 1997) and recent evidence suggests that one molecule of decorin may 
interact with four to six collagen molecules (Orgel et al., 2009).
Decorin is proposed to be dimeric and each monomer folds into the curved solenoid 
characteristic of leucine rich domains with parallel p-sheets on the inside of the structure 
(Scott et al., 2004). Dimerisation occurs through the concave surfaces of the leucine rich 
repeat domains and the possible ligand-binding scenarios were reviewed by McEwan and 
colleagues (2006). Glycosaminoglycan attachment loci within decorin’s structure is located at
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a Ser residue in the N-terminal end situated proximal to the cysteine rich region (Iozzo,
1999).
Fig. 1.12 Ribbon diagram of the dimeric leucine rich repeat domain of bovine decorin. Green arrows -  0- 
strands, red ribbons -  a-helical turns, pink tubes -  polyproline II helix, orange ribbons -  3.10 helices and 
0-turns, yellow sticks -  disulphide bonds (Taken from Scott et al., 2004).
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Decorin is a multi-functional protein involved in diverse processes including the control of 
collagen fibril morphology (Danielson et al., 1997), cell adhesion and also the regulation of 
growth factors (Winnemoller et al., 1992, Yamaguchi et al., 1990). It has been established 
that in the absence of the decorin proteoglycan, collagen fibril diameters are increased when 
compared to fibrils that are associated with unglycanated decorin (Rada et al., 1993). Decorin 
has been shown to be involved in the delaying of collagen fibril lateral assembly and 
aggregation in vitro (Vogel et al., 1984). Evidence also suggests that the glycosaminoglycan 
chain of decorin may have a reducing affect on collagen fibril diameter, whilst the affinity of 
decorin to collagen fibrils is greater than that of glycosaminoglycan-deficient decorin 
(Ruhland et al., 2007). Kadler (1996) proposed that decorin may initiate the prevention of 
fibril lateral aggregation as early as in collagen biosynthesis, postulating that decorin may be 
secreted along procollagen molecules in their development within secretory vesicles.
Sufferers of Ehlers-Danlos syndrome display a lack of glycanated decorin, with 
approximately 50% of secreted decorin produced in patients is unglycanated. Ehlers-Danlos 
patients also exhibit the same skin-fragility that is displayed in decorin-null mice (Ruhland et 
al., 2007).
1.12 Proteoglycan -  Collagen Interactions
Scott (1991) proposed the idea that proteoglycans and collagen fibrils form part of a ‘shape 
module’ that is a major component responsible for the structural integrity of extracellular 
matrices. The ‘shape module’ consists of proteoglycans lying along the length of a collagen 
fibril and are bound non-covalently at specific attachment sites, in addition to the 
glycosaminoglycan chains that extend outward and form interfibrillar bridges with adjacent 
proteoglycans. The SLRP is considered to inhibit lateral aggregation of collagen fibrils and 
therefore, exists as a regulator of collagen flbrillogenesis. SLRPs exist in a horseshoe 
conformation whereby their respective glycosaminoglycans chains extend from the convex 
side, leaving the protein free to bind to fibrils and consequently restrict the lateral aggregation 
of collagen. The result of which is the formation of narrow diameter collagen fibrils that are 
necessary for the low level of light scattering in the cornea. Projecting out from the leucine 
rich repeat protein is a bound, highly anionic glycosaminoglycan chain that interacts with
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other protruding glycosaminoglycan chains facilitating the control of interfibrillar spacing. 
The interfibrillar anionic glycosaminoglycan bridges organise fibrils by ‘tying’ them 
together, bridging between and spanning fibrils, often several at a time (Scott and 
Thomlinson, 1998).
The SLRP core of a proteoglycan binds to certain axial locations of the collagen fibril, with 
one protein per binding site (Scott and Haigh, 1988a). Meek (1986) deduced that 
proteoglycans are situated at the ‘a’, ‘c’, ‘d’ and ‘e’ axial regions of collagen fibrils using x- 
ray diffraction methodology on bovine corneas. Scott (1991) expanded on the study; 
elucidating that keratan sulphate proteoglycans bind to the ‘a’ and ‘c’ regions whereas ‘d’ and 
‘e* bands accommodate CS/DS associated proteoglycans. Decorin therefore binds to ‘d’ and 
ke’ whereas lumican, keratocan and mimecan all bind to ‘a’ and ‘c’ sites due to the presence 
of their keratan sulphate glycosaminoglycan chain.
KSPG Binding SiteCS/DS PG Binding
Q u ar te r
Stagger
Collagen
V i
d
Fig 1.13 Representation of the proteoglycan-collagen binding sites. The quarter-stagger arrangement of 
collagen molecules is illustrated against the a-e banding pattern within the D-period. The proteoglycan 
locations are indicated across the quarter-s tagger region, correlating with the a-e banding pattern. 
Keratan Sulphate proteoglycans are  found positioned at the collagen bands ‘a ’ and ‘c’ whereas 
Chondroitin Sulphate and Dermatan Sulphate are  located at the ‘d ’ and ‘e’ positions (Adapted from 
Scott and Haigh, 1988a).
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Proteoglycans are also important for the balanced hydration of the corneal stroma. The highly 
anionic character of glycosaminoglycans means they have a high water binding capacity 
(Bettelheim and Plessy, 1975) and also attract counter-ions such as Na+ into the stroma, 
necessary for the correct hydration of the tissue. Mice deficient in corneal 
glycosaminoglycans often exhibit noticeably thinner corneas as a result of dehydration and 
the imbalance of water intake into the stroma (Chakravarti et al., 2000, Liu et al., 2003). The 
apparent alteration of proteoglycan biosynthesis can also have differing effects on the 
development of the cornea. Disruption in normal matrix formation can lead to opaque tissue 
and blindness, as is the case in macular cornea dystrophy. Corneal scars that have reduced 
transparency display highly sulphated CS/DS and a reduction in keratan sulphate indicating 
that defects in processing have implications in the development of transparency and the ratio 
of different proteoglycans (Funderburgh, 2000).
1.13 Corneal Transparency
The development of corneal transparency is fundamental to the functionality of the eye. 
Several models have been proposed as to how the cornea develops and maintains its clarity. 
Initially, it was proposed that the components of the corneal stroma exhibit uniform refractive 
indices (RI) which results in the minimal scattering of light and consequently conferring 
transparency (Leber 1903, Smith and Frame, 1969). Further investigation into the RI of 
collagen fibrils (Leonard and Meek, 1997) negated this theory, illustrating that collagen 
fibrils display a RI of 1.411 as opposed to the overall extracellular matrix RI of 1.365 which 
is significantly lower. Currently, the refractive index of keratocytes is unknown, although 
they are normally able to transmit light. However, evidence suggests that when keratocytes 
become active, normally through injury, and take the form of either fibroblasts or 
myofibroblasts, they display intense light scattering (Moller-Pedersen, 2004).
Caspersson and Engstrom (1949) first developed the idea that transparency may be a result of 
the regular arrangement of collagen fibrils, whereby individual scattered waves cause 
destructive interference in all directions with the exception of the forward direction. In his 
now seminal work, Maurice (1957) compounded the idea of lattice theory and the notion that, 
as a result of regular interfibrillar spacing with a lower magnitude than the wavelength of
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light, destructive interference of scattered light by individual fibrils occurs in all but the 
forward direction. The lattice theory proposes that the cornea appears transparent due to 
scattered light being projected only in the forward direction and therefore, light only enters 
through the primary visual axis (Maurice, 1957).
Maurice’s theory (1957) was modified by Goldman and Benedek (1967) as the lattice theory 
could not explain the transparency of the dogfish cornea. Their findings centred on 
Bowman’s layer, where a lack of fibril lattice-like arrangement scattered light less than the 
corneal stroma. It was deduced that transparency of Bowman’s layer was a result of the 
regular interfibrillar spacing in distances that reached half the wavelength of light. As a 
result, it was elucidated that only a short-range order of collagen fibrils is a pre-requisite for 
the destructive interference of scattered light (Goldman and Benedek, 1967, Farrell and Hart, 
1969).
Due to the nature of proteoglycan control of collagen fibrillogenesis, proteoglycans are 
fundamental to the development and maintenance of corneal transparency. Borcherding et al 
(1975) illustrated the differences between the concentrations of proteoglycans between the 
highly organised centre of the cornea and the opaque sclera. This finding is also compounded 
by the fact that an inability in humans to synthesize a mature keratan sulphate can result in 
the formation of corneal opacity (Hassell et al., 1980). Hassell et al (1980) also illustrated that 
keratan sulphate proteoglycans are uncommon in corneal scars, observing larger than normal 
interfibrillar spacing and a decrease in transparency that can be partially rectified by the re- 
introduction of keratan sulphate proteoglycans. Furthermore, it has also been indicated that 
stromal swelling can have a bearing on transparency due to the formation of water Takes’ 
(Benedek, 1971), causing disruption in the regulation of collagen interfibrillar spacing 
(Goodfellow et al., 1978). Corneal opacity will occur if the Takes’ containing no collagen 
reach or exceed half the wavelength of visible light (Benedek, 1971). As proteoglycans are 
involved in the attraction of counterions and the subsequent hydration of corneal tissue, any 
deficiency in proteoglycans can result in stromal hydration problems.
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Both collagen fibril diameter and centre-to-centre fibril spacing are pivotal in the 
development of comeal transparency due to their scattering properties. Each collagen fibril, 
although they are the main scattering element within the cornea, is deemed to be ineffective 
at scattering light due to the narrow diameters they exhibit (McCally and Farrell, 1999). The 
size of the fibril diameter is much smaller than the wavelength of light (400-700nm) and if 
they were effective at scattering light the tissue would become opaque. At the early stages of 
development, both cornea and sclera are transparent and display relatively similar collagen 
diameters. Differences in fibril diameters between the tissues increases as the sclera tissue 
increasingly becomes more opaque (Smelser and Ozanics, 1959). The extent of fibrillar 
collagen within the cornea also requires destructive interference of scattered light in order to 
allow for transparency. Independent fibril scattering would result in a greater incidence of 
constructive interference (Freund et al., 1995) and subsequently defects in transparency. 
There is also the requirement to minimalise the size of the actual comeal tissue as the 
thickness dictates the amount of light scattering that occurs (Scott and Bosworth, 1990).
Farrell (1994) proposed a model which is currently the most widely accepted theory relating 
to comeal transparency. It states that comeal transparency at a given light incident 
wavelength, X, relies on several factors that include fibril density packing, p, the diameter, a, 
of the collagen fibrils, the ratio, m, between the “ground substance”, «g, and collagen’s 
refractive index, nc, as well as the angle of scattered light, 0, and also the relative positions of 
fibrils to each other and the thickness of the cornea.
1.14 Stromal Hydration
The endothelial monolayer serves as a passage for nutrient uptake and waste removal in and 
out of the stroma whilst it also secretes fluid, counteracting the continuous leak of fluid into 
the stroma through ion transport (Bonanno, 2003). Maurice (1972) illustrated that the 
endothelium was responsible for 90% of the fluid transport into the rabbit cornea. Stromal 
polysaccharides, including keratan, dermatan and chondroitin sulphate, have several sulphate 
and carboxyl groups that are responsible for the binding of cations as well as hydration; the 
anionic glycosaminoglycan extensions are functionally important in stromal swelling due to 
their hydration properties (Hedbys et al., 1963). Enzymatic degradation of individual
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glycosaminoglycans reduces the swelling pressure according to the glycosaminoglycan 
concentration (Maurice and Monroe, 1990).
Fluid uptake into the stroma occurs as a result of the ionic permeability of the endothelium as 
well as the presence of hydrophilic glycosaminoglycans responsible for the swelling pressure 
within the corneal stroma. Transendothelial transport results in the removal and uptake of 
ions to and from the aqueous humor. However, there is no net fluid intake into the stroma due 
to the active secretion and active counter-balance of fluid by action of the ‘pump-leak’ 
mechanism (Maurice and Giardini, 1951). The pump that forces fluid out of the stroma is also 
situated within the endothelium. The pump-leak mechanism, and essentially the endothelium, 
is therefore believed to modulate corneal hydration and the water balance between the 
aqueous humor and cornea.
Corneal thickness and transparency are both dependent on the regulation of corneal stroma 
hydration. A reduction in endothelial ion transport activity results in a loss of corneal 
transparency and impaired vision (Bonanno, 2003). Initially, it was postulated that the 
swelling pressure of the stroma was a result of the presence of excess ions in the aqueous 
humor (Maurice and Giardini, 1951). Maurice (1951) indicated that a difference in electrical 
potential, a result of excess ion transport across the endothelium, allows ions of the opposite 
charge (Na+, K+, Cl" or HCO3 ) to achieve electrochemical equilibrium across the endothelial 
cell layer. The epithelium is also involved in fluid transport through the cornea, absorbing 
nutrients from the tear fluid due to the avascular nature of the cornea. Klyce (1977) 
demonstrated that the epithelium can contribute to fluid transport when the Cl" transport was 
stimulated by p-adrenergic agonists by way of increased cAMP.
1.14.1 Leak
Swelling pressure within a charged gel is created by ion imbalance, described by the Donnan 
effect. Hodson (1993) compounded earlier studies by establishing a relationship between the 
magnitude of the swelling pressure and charge density within the stroma over a range of 
hydration, a result of which was accounted for by the Donnan effect. The Donnan effect
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describes the behaviour of charged particles which do not distribute evenly across a 
selectively permeable membrane. Hodson (1993) also found that the ratio of concentrations 
between Cl" in the stromal tissue and the aqueous humor was different for Na+ and added 
lactate, believed to be the result of an unknown ligand binding Cl' transiently. The fixed 
charge density within stromal tissues can be attributed to the glycosaminoglycan chains of 
proteoglycans as well as the ion contribution. It has been found that glycosaminoglycan 
synthesis is according to the oxygen level within the tissue, a function of the thickness, 
varying from species to species (Scott and Bosworth, 1990).
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Fig 1.14 Schematic representation of transendothelial H C 0 3 '  transport  (Taken from Bonanno, 2003).
1.14.2 Pump
Investigations into the endothelial pump have focused primarily on the role of the bicarbonate 
ion as the prime mover in fluid transport. Several studies (Doughty and Maurice, 1988, 
Kuang et al., 1990) measured the fluid transportation across endothelium - stromal 
preparations in the absence of high bicarbonate concentrations with significant results,
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challenging the importance of the bicarbonate ion. However, Sanchez (2002) showed that 
fluid pumping is maintained by both bicarbonate transport and sodium recirculation through 
apical Na+ channels. In order to control hydration and ultimately thickness of the tissue, it is 
believed that a set of receptors would be needed to control the active system, modulating 
endothelial pump activity and identifying the hydration levels of the tissue. No mechanism 
has been identified as of yet although several membrane proteins, such as adenosine and 
acetylcholine receptors (Walkenbach and Chao, 1985, Lind and Cavanagh, 1995) have been 
implicated in possible roles of cAMP regulation and stromal hydration control.
1.15 Gene-targeting
Gene knockout mice can help us establish the roles of functionally important molecules such 
as proteoglycans. Transgenic animals have induced modifications to their genome whereby 
an endogenous sequence is changed in embryonic stem (ES) cells. Valid assumptions 
concerning protein structure and functionality can often be made on the basis of what is 
evident in the absence of that specific protein.
Gene-targeting involves interrupting the gene that encodes a specific protein in order to 
remove its expression. In mouse embryonic stem cells, the endogenous gene of interest is 
disrupted and replaced with a DNA construct containing a selectable marker gene 
(Doetschman et al., 1987, Thomas and Capecchi, 1987). This method favours positive 
selection of transfected ES cells as the integrated gene is not transcribed.
DNA is introduced into ES cells by subjecting them to an electrical potential which disrupts 
the cell membrane -  enabling exchange between cellular components and the culture that 
surrounds it. It is also necessary for the DNA construct to contain identical flanking target 
sequences as the endogenous gene so as to produce homologous recombination. The 
transfected cells are inserted into the uterus of a foster carrier and the offspring are mated in 
order to produce a homozygous breed of mouse.
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1.15.1 Mice Proteoglycan Knockouts
Several studies have investigated the result of specific corneal proteoglycan-null mice, 
elucidating that collagen fibrillogenesis is affected with proteoglycan removal in most cases. 
Analysis into the collagen-proteoglycan association three-dimensionally in knockout mice 
may offer a valuable insight into the functionality of proteoglycans and whether any 
compensatory mechanisms occur in their absence. In the absence of components that form the 
‘shape module’, induced by genetic manipulation, extracellular matrices do not form ordered 
tissue. Investigations into the organisation of corneal collagen in proteoglycan knockouts 
have been carried out extensively, although the interpretation of collagen order is mostly 
carried out via X-ray diffraction analysis. Using electron tomography as a visual tool we may 
be able to elucidate the role of proteoglycans in the collagen meshwork to a greater extent.
Chakravarti (1995) established the position of the gene encoding lumican and also developed 
lumican-deficient mice that exhibit a high degree of collagen disorder and corneal 
opacification as a direct result (1998). The 1 lkb gene encoding lumican localises to the same 
region as the decorin gene on distal mouse chromosome 10 (Iozzo and Murdoch, 1996) and 
so detection of decorin expression is necessary in order to evaluate whether or not the decorin 
gene has been disrupted in the process of lumican gene knockout. Lumican, similarly to 
keratocan, is encoded on a 6.5kb gene in mice whereby three exons are responsible for the 
transcription of the lumican mRNA.
Mimecan was initially isolated in truncated form from bovine bone (Madisen et al., 1990) and 
found to be part of the SLRP family of proteins. The single copy gene that encodes mimecan 
is situated on chromosome 9q22 in humans (Tasheva et al., 2002); transcription of the gene 
produces 8 mRNAs and its homology is conserved throughout mice, bovine and humans 
(Tasheva et al., 1997). The evolutionary conservation may serve as an indicator of mimecan's 
functional importance. Although it is currently unclear as to how mimecan exerts it biological 
function, it is suggested that mimecan plays a part in cellular growth control due to the ability 
for growth factors and cytokines to regulate its mRNA expression in comeal keratocytes 
(Long et al., 2000).
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The gene encoding keratocan in mice spans 6.5kb of the genome and contains three exons 
and two introns (Liu et al., 1998). The second exon is responsible for encoding all ten of the 
leucine repeats. Keratocan has been found to be expressed more selectively than other SLRPs 
such as lumican, being transcribed almost solely within the cornea. Interestingly, keratocan 
mRNA can be found to be expressed within corneal keratocytes but not in sclera cells. Both 
keratocan and lumican genes found on the mouse distal chromosome 10 are deficient of a 
TATA box -  an indication of how closely related they actually are (Ying et al., 1997).
The decorin gene exists at the 12q23 locus in humans. The high conservation of the decorin 
protein core when compared to homologous proteins in other species compounds the general 
assumption of the functional importance of this molecule. Decorin is found localised within 
many connective tissues other than the cornea and highly ‘decorates’ fibrils and is therefore 
seen as an important molecule for the order of the extracellular matrix. A mutation in the 
gene encoding decorin within humans, 12q22 , causes congenital stromal dystrophies, 
indicative of decorin’s role in stromal morphology (Bredrup et al., 2005).
1.16 Electron Tomography
The idea of using three-dimensional reconstructions for the elucidation of ultra-structural 
details at high-resolution was first described in 1968 (DeRosier and Klug, 1968). Electron 
tomography is a high resolution methodology for reconstructing the interior of an object from 
the two-dimensional projections collected at varying angles, rotated around a single or dual 
axis, using transmission electron microscopy. The electron beam within an electron 
microscope is fixed, and so the specimen holder is tilted around a single axis in order to 
create a tilt series. The projections are then collected from the specimen the micrograph 
images are then used to reconstruct the desired object in its entirety through a back-projection 
algorithm (Frank, 2006).
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1.17 Aims and Objectives
The aim of this project is to achieve a greater understanding of the organisation of 
proteoglycans in the mouse corneal stroma and their role in collagen fibril assembly. A 
clearer comprehension of collagen-proteoglycan association and proteoglycan morphology 
will enable us to elucidate how proteoglycans regulate collagen fibril architecture in the 
corneal stroma extra-cellular matrix and therefore, understand more clearly how corneal 
transparency is achieved. Elucidating collagen-proteoglycan interactions in the wild-type 
mouse corneal stroma will provide a basis for interpreting the effects on collagen 
organisation in proteoglycan altered mouse corneas.
Specific aims:
• To visualise the organisation of proteoglycans in the wild-type mouse cornea three- 
dimensionally
• To understand the role of sulphation of proteoglycans and how it affects packing of 
proteoglycans
• To achieve a greater understanding of how proteoglycans regulate the uniform collagen 
architecture in the comeal stroma
4 6
Chapter 2 -  Materials and Methods
2.1 Introduction
The methods detailed within this chapter were used to obtain three-dimensional 
reconstructions of collagen-proteoglycan associations in the mouse corneal stroma of wild- 
type and genetically manipulated mice. From the reconstructions, it is possible to ascertain 
proteoglycan dimensions as well as their three-dimensional conformations, allowing us to 
elucidate proteoglycan organisation in the mouse cornea. Digestion with specific 
glycosaminoglycan degrading enzymes reveals the identity of proteoglycans present in the 
different corneal specimens used. Utilising these techniques enabled a clear definition of 
specific proteoglycan organisation in the cornea, which provides a basis for the understanding 
of how proteoglycans regulate collagen fibril architecture. Image analysis was carried out 
using ImageJ, which allowed for the measurement of proteoglycan dimensions, fibril 
diameters and the calculation of radial distribution functions.
Both conventional electron microscopy and electron tomography was carried out on a JEOL 
1010 transmission electron microscope operating at 80kV with a Gatan ORIUS SC 1000 CCD 
camera attached.
The methodologies are subdivided into sample preparation and staining, enzyme digestion, 
transmission electron microscopy, image alignment and segmentation -  the steps required for 
the generation of three-dimensional reconstructions.
2.2 Corneal Sample Collection and EM Preparation 
Materials
0.05% Cuprolinic Blue (0.0 lg)
2.5% Glutaraldehyde (2ml)
25mM Sodium Acetate (20ml, pH5.7)
0.1M MgCl2
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Aq. 0.5% Sodium Tungstate 
Ethanol (50%, 70%, 90%, 100%)
Mature, wild type (CD1 and C57BL/6) mice were obtained from Cardiff School of 
Biosciences, Cardiff University and their corneas were dissected in half to be fixed and 
stained accordingly. Eyes were removed within 5 minutes post-mortem after carbon dioxide 
anaesthesia and cervical dislocation. Animals were treated in accordance with the ARVO 
statement for the Use of Animals in Ophthalmic and Vision Research as well as local 
regulations at all times.
Chst5-nu\\ mice were bred and kindly provided by Professors Kohji Nishida (Osaka 
University) and Tomoya Akama (Sanford-Bumham Medical Research Institute). Lumican- 
null mice were collected from the lab of Dr. Shukti Chakravarti at Johns Hopkins School of 
Medicine, Baltimore and treated in exactly the same way as the wild-type mice detailed 
below.
In order to visualise the corneal proteoglycans, half mouse corneas were fixed for 24 hours in 
2.5% glutaraldehyde in 25mM sodium acetate buffer (pH5.7) with 0.1M M gC^and 0.05% 
Cuprolinic blue (Quinolinic phthalocyanate), a cationic dye for characterisation of 
proteoglycans (Scott and Haigh, 1988a). Glutaraldehyde was used to fix and preserve the 
tissue, helping to maintain the position and shape of the collagen and proteoglycan matrix. 
The samples were then rinsed three times with sodium acetate buffer (pH5.7) for ten minutes 
each and subjected to subsequent washes with aqueous 0.5% sodium tungstate, also for three 
ten minute periods. After rinsing, the samples were dehydrated using 50% ethanolic tungstate 
(0.5%) initially, followed by 15 minute washes in an incremental ethanol series (70%, 90%,
100%). Ethanolic tungstate was used to increase the electron density of Cuprolinic blue and, 
in turn, enhance the contrast of proteoglycan-dye complexes in electron microscopy.
Cuprolinic blue is an electron dense cationic dye which has a high affinity for the highly 
negative charge component of proteoglycans; the glycosaminoglycan side chain. The electron 
density of the stain is attributed to the presence of a Cu+ ion. The corneal samples were
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subject to a critical electrolyte concentration staining method (Scott and Haigh, 1988a) which 
allows us to visualise the proteoglycans as electron dense elongated, filament-like shapes. 
MgCh, a negatively charged salt, is also used to inhibit Cuprolinic blue staining on certain 
polyanions. The concentration we shall use is 0.1M MgCh, which is the concentration 
required for the prevention of Cuprolinic blue staining of a given polyanion, notably 
carboxylates (COO ), phosphate esters (P 04') and sulphate esters (S04‘) as they are prevalent 
within the cornea.
Cupromeronic blue, another cationic dye for staining of proteoglycans, was used in order to 
compare and contrast the two dyes performance and whether or not any proteoglycans were 
left unstained in either treatment. Initial analysis alluded to the fact that both dyes exert 
similar properties and stain glycosaminoglycan chains as effectively as each other; any 
differences were negligible. Although the critical electrolyte concentration (MgCh) was 
altered to 0.3M according to Scott (1988a).
2.2.1 Enzyme Digestion 
Materials
Chondroitinase ABC (2.5U/ml)
Keratanase II (lU/ml)
1 % Paraformaldehyde 
Tris/sodium acetate buffer (pH 8)
To reveal the specific identity of proteoglycans in various comeal specimens, 
glycosaminoglycan-degrading enzymes were used; namely chondroitinase ABC (from 
Proteus Vulgaris) and keratanase II (isolated from Bacillus sp.). Chondroitinase ABC cleaves 
chondroitin sulphate/dermatan sulphate proteoglycans and, in mouse corneas, removes the 
majority of proteoglycans, whereas Keratanase II is responsible for targeting keratan sulphate 
associated proteoglycans (Young et al., 2005). Chondroitinase ABC cuts the p i-4 N- 
acetylhexosaminidic link to either D-glucuronic acid and L-iduronic acid, however 
keratanase II cleaves the p i-3 glucosaminidic linkages to galactose of keratan sulphate
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glycosaminoglycans where the disaccharide sequence may be mono- or di-sulphated 
(Quantock et al., 2010).
As the proteoglycan population of the wild-type and C/w/5-null mouse corneal stroma was 
deduced via enzyme digestion by Young and colleagues (2005) and Hayashida et al (2006) 
respectively, only lumican-null corneas required enzyme treatment to determine the nature of 
proteoglycans observed in electron microscopy. Excised corneas were dissected in quarters 
and prefixed with 1% paraformaldehyde to be washed with lU/ml tris/sodium acetate buffer 
(pH 8), with one cornea to remain in the buffer as a control. Chondroitin sulphate/dermatan 
sulphate proteoglycans were removed initially, whereby one cornea was incubated in 2.5 
U/ml chondroitinase ABC (Sigma Aldrich) for 4h at 37°C, whereas Keratan sulphate 
associated proteoglycans were degraded by treating another cornea with 1 U/ml keratanase, 
also for 4h at 37°C. To remove both types of proteoglycans, a combination of both enzymes 
was used and subject to the same temperature and duration. Samples were then fixed and 
proteoglycan-stained with Cuprolinic blue to be embedded for electron microscopy as 
detailed in 2.2.2.
2.2.2 Resin Embedding
Materials
Propylene Oxide 
Araldite Monomer CY212 
DDSA Hardener 
BDMA Accelerator
After the initial fixation and staining of glycosaminoglycan chains, the samples were exposed 
to a series of dehydration steps in 70%, 90% and 100% ethanol. An intermediate treatment of 
Propylene oxide (PO2) and 100% ethanol for 15 minutes was used prior to two treatments of 
only P 02 for 15 minute intervals to ensure dehydration. Samples were then put into a mixture 
of 50% araldite resin and PO2 for an hour before a 100% araldite resin treatment, also for an 
hour period. The specimens were then transferred to another araldite resin treatment where
50
Chapter Two - General Methods
they were left for 12 hours being rotated gently. The araldite monomer and hardener are 
required to be pre-warmed in order to facilitate the easy, fluid measuring and pouring of 
araldite. The corneal samples were then inserted into moulds containing fresh araldite which 
was allowed to polymerise and form embedding moulds at 60°C for 48 hours. Polymerised 
blocks containing the half mouse corneas were then sufficiently hardened for glass knife 
sectioning.
2.2.3 Polyetherimide Support Films 
Materials
Ethylene Dichloride (1,2 -  Dicholoroethane) solution 
Polyetherimide granules 
Microscope Slides 
Water Bath 
Detergent
EM slot grids (2mm x 1mm)
Coplin Jar
Support films were made using 0.38% polyetherimide (PEI)
0.76g of PEI granules were dissolved in 200ml of ethylene 
approximately 72 hours. Microscope slides, wiped with detergent to ensure a clean side and 
also to coat a hydrophobic layer, were dipped into coplin jars containing PEI solution for 
approximately 20 seconds and then left to dry within the fume hood. After being left to dry in 
a desiccated area, the slides coated with PEI were scored along each edge with a razor-blade 
forming a rectangle and drawn off in a water bath. Grids (TAAB 2mm x 1mm slot) were 
placed shiny side up on the floating film which was then attached to another slide coated with 
PEI. The slides covered with grids were then left to dry for a few hours and lifted off gently 
with forceps.
in ethylene dichloride solution, 
dichloride and left to stand for
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2.3 Sectioning 
Materials
Reichart-Jung Ultracut Microtome 
Leica EMKMR2 Glass-cutter 
Glass
De-ionised Water 
Chloroform
Araldite resin embedded mouse corneal specimens were sectioned using glass knives on a 
Reichart-Jung Ultracut ultra-microtome and attached to the PEI film which was suspended in 
a 2mm x 1mm slot of a 3.05mm copper grid. Glass knives were obtained by using a Leica 
EMKMR2 glass cutter (Leica, Austria). Knives were tilted at 6° for cutting and sections were 
carefully cut using areas of the knife that did not appear to be serrated due to stress fracture 
occurrence when knives were created. Tape was carefully put from edge to edge at the top of 
the knife and sealed with wax to create a small water bath that allowed sections to be 
collected upon slicing with the knife. De-ionised water was pippetted into the bath and 
sections collected were placed onto the support film slot of the grids. Sections cut on the 
Reichart ultra-microtome approximately 90nm thick and gold in colour were lifted onto the 
PEI coated grids after being stretched out with chloroform. Initially, semi-thin (500nm) 
sections were obtained and transferred to a microscope slide using a single hair. The semi- 
thin sections were stained with toluidine blue which allowed us to check under the light 
microscope whether the tissue was adequate for visualisation using the electron microscope.
2.3.1 Section Staining and Gold Fiducial Markers
Materials
2% Uranyl Acetate 
1 % Phospho-tungstate Acid 
lOnm Colloidal Gold
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For the contrast enhancement and definition of collagen fibrils within the sections cut, 2% 
uranyl acetate (UA) and phospho-tungstic acid (PTA) were used as negative stains. Gold 
fiducials work as markers for the plane in which the specimen is lying when applying the 
computer analysis part of electron tomography. Fiducials also enable the tracking of the 
specific region desired when proceeding with each individual tilt in the series. As we were 
expecting to work at magnifications of approximately x20k-x30k, lOnm diameter fiducials 
were the most appropriate gold markers to use.
To coat the grids with the staining solutions, droplets of UA, PTA and distilled water (x4 for 
each stain) were aligned on top of parafilm-covered distilled water, large enough for the grids 
to sit on top. Grids were placed face down and left for 2 minutes in PTA, 2 minutes each on 
four drops of distilled water, followed by 12 minutes in UA and a further 2 minutes each on 
four more droplets of distilled water.
After the staining treatments, grids were dipped into water approximately 30 times and then a 
steady flow of water was streamed onto the grid to wash any excess stain. The grids were 
then left to dry where they were then subject to gold fiducial staining in order to create the 
three-dimensional reconstructions. Similar to the UA, PTA staining technique, gold fiducial 
solution was pippetted into small (10pL) droplets onto water-covered parafilm. The grids 
were then placed face-down onto a single droplet for 20 seconds and then placed on a new 
droplet, face-up for a further 20 seconds. Once dried, the sections on the PEI support film 
grids were ready to be analysed using TEM.
2.4 Electron Microscopy and Electron Tomography
Transmission electron microscopy (TEM) is a powerful imaging tool that allows the user to 
visualise macromolecular organisation both inside and outside the cell, two-dimensionally. 
The first electron microscope was built in 1931 by Ernst Ruska and Max Knoll and although 
it was not capable of the high resolutions we can achieve today, it laid the foundations for the 
field of electron microscopy. Electron microscopy, as the name suggests, uses a highly 
charged beam of electrons to illustrate the composition of the specimen that is to be
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investigated. The electron beam is focused onto the specimen and the resulting image is 
projected using a charge-coupled device (CCD) camera according to the scattering of 
electrons. Electrons are used as opposed to light as they are known to have a much shorter 
wavelength. The de Broglie wavelength of an electron is much smaller than that of a photon 
of light and this allows the electron microscope to achieve much higher resolutions than a 
light/confocal microscope.
The electron microscope is composed of magnetic lenses and metal apertures that are 
necessary for the focusing and restriction of the size of the beam. An electron source is used 
which creates a beam of monochromatic electrons that is accelerated by a positive electric 
potential. The electrons transmitted penetrate the specimen, illuminating a phosphorescent 
screen/CCD camera that depicts the content of the sample. However, TEM only permits two- 
dimensional illustration of a sample and so we must use the goniometer attached to the 
microscope to create a tilt series from a number of pictures taken at incremental degrees in 
order to create a three-dimensional reconstruction.
Electron tomography is a high resolution methodology for reconstructing the interior of an 
object from the projections collected using electron microscopy. The electron beam within an 
electron microscope is fixed, and so the specimen holder is tilted around a single axis, by one 
degree increments, in order to create a tilt series. The series of tilts is aligned into a stack and 
subjected to back-projection in order to generate a three-dimensional reconstruction (Frank, 
2006). Electron tomography enables the assembly of a reconstruction of detailed three- 
dimensional structures whereby the electron microscope collects the initial two-dimensional 
data. The electron beam is passed through the sample at incremental degrees of rotation 
around the centre of the sample. The resolution of electron microscopes is at the nanoscopic 
scale and therefore, supra-molecular organisation and multi-protein structures, such as 
collagen, can be examined and reconstructed three-dimensionally.
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2.4.1 Radial Distribution Functions
The extent of collagen fibril order in the corneal stroma may be calculated through examining 
radial distribution functions of their cross-sectional profiles in electron micrographs. Initially, 
a single reference fibril is selected and the interfibrillar distances of surrounding fibrils in a 
square region of interest are measured using ImageJ. Measurements are based on the pixel 
size of each image, which is 0.33nm per pixel for an image captured at 20kx magnification. A 
frequency plot of these interfibrillar distances with respect to the reference is determined 
through in-house software and is normalised to account for the number of fibrils that 
diminishes as the distance from the reference increases. Each fibril is then used as a reference 
and then all frequency plots are summed together in turn. The radial distribution function 
describes the order of lateral distribution of collagen fibrils and whether order exists past 
neighbouring fibrils and indicates what organisation of fibrils is required for corneal 
transparency. However, electron microscopy preparation, including fixation and staining, 
may affect the native fibril characteristics such as diameter and interfibrillar spacing. For 
more accurate measurements, x-ray diffraction offers precise insights into fibril organisation 
of the cornea.
Radial distribution functions for human (Freund et al., 1995), rabbit (Connon et al., 2003, 
Freund et al., 1995) and chick (Connon et al., 2004) corneas all suggest a short range ordering 
of collagen fibrils in the comeal stroma. Interfibrillar distances are maintained with 
considerable uniformity between neighbouring fibrils and so a prominent first peak is 
expected to indicate a distinct probability of two fibrils being in close proximity of between 
40-60nm. Each distribution function appears to be defined by a second, less prominent peak 
suggesting that order exists, although, it does not appreciably extend past next-nearest 
neighbours at approximately 90nm. As a perfect lattice is not required, these radial 
distributions imply that short range ordering of fibrils in the stroma is enough to fulfill the 
requirements for the tissue's transparency
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Fig 2.1 Jeol 1010 Electron Microscope
2.4.2 Tilt Series
Using the goniometer, we were able to create a tilt series of images from -  60° to + 60° 
rotation of the specimen. In order to be able to create the series, the axis of the sample is 
required to be aligned and centred so that the increments are at proportional degrees. Due to 
the fact that the electron beam is obstructed by the specimen holder after 60°, we are unable 
to reconstruct the full volume in its entirety. This experimental restriction is known as the 
'missing wedge’ and occurs as a direct result of not being able to tilt the specimen a full 180°. 
At every degree increment, we are required to return the image to the same position to that 
which is seen in the previous micrograph captured a degree before. This is achieved by 
marking a contour around a fiducial or group of fiducials that can be easily traced and 
returning the contour to its original position after every increment. Modern microscopes are 
capable of automated tomography, whereby tracking of the specimen and subsequent 
capturing of micrographs at each increment is completely automated; sections are preserved 
to a greater extent as they experience a lower dose of radiation due to the speed of 
automation.
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Collection of a Dual axis tilt series data set offers improved resolution in the reconstruction 
as the size of the ‘missing wedge’ is reduced. Although, analysis of a reconstruction 
generated through a dual axis tilt series showed no qualitative differences in the ultrastructure 
o f  the corneal stroma when compared with a reconstruction obtained from a single axis data 
set. Therefore, single axis tilt series were collected for all specimens as there is significantly 
reduced irradiation of the plastic section, and image file sizes were also greatly minimised 
and much more manageable on desktop computer systems.
2.4.3 Alignment of Tilt Series
Once the 121 micrograph images are obtained, they are required to be converted from TIFF 
images into a .mrc file extension and also into an image stack with the file extension .st. The 
.st file extension is created as the eTOMO alignment program requires files of this type. The 
file conversions are carried out using the programs tif2mrc and newstack, respectively. 
Tif2mrc and newstack are programs within the IMOD software package. IMOD is a set of 
image processing, modelling and display programs that enable tomographic reconstruction of 
an object. IMOD is an open source program that is developed by the Boulder Laboratory for 
3D electron microscopy of cells at Colorado University (Kremer et al., 1996). The end .st file 
is then inputted into the eTOMO program, a sub-program of IMOD.
The eTOMO program within IMOD enables the user to input their stack of images and 
through a series of alignment steps, a final tomogram is generated. The images are subject to 
coarse/fine alignment and tomogram positioning which results in the final tomogram that can 
also be post-processed within eTOMO. Alignment is computed through the tracking of 
fiducial markers and so the even distribution of fiducials in the specimen is paramount to 
acheiving a good alignment of images that is not skewed in any way. Once coarse alignment 
is calculated, fine alignment is computed through an iterative process and then tomogram 
positioning is processed by analysing sample tomograms. When the final stack is aligned, the 
eTOMO program generates a final tomogram which is a three-dimensional reconstruction of 
the initial two-dimensional micrograph. When creating the final tomogram, eTOMO uses 
back-projection to effectively ‘smear’ the aligned images onto each other to create a
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reconstruction that allows the user to penetrate through the three-dimensional stack of
images.
Fig 2.2. Screenshot of eTOMO program illustrating the fine alignm ent stage and the 0° m icrograph with 
contours around fiducials for alignment.
2.4.4 Segmentation o f Three-Dimensional Reconstruction
The final tomogram is a stack of images that represents the three-dimensional conformation 
of the object in question. The tomogram, similar to a micrograph, is greyscale format and by 
nature, it is difficult to interpret. In order to make the tomogram more meaningful and easier 
to analyse, we draw on each individual image in the stack in the segmentation process.
Segmentation of the wild type mouse cornea was carried out using EM3D, a software 
program for electron microscope tomography developed at Stanford University, USA (Ress 
et al., 2004). It is also possible to create a reconstruction in EM3D from the alignment 
calculated in eTOMO. The EM3D program requires contours to be selected around an object 
to be segmented manually. Once each image has been segmented, the image is rendered and a 
model of the object can be visualised in its entirety. Segmentation and modelling allows us to
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analyse a much more meaningful image that can be interpreted and manipulated with greater 
ease than a two-dimensional greyscale image or tomogram.
CoortftMHesdmi): 173 0.170,14.5
Fig 2.3. Screenshot of the EM3D program  and  the segm entation process. Three-dimensional 
reconstruction of the posterior region of the Chst5-nuU  mouse corneal strom a.
2.4.5 Measurement o f Proteoglycan Dimensions
Proteoglycan dimensions have previously been measured from conventional two-dimensional 
micrographs (Scott, 1992, Muller et al., 2004), which may be erroneous due to the fact that 
they may have been cropped or could be running obliquely through the section. It is possible 
to bypass these inaccuracies by consulting the three-dimensional reconstruction and 
determining which proteoglycans are wholly contained within the section and are suitable for 
measurement. Measurements are carried out using ImageJ after calibration using the 
characteristic collagen fibril D-period (approximately 65nm) and are based on an individual 
pixel size of 0.33nm from an image of 20kx magnification.
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3.1 Introduction to Chapter
Models proposed to describe the precise arrangement of proteoglycans in the cornea suggest 
a six-fold symmetrical order around collagen fibrils (Maurice, 1962, Farrell and Hart, 1969, 
Muller et al., 2004). Structural observations made from conventional two-dimensional 
micrographs may be misleading however, as they do not offer a true representation of 
proteoglycan organisation in three-dimensions. Moreover, recent evidence has suggested that 
proteoglycans in the mouse cornea vary in morphology and are undersulphated when 
compared to other mammalian corneas (Young et al., 2005). It is therefore necessary to 
obtain a more detailed understanding of proteoglycan morphology and organisation in the 
wild-type mouse corneas, so that observations made when studying proteoglycan-knockout 
mice can be successfully interpreted, and in some cases, related to a human disorder. Electron 
tomography allows for the internal three-dimensional reconstruction of comeal collagen 
fibrils and proteoglycans at a high resolution, offering potential new insights into the complex 
matrix assembly of the comeal stroma. Therefore, three-dimensional reconstructions of the 
anterior, mid and posterior mouse comeal stroma were obtained to re-evaluate the 
proteoglycan arrangement in the wild-type mouse cornea. Image analysis from electron 
micrographs verified with three-dimensional reconstruction data also enables the evaluation 
of proteoglycan and collagen fibril characteristics in the mouse comeal stroma.
In this chapter, methods used to obtain three-dimensional reconstructions of collagen- 
proteoglycan interactions in the cornea are detailed and used as a platform to suggest 
potential mechanisms of fibril control exerted by the proteoglycans.
3.2 Introduction
The relatively small diameters of collagen fibrils and their uniform interfibrillar spacing in 
the stroma are essential to the physical basis of comeal transparency. This is exemplified by 
the remarkable regularity of comeal collagen fibril diameter across a wide range of species
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(Craig and Parry, 1981, Craig et al., 1986). As discussed in Chapter One, type V collagen 
limits lateral aggregation of collagen (Birk et al., 1990) and can therefore govern fibril 
diameter, as can proteoglycans with or without their glycosaminoglycan chains (Rada et al., 
1993). However, how proteoglycans regulate the uniform interfibrillar spacing is less well 
understood. New evidence suggests that a systematic six-fold arrangement of proteoglycans 
is not present, and it is postulated that the proteoglycans govern interfibrillar spacing through 
a combination of thermal motion and a control of osmotic pressure instead (Lewis et al., 
2010, Knupp et al., 2009). Elucidation of proteoglycan organisation in the mouse corneal 
stroma may help to compound these studies.
It is also possible to determine the spatial distribution of fibrils in the corneal stroma by 
calculating their radial distribution function from electron micrographs, as has been done for 
human (Connon et al., 2003) and rabbit corneas (Connon et al., 2000). Short-range order of 
neighbouring fibrils has been shown to correspond with the onset of transparency and proper 
formation of the developing avian cornea (Connon et al., 2004), and by determining the radial 
distribution function for fibrils in the mouse corneal stroma, it is possible to ascertain whether 
order extends beyond next-nearest neighbours.
The mouse comeal stroma extracellular matrix differs from other mammalian corneas as its 
proteoglycans are distinctly undersulphated, and a significant proportion of its chondroitin 
sulphate/dermatan sulphate is present as dermatan sulphate (-60% (Scott and Bosworth, 
1990)). It also has the highest ratio of iduronateiglucuronate disaccharides within dermatan 
sulphate (Scott and Bosworth, 1990). Moreover, only 18% of the total glycosaminoglycan 
content within the mouse comeal stroma is present as keratan sulphate (Scott and Bosworth, 
1990), significantly lower than in the thicker corneas of larger mammals, where keratan 
sulphate associated proteoglycans are the predominant type. In the mouse cornea, production 
of chondroitin sulphate/dermatan sulphate is likely to be preferentially facilitated by the 
availability of oxygen by diffusion from the atmosphere into the thin mouse comeal stroma 
(Stockwell and Scott, 1965).
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For this investigation, we utilised three-dimensional reconstructions of the mouse cornea in 
order to gain a better understanding of collagen-proteoglycan organisation in the stroma. 
From structural information revealed through electron tomography we suggest mechanisms 
through which the organisation of collagen architecture and regulation of interfibrillar 
spacing by proteoglycans might be maintained.
3.3 Materials and Methods
3.3.1 Specimen Collection
Mature, wild type CD1 mice were obtained from breeding colonies at the School of 
Biosciences, Cardiff University, and eyes removed within 5 minutes post-mortem after 
carbon dioxide asphyxiation and cervical dislocation. Corneas were immediately excised for 
fixation and staining and animals were handled in accordance with the ARVO Statement for 
the Use of Animals in Ophthalmic and Vision Research and local regulations at all times.
3.3.2 Specimen Preparation
Corneas were cut into halves with a scalpel and fixed for 24 hours in 2.5% glutaraldehyde in 
25mM sodium acetate buffer (pH5.7) with 0 .1M MgCl2 and 0.05% Cuprolinic blue 
(Quinolinic phthalocyanate), a cationic dye for characterisation of proteoglycans (Scott, 
1972). Cuprolinic blue complexes with the glycosaminoglycan chains of proteoglycans 
owing to the presence of negatively charged sulphate and carboxylate residues. After fixation 
and staining, the samples were washed with sodium acetate buffer followed by aqueous, then 
50% ethanolic, sodium tungstate at 0.5%. The samples were dehydrated using an incremental 
ethanol series and embedded in Araldite resin. 90nm sections (gold interference) were cut 
using glass knives and collected on copper slot grids coated with a support film made using 
0.38% polyetherimide (PEI) in ethylene dichloride solution. Sections were contrasted with 
saturated aqueous uranyl acetate solution and 1% aqueous phosphotungstic acid. Finally, 
grids were exposed to a solution of lOnm colloidal gold (BBI, Cardiff, UK) to provide gold 
particles on each face of the slot grid as fiducial markers to be used in the image alignment 
process.
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3.3.3 Electron Tomography
Collagen lamellae in each stromal region were imaged via a tilt series ranging from -60° to 
+60° captured at a magnification of x20k, in one degree increments, using a Gatan ORIUS 
SC 1000 CCD camera linked to a JEOL 1010 transmission electron microscope operating at 
80kV. The images captured were then aligned using the IMOD software package (Kremer et 
al., 1996). Once the images had been carefully aligned according to the positions of 
individual gold marker fiducials, back-projection and tomogram generation was carried out 
using the EM3D program (Ress et al., 2004). Segmentation of the three-dimensional 
reconstruction was also carried out using EM3D.
3.3.4 Radial Distribution Function
The spatial distribution of collagen fibrils in the mouse cornea was assessed by determining 
the radial distribution function of fibrils (n= 11201) throughout the stroma (Cox et al., 1970). 
A collagen fibril is selected as a reference and the center-to-center distances of the 
surrounding fibrils are measured using ImageJ (Abramoff, 2004). The frequency plot of the 
distances of neighbouring fibrils with respect to the reference fibril is then obtained using in- 
house software. This plot is normalised to account for the fact that the number of fibrils per 
unit area diminishes as the distance from the reference fibril increases. All fibrils are then 
utilised in turn, and all frequency plots are summed together in order to improve statistics. 
Because of the way it is constructed, the radial distribution function describes the lateral 
packing of collagen fibrils and indicates whether long and/or short-range order exists within a 
system (Eikenberry et al., 1982).
3.3.5 Measurement o f Collagen Fibril and Proteoglycan Dimensions
Measurements of collagen fibril and proteoglycan dimensions were carried out using ImageJ 
software after internal calibration using the collagen D-period (~65nm in cornea). For the 
measurement of fibril diameters, 142 collagen fibrils were used. The measurement of 
proteoglycan length and thickness was limited to those proteoglycans entirely contained 
within a plastic section (n=50), as shown by their three-dimensional reconstruction.
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3.4 Results
Electron micrographs of the central corneal region showed two prominent populations of 
Cuprolinic blue-positive proteoglycans and regular collagen fibril order in the anterior (fibril 
diameters: 30.8 ± 1.9nm), mid (fibril diameters: 32.0 ± 2.8nm) and posterior (fibril diameters: 
28.9 ± 1.7nm) mouse comeal stroma (fig. 3.1). In between the collagen fibrils, small 
filament-like structures were numerous (arrows in fig. 3.1), as were larger, curved, electron- 
dense complexes (arrowheads in fig. 3.1). These results confirm what was seen in previous 
electron microscopy investigations o f the mouse cornea in two dimensions (Scott and Haigh, 
1988b, Young et al., 2005, Hayashida et al., 2006).
Figure 3.1. U ltrastructure o f the mouse corneal s trom a. Two proteoglycan populations are  evident in the 
m icrograph. Small, poorly contrasted  proteoglycans (arrow s) are frequently positioned orthogonally 
whereas the larger, electron-dense com plexes (a rrow heads) exhibit sinuous profiles. Scale bar = lOOnm
Three-dimensional reconstructions of collagen fibrils and associated proteoglycans in 
longitudinal and transverse sections in the anterior, mid and posterior stroma in the central, 
prepupillary region of the wild-type mouse cornea were obtained (fig. 3.2). The 
reconstructions of each stromal region showed similar collagen fibril organisation, in which
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fibrils were of a regular average diameter throughout the stroma and the interfibrillar spacing 
between fibrils was consistently uniform. No distinct structural differences in proteoglycan 
content, at the resolution obtained, were observed in the reconstructions of the anterior, mid, 
or posterior stroma and the distribution of proteoglycan types was also relatively similar.
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Figure 3.2. Three-dimensional reconstructions o f proteoglycan and  collagen fibril organisation within the 
an terio r (a and b), mid (c and d) and posterio r (e and  0  strom a o f the mouse cornea. Stereo-pairs of 
segmented tom ographic reconstructions in both (a, c, e) longitudinal and (b, d, e) transverse views. 
Proteoglycans are yellow in colour and collagen fibrils a re  coloured blue. Small proteoglycans are 
depicted by green arrow heads; in term ediate proteoglycans a re  pointed out by orange arrowheads 
whereas the largest proteoglycans are  m arked by red arrow heads. Scale b a r = SOnm
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A scatter plot of proteoglycan length versus thickness revealed three morphologically distinct 
populations throughout the corneal stroma (fig. 3.3). Small proteoglycans (31.4 ± 3.5nm in 
length measured over the three regions; green arrowheads in figs. 3.2(a) and 3.2(b)) were 
seen interconnecting only neighbouring fibrils, and were frequently positioned orthogonal to 
the fibril. Lengths were approximately equivalent to the surface separation of collagen fibrils. 
Larger proteoglycans varied in thickness, had sinuous profiles and were of two distinct 
lengths; intermediate sized proteoglycans (64.5 ± 3.9nm long; orange arrowheads in figs. 
3.2(a) and 3.2(b)) usually interconnected two fibrils, but sometimes could be seen to run 
alongside a collagen fibril, whereas the largest proteoglycans linked three fibrils (122.5 ± 
9.8nm long; red arrowheads in figs. 3.2(a) and 3.2(b)) and were seen less frequently than the 
other types.
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Figure 3.3. Scatter plot of proteoglycan length versus thickness in the anterior, mid and posterior stroma 
of the mouse cornea. Proteoglycan m easurem ents a re  restricted to the proteoglycans that display a 
complete structure within the reconstruction. Small proteoglycans = 5.0 ± l.Onm (thickness in diameter); 
31.4 ± 3.5nm (length). Interm ediate proteoglycans = 9.5 ± 1.9nm (thickness in diam eter); 64.5 ± 3.9nm 
(length). Largest proteoglycans = 10.4 ± 1.3nm (thickness in diam eter); 122.5 ± 9.8nm (length).
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The radial distribution function in figure 3.4 shows that localised, short-range order exists in 
the mouse corneal stroma, whereas long-range order beyond next-nearest neighbours is not 
apparent. The function g(r) indicates the probability of locating two fibril centres by a 
distance r. Nearest neighbour separation is illustrated by a prominent first peak at a ~44nm 
distance and a more diffuse, less prominent second peak at ~90nm suggests that next-nearest 
fibrils show some slight positional regularity. Beyond the second peak, there is little 
appreciable evidence of positional order between fibrils.
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Figure 3.4. Radial distribution function obtained from  the distances of fibril centres in electron- 
micrographs of the anterior, mid and posterior regions of the mouse corneal stroma.
Reconstruction of an interface between two orthogonal lamellae (Fig. 3.5) reveals the 
proteoglycan organisation at the junction between fibrils positioned perpendicular to each 
other in the mouse comeal stroma. Again, the proteoglycans appear to have no pre-defined 
orientation or symmetry in their organisation. Proteoglycans interconnect neighbouring 
orthogonally positioned fibrils, which is likely to provide a robust enough attachment to 
prevent slippage of lamella whilst allowing the transport of nutrients and water through the 
tissue.
67
Chapter Three - Three-Dimensional Reconstruction of Collagen-Proteoglycan Interactions in the Mouse
Corneal Strom al by Electron Tomography
Figure 3.5. Surface-rendered volume of an interface between orthogonal lamellae. Proteoglycans 
interconnect orthogonally positioned collagen fibrils, most likely for the structural integrity between 
adjacent lamellae. Scale Bar = 50nm
In the reconstructions, proteoglycans showed no specific symmetrical arrangement around 
collagen fibrils, neither within lamellae or at the interface between two orthogonally 
positioned collagen fibrils (see figure 3.5). Neighbouring fibrils were frequently connected at 
near-regular axial distances, primarily by the small proteoglycans with up to three collagen 
fibrils often inter-connected by the largest proteoglycans.
3.5 Discussion
Our reconstructions provide an insight into the interactions between the structural 
components of the mouse corneal stroma, illustrating the highly organised collagen fibril 
architecture and the less well organised three-dimensional arrangement of proteoglycans. A 
complex, almost random relationship between proteoglycans and collagen is observed, in
68
Chapter Three - Three-Dimensional Reconstruction o f Collagen-Proteoglycan Interactions in the Mouse
Corneal Stromal by Electron Tomography
which adjacent and next-nearest neighbour collagen fibrils are connected by proteoglycans 
which ultimately are likely to hold the fibril pseudo-lattice arrangement in a three- 
dimensional matrix.
When interpreting the results presented here, particular attention should be paid to the fact 
that mouse cornea contains considerable amounts of low-sulphated or unsulphated keratan 
sulphate (Scott and Bosworth, 1990, Young et al., 2005). Thus, not all keratan sulphate 
associated proteoglycans may be observed owing to the lower affinity of undersulphated 
proteoglycans for the cationic Cuprolinic blue dye. Chondroitinase ABC digestion of mouse 
cornea, which cleaves chondroitin sulphate/dermatan sulphate associated 
glycosaminoglycans, reveals a low population of small, poorly-contrasted filamentous 
structures considered to be keratan sulphate (Young et al., 2005, Hayashida et al., 2006). 
Keratan sulphate proteoglycans are observed bridging neighbouring fibrils at regular, 
frequently orthogonal intervals. Chondroitin sulphate/dermatan sulphate proteoglycans on the 
other hand interconnect neighbours and also next-nearest neighbours, and in some cases lie 
along the fibril axis.
To accurately determine the morphometry of proteoglycans in mouse cornea, the dimensions 
of proteoglycans which were wholly contained within the plastic section were measured. The 
variation in length of chondroitin sulphate/dermatan sulphate proteoglycans suggests a 
possible end-to-end aggregation (figs 3.5 and 3.6). There are numerous potential mechanisms 
that may make this possible, for example, hydrophobic attraction and hydrogen bonding 
could enable the highly anionic glycosaminoglycans to associate (Scott, 2001), whilst 
positive ions (i.e. Na+, K+) drawn into the stroma could screen negative charges and negate 
the chains’ mutual repulsion. An increase in ionic strength has been shown to disrupt 
aggregation of proteoglycans (Roughley et al., 1995), thus ionic balance might be important 
for self-association. Ionic strength changes have also shown both changes in comeal stromal 
transparency and in the order of collagen fibrils (Regini et al., 2004) The observed 
differences in thickness of our stained proteoglycan filaments (fig. 4) could be accounted for 
by variations in sulphation, resulting in a greater accumulation of Cuprolinic blue stain. 
However, the relative size of Cuprolinic blue (<0.5nm) and tungstate ions used for staining of
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proteoglycans is probably insufficient to account for the observed differences in glycan chain 
thicknesses (Scott, 1992). This gives rise to the possibility that in mouse corneas chondroitin 
sulphate/dermatan sulphate proteoglycans aggregate laterally in the form of tetramers or 
polymers. Lateral aggregation of proteoglycans may be facilitated by adjacent protein cores 
contributing their glycosaminoglycan chains to form complementary, anti-parallel multimers 
through the attractive forces described previously (fig. 3.6). The lateral association of several 
proteoglycans would confer enhanced structural integrity, and it is also possible that they may 
exist in helical conformations, similar to the structure of hyaluronan (Amott et al., 1983). 
Multiple aggregations of this type would be able to account for the overall thickness of 
proteoglycans. The observed variation in proteoglycan thickness thus suggests a higher 
potential for self-association such that different phases of aggregation are evident. In 
addition, such a property could accommodate an ability of proteoglycans to readily dissociate 
and re-aggregate to enable fibril flexibility. This flexibility would allow for the passive 
movement of water and nutrients through the tissue. In addition to lateral associations of 
proteoglycans, it appears that end-to-end linear associations also occur, so that proteoglycans 
can bridge more than two adjacent fibrils. The proposed end-to-end accretion of chondroitin 
sulphate/dermatan sulphate may be facilitated by the dimerisation of decorin (Scott et al., 
2004), the chondroitin sulphate/dermatan sulphate-containing protein core. Decorin 
dimerisation allows chondroitin sulphate/dermatan sulphate proteoglycans to have two 
opposing glycosaminoglycan extensions each of which may connect neighbouring fibrils by 
association of proteoglycans substituted with only a single glycosaminoglycan chain (fig. 
3.6). Dimerisation of decorin could potentially result in an overlapping end-to-end system 
extending over many fibrils, although in mouse cornea bridges of only three fibrils were most 
frequent. The dimerisation of decorin in solution is not universally accepted, however 
(Goldoni et al., 2004).
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Figure 3.5. Models of proteoglycan and collagen fibril organisation in the mouse cornea. Keratan 
sulphate proteoglycans are illustrated in green and chondro itin /derm atan  sulphate proteoglycans are 
represented in red. (a) Proteoglycans are shown exerting opposite forces to control the spatial 
characterisation of collagen fibrils according to the charges th a t surround them and their therm al 
motion, (b and c) The azimuthal disorder of proteoglycans is represented, reflecting the three- 
dimensional reconstructions. Proteoglycans in teract with each other through hydrophobic and hydrogen 
bonding attraction with their respective glycosaminoglycan side-chains, countering the mutual repulsion 
created by sulphate and carboxylate residues th a t a re  positioned on the repeating disaccharides. Also, 
negative charges may be screened by positive ions lim iting repulsive forces, o r from salt bridges. 
C hondroitin/derm atan sulphate proteoglycans have longer glycosaminoglycan chains, aggregate further 
and occupy a larger volume of space than the sm aller keratan  sulphate proteoglycans.
To explain the uniformity of interfibrillar distances, we propose a three-dimensional model 
for the mouse corneal stroma, similar to that proposed for bovine cornea (Lewis et al., 2010, 
Knupp et al., 2009) in which two equal but opposite forces are exerted simultaneously on the
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collagen fibrils (fig. 3.5). As well as inhibiting the lateral accretion of collagen fibrils, 
proteoglycans are likely able to both contract and expand space between individual collagen 
fibrils in order to accurately optimise their spatial characterisation. The control of 
interfibrillar spacing, an important factor in the formation of comeal transparency, is 
governed by the glycosaminoglycan components of proteoglycans most likely according to 
their sulphation patterns and the consequent electrostatic forces surrounding them that permit 
their aggregation and dissociation. In the mouse cornea, we contend that undersulphated 
keratan sulphate proteoglycans form stable interfibrillar bridges that dictate interfibrillar 
spacing possibly thanks to their thermal motion that tends to bring their terminal ends, which 
are attached to adjacent fibrils, closer together. These proteoglycans would not influence 
stromal hydration to any great extent, conferring mechanical stability whilst also restricting 
osmotic swelling. Under sulphation of glycosaminoglycans results in a decrease in mutual 
repulsion between proteoglycans and a stable interaction between associated 
glycosaminoglycans arises. Keratan sulphate proteoglycans are approximately the size of the 
interfibrillar space between individual fibrils and so they can act as ‘spacers’ between fibrils.
Large chondroitin sulphate glycosaminoglycans, where 60% is present as dermatan sulphate 
in mouse (Scott and Bosworth, 1990), may also control interfibrillar spacing through 
stabilising more than two adjacent fibrils, forming multimers and regulating the swelling 
pressure of the tissue through their sulphate residues. These proteoglycans, specifically in the 
mouse cornea, are likely to contribute to the expansion of interfibrillar spacing to a greater 
extent. In fact, chondroitin sulphate contains more disaccharide motifs than keratan sulphate 
(Plaas et al., 2001), and therefore has more potential sites for sulphation and a higher 
proportion of hydrophobic regions. We hypothesise that undersulphated proteoglycans, or 
proteoglycans with more hydrophobic regions ‘pull in’ fibrils to restrict, stabilise and tether 
interfibrillar spacing through their interactions. Conversely, highly sulphated proteoglycans 
capable of attracting counterions ‘push out’ fibrils through an influx of water because of the 
Donnan effect (Elliott and Hodson, , 1998) (Fig. 3.5). Thus, proteoglycans govern the intake 
of water and ions from outside the tissue to control interfibrillar spacing and the overall 
thickness of the tissue, and are interchangeable when oxygen may not be readily available.
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Figure 3.6. Proposed modes of aggregation of proteoglycans. The dim erisation of decorin (black) allows 
the end-to-end aggregation of chondroitin/derm atan sulphate (red) proteoglycans forming an elongated 
proteoglycan able to attach three Fibrils. Also, proteoglycans may bind to adjacent binding sites and form 
multiple aggregates, possibly tetram ers, with proteoglycans on a neighbouring Fibril.
Collagen fibrils within the mouse cornea have a defined range of nearest neighbour 
separation as confirmed by the radial distribution function, although order does not 
appreciably extend beyond next-nearest neighbours (fig. 3.4). The regularity of collagen fibril 
diameter, coupled with the short-range order the fibrils exhibit, is essential for mutual 
interference of light entering the cornea (Cox et al., 1970). Light rays impinging on collagen 
fibrils are scattered in all directions and if the collagen fibrils in the cornea are of equal 
diameter, the scattered light from each fibril will have equal intensity and wavelength. If the 
separation between adjacent fibrils is less than half the wavelength of the light rays, the rays 
scattered from all fibrils will interfere destructively in all but the forward direction so that 
light entering the cornea will pass through unaffected (see Hart and Farrell, 1969, Cox et al., 
1970 for a detailed explanation). However, if the collagen fibrils have different diameters, as 
is the case in the white sclera of the eye, this is no longer the case and the scattered rays will 
interfere destructively, making the cornea opaque. The degree of corneal opacity depends on 
the degree of collagen fibril inhomogeneity, where small variations will cause only a small 
degree of opacity. Proteoglycans do not show, and being weak scatterers do not need to show, 
the same co-ordinated arrangement as collagen fibrils in order to guarantee transparency. The 
cornea, we propose, is a flexible, adaptive system in which proteoglycans adopt different,
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reversible conformations allowing fibrils to re-model slightly to accommodate the passage of 
water and nutrients whilst preventing irreversible deformation upon impact injury and loss of 
transparency.
3.6 Conclusion
Proteoglycans within the mouse corneal stroma, like those in bovine cornea (Lewis et al., 
2010, Knupp et al., 2009), appear to show no specific order whereas collagen fibrils maintain 
a regular pseudo-hexagonal arrangement. Both keratan sulphate and chondroitin 
sulphate/dermatan sulphate are likely to utilise their electrostatic charges and self-aggregation 
as a means to govern and optimise the spatial distribution of collagen fibrils. We consider that 
proteoglycans possibly form tetramers and in some cases extend end-to-end which allows 
them to adopt different conformations and connect more than two fibrils. This arrangement of 
proteoglycans is likely to be paramount to the transparency, flexibility and resilience of the 
cornea. Ongoing studies of mouse strains with genetic alterations in proteoglycans and/or 
glycosaminoglycans will allow us to test these conclusions more fully.
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4.1 Introduction to chapter
To gain a more precise understanding of proteoglycan function, their native structure, and 
how they are intricately assembled and packed in the corneal stroma, requires elucidation. 
Earlier investigation by Fransson and colleagues (Fransson, 1976, Fransson and Coster, 1979) 
showed, through affinity chromatography, that glycosaminoglycans are able to self-associate 
even though they are highly anionic in nature. Scott (2001) elaborated on this study, 
postulating that glycosaminoglycan self-aggregation was analogous to DNA, in that 
hydrophobic and hydrogen bonding counter-acts the expected mutual repulsion so that 
complexes may be formed. As indicated in the previous chapter, mouse corneal 
proteoglycans exhibit much larger thicknesses than which may be accounted for by the 
cationic stain coating and the width of an individual glycan chain, and so further analysis is 
required to determine how proteoglycans pack in the mouse cornea.
In order to understand more about the structure of proteoglycans and their aggregation 
mechanisms in the cornea, three-dimensional reconstructions of collagen-proteoglycan 
interactions in the anterior, mid and posterior stroma from a Chst5 knockout mouse, which 
lacks a keratan sulphate sulphotransferase, were obtained. The disruption in transfer of 
sulphate groups to keratan sulphate appears to affect the morphology of proteoglycans and 
their significantly increased size is suggestive of increased self-association (Hayashida et al., 
2006). Therefore, high resolution three-dimensional reconstruction of the proteoglycans 
inherent in the C/zs/5-null mouse may shed light on how proteoglycans aggregate and 
maintain the ordered fibril assembly in the cornea. From this, we suggest possible 
mechanisms as to how sulphation differences may lead to this increase in aggregation of 
proteoglycans in the Chst5-nu\\ mouse corneal stroma and how this relates to proteoglycan 
packing in healthy corneas.
75
Chapter Four - Electron Tomography reveals multiple packing of chondroitin sulphate/dermatan 
sulphate proteoglycans in Chst5-null mouse corneas.
4.2 Introduction
In humans, the gene CHST6 is responsible for encoding the N-acetylglucosamine 6-0 
sulphotransferase enzyme, and its mutation has been implicated in macular comeal dystrophy 
- a disease which causes abnormal collagen fibril assembly and comeal opacity, coupled with 
oversulphation of chondroitin sulphate/dermatan sulphate proteoglycans (Nakazawa et al., 
1984, Meek et al., 1989, Akama et al., 2000, Plaas et al., 2001). In mice, the N- 
acteylglucosamine 6-0 sulphotransferase enzyme is encoded by the gene named ChstS. Mice 
with mutated Chst5 exhibit no detectable sulphated keratan sulphate as well as altered 
chondroitin sulphate/dermatan sulphate proteoglycan morphology compared to the wild-type, 
even though comeal transparency remains unaffected (Hayashida et al., 2006).
From Chapter Three we have seen that chondroitin sulphate/dermatan sulphate proteoglycans 
interact with up to three adjacent fibrils in the mouse cornea and exhibit a variety of 
morphologies which suggest different modes of self-association. The aggregation of 
chondroitin sulphate/dermatan sulphate proteoglycans was initially demonstrated through gel 
chromatography (Fransson, 1976, Fransson and Coster, 1979) and then rotary-shadowing 
electron microscopy (Ward et al., 1987, Scott et al., 1992). Later evidence suggested that 
complementary, anti-parallel disaccharide chains may counter the expected mutual repulsion 
owing to sulphation and unbalanced charge distribution by hydrophobic and/or hydrogen 
bonding (Scott, 2001), as well as, possibly, through the formation of saline bonds via counter­
ions present in the extra-cellular matrix. These aggregation mechanisms are likely to be 
influenced by the arrangement of disaccharides in the glycosaminoglycan chains; frequently 
alternating, iduronate-rich sequences being more prone to association (Fransson and Coster, 
1979). Although comeal proteoglycan self-association in situ has been postulated, little is 
known about the influence sulphation has on glycosaminoglycan aggregation potential and 
the manner in which proteoglycans pack, as well as how this influences proteoglycan 
properties and the regulation of collagen fibril architecture in the corneal stroma.
This investigation utilised electron tomography techniques to visualise the interactions 
between collagen and proteoglycans in the cornea of C/w/5-null mice. From the three- 
dimensional conformations of proteoglycans, we postulate mechanisms as to how
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proteoglycans may aggregate and interact with each other in the C/zs/5-null mouse. It is 
hoped that this will help to throw light on how proteoglycans, in healthy corneas, associate 
and regulate fibril organisation and in turn, corneal transparency.
4.3 Materials and Methods
4.3.1 Specimen preparation
3-month old, wild-type C57BL/6 and homozygous Chst5-nu\\ mice were obtained and 
corneas were excised within 5 min post-mortem. Animals were handled in accordance with 
the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and local 
regulations at all times. Half corneas from a mouse of each genotype were fixed in 2.5% 
glutaraldehyde in 25 mM sodium acetate (pH 5.7) with 0.05% Cupromeronic blue dye 
(wt/vol). Cupromeronic blue stains sulphated proteoglycans owing to fixed anionic charges 
on both the sulphate and carboxylate residues present on the glycosaminoglycan extension 
(Scott, 1972). The dye was included in the glutaraldehyde fixative in a critical electrolyte 
concentration method, competing with MgCb at either 0.1M or 0.3M. Qualitatively, no 
obvious difference was seen between these two preparative regimes. Corneal samples were 
then washed with sodium acetate buffer followed by immersion in sodium tungstate at 0.5% 
to increase the contrast of proteoglycan complexes. Dehydration was carried out by washes in 
an incremental ethanol series (70 - 100%) followed by embedding in Araldite resin.
4.3.2 Electron Tomography
Araldite-embedded corneal tissue was cut into 100 nanometre sections, gold in colour, which 
were then stained with 1% aqueous phosphotungstic acid and saturated uranyl acetate for 2 
minutes and 12 minutes respectively, with washes in-between and after. Colloidal gold (lOnm 
- BBI, Cardiff, UK) solution was then added to each face of the section, which was supported 
on a 0.38% polyetherimide film-coated grid. For electron tomography, a -60° to +60° single 
axis tilt series of collagen and proteoglycans was captured, in one degree increments, in the 
anterior, mid and posterior comeal stroma using a JEOL 1010 transmission electron 
microscope (80kv) attached to a Gatan ORIUS SC 1000 CCD camera at 20k magnification. 
Both longitudinal and transverse sections, in each stromal zone, were reconstructed and
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segmented for a full three-dimensional insight into proteoglycan-collagen interactions (n=6). 
These images, at a pixel size of 0.33nm, were then aligned according to the position of the 
gold fiducial markers on each image using the IMOD software package (Kremer et al., 1996). 
Backprojection of the aligned tilt series to generate the final tomograms, and their subsequent 
segmentation, was carried out using the EM3D program (Ress et al., 2004).
4.3.3 Measurement o f Proteoglycan Dimensions
All measurements were made using ImageJ software after internal calibration with the 
diameter of gold fiducial markers (lOnm). Proteoglycans were measured selectively 
according to their orientation; only those wholly contained within the three-dimensional 
reconstruction and lying in the plane o f the plastic section were analysed (n=52). For 
calculation of the average distance between neighbouring quasi-orthogonal branches, n=15.
4.4 Results
Cupromeronic blue-enhanced electron microscopy of the C/zs/5-null mouse cornea discloses 
proteoglycans with altered morphologies with respect to the C57BL/6 wild-type mouse 
cornea. The proteoglycans in the mutant cornea appear variably elongated (Fig. 4.1(b), black 
arrow) and are more electron-dense than the proteoglycans apparent in the wild-type (Fig. 
4.1(a), white and black arrowhead). Cross-section of an oversized Chst5-nu\\ proteoglycan 
reveals off-shoots around the periphery of the main proteoglycan body (Fig. 4.1(b), white 
arrow) and reconstructions also point to a spindle-like appearance (Fig 4.1(c)).
Segmented tomographic volumes of the wild-type C57BL/6 comeal stroma show organised 
collagen fibrils with uniform diameter and distribution, embedded in a matrix of interfibrillar 
proteoglycans (Fig. 4.2). A non-specific arrangement of proteoglycans is evident, and 
although fibrils are often interconnected at near regular axial distances, there appears to be no 
symmetrical order of proteoglycans around any collagen fibrils. Proteoglycans also appear to 
vary in morphology; small interfibrillar proteoglycans (Fig. 4.2(a and c), red arrowhead), as 
well as more sinuous types (Fig. 4.2(a and d), green arrowhead), are able to interconnect two
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adjacent fibrils. Three fibrils may also be connected by elongated proteoglycans (Fig. 4.2(a 
and e), white arrowhead), although less frequently.
Fig. 4.1. Electron micrographs of the corneal s trom a o f (a) C57BL/6 and (b) CVi.sf5-null mice with collagen 
Fibrils running in longitudinal section. Large (b lack arrow head) and small (white arrow head) 
proteoglycan Filaments are evident in w ild-type sections (a). Previous enzyme digestion (Hayashida et al., 
2006, Young et al., 2005) revealed tha t small collagen-associated Filaments were keratan sulphate and the 
larger ones are of the chondroitin su lphate /derm atan  sulphate type. In the Chst5 m utant (b), enlarged 
chondroitinase ABC-susceptible Filaments a re  branched , giving them a "caterpillar-like" morphology in 
longitudinal section (black arrow ) and a star-shaped  appearance with proteoglycans around the 
circumference in both cross-section (white arrow ), and successive slices through the reconstruction (c). 
Scale bars = lOOnm ((a) and (b)); 50nm ((c)).
Previous investigation has shown that Chst5-nu\\ mouse corneas retain transparency despite a 
marginal decrease in interfibrillar spacing (Hayashida et al., 2006). When compared to the 
non-mutated mouse cornea, many proteoglycans in the Chst5-nu\\ mouse cornea appear 
grossly enlarged both in thickness and length, and near-periodic, orthogonal off-shoots are 
also evident, as shown by the three-dimensional reconstructions and segmented volumes (Fig.
79
Chapter Four - Electron Tomography reveals multiple packing of chondroitin sulphate/dermatan
sulphate proteoglycans in Chst5-null mouse corneas.
4.3, purple arrowhead and Figs. 4.3(g - j), white arrowheads). These branched proteoglycans 
are significantly longer and thicker, to variable extents (up to 450nm in length, 29nm in 
thickness; Fig. 4.4), than both the unbranched types seen in the C/w/5-null mouse cornea (71 
± 17nm (length), 9 ± 2nm (thickness); Fig. 4.4) and any of the proteoglycans prevalent in the 
wild-type mouse cornea (Parfitt et al., 2010 - (Chapter Three)). However, there are 
unbranched proteoglycans similar in morphology and dimensions to the largest proteoglycans 
observed in the wild-type corneas (Fig. 4.3(c), green arrowhead; Fig. 4.4).
Fig. 4.2. Segmented reconstruction volumes o f collagen and proteoglycans in the C57BL/6 wild-type 
mouse corneal stroma. S tereo-pairs of su rface-rendered  volume in (a) longitudinal and (b) transverse 
section whereby proteoglycans are  coloured yellow and collagen fibrils are blue. In the segmented 
volumes (a and b) and reconstructions (c,d,e), proteoglycans adopt a non-symmetrical organisation and 
are able to connect neighbouring fibrils (red and green arrow heads) and, in some cases, next-nearest 
neighbours (white arrow heads). Scale bars = 50nm
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Fig. 4.3. Surface-rendered volumes of collagen and proteoglycans in the corneas of the C/is/5-null mouse 
(a and b) anterior, (c and d) mid and (e and 0  posterio r corneal strom a shown as stereo-pairs of (a,c,e) 
longitudinal and (b,d,f) transverse sections o f segm ented tom ogram s. Proteoglycans are yellow in colour 
whereas collagen is depicted in blue. Red arrow heads highlight significant proteoglycan curvature and 
flexibility. Yellow arrow heads indicate tight packing o f fibrils along glycosaminoglycan extension. The 
orange arrow head shows a proteoglycan main body in cross-section whereas the green (unbranched) and 
purple (branched) arrow heads m ark  out the two prom inent proteoglycan types observed. The near- 
periodic appearance of quasi-orthogonal off-shoots ((g-j), white arrow heads) are evident in the 
reconstructions (right hand panel). Scale bars = 50nm
The elongated proteoglycans in the Chst5-nu\\ cornea are able to span and connect many 
more fibrils than the largest proteoglycan type evident in wild-type corneas. More than 10 
fibrils may be connected by the enlarged sinuous proteoglycan filaments which display 
remarkable flexibility, bending around fibrils in some cases (Fig. 4.3(a) and 4.3(d), red 
arrowheads). The chondroitinase ABC susceptible proteoglycans seen here (Hayashida et al., 
2006) have diameters comparable to collagen fibrils when viewed in cross-section (Fig. 
4.3(f), orange arrowhead), indicative of significantly increased thickness. Also, the 
proteoglycan off-shoots are markedly thinner than the proteoglycan body to which they are 
attached (Fig. 4.4.).
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Fig. 4.4. Scatter plot of proteoglycan dim ensions in the Chst5-nul\ mouse cornea strom a. M easurements 
were limited to those proteoglycans th a t exhibit com plete morphologies in the three-dimensional 
reconstruction. Branched proteoglycans = 260 ± 83nm (length); 20 ± 4nm (thickness in diameter). 
O rthogonal branches = 64 ± 7nm (length); 9 ± 2nm (thickness in diam eter). U nbranched proteoglycans = 
71 ± 17nm (length); 9 ± 2nm (thickness in d iam eter). A verage distance between quasi-orthogonal 
branches = 46 ± lOnm.
Collagen fibril organisation in the C/is/5-null appears to have developed with similar 
uniformity as in the wild-type tissue (Fig. 4.2(a) and 2(b)). However, in some regions of the 
mutant tissue collagen fibrils appear to pack tightly to the main body of the enlarged 
Cupromeronic blue-enhanced glycosaminoglycan filaments (Fig. 4.3(b) and 4.3(d), yellow 
arrowhead). Proteoglycans of the mutant corneas show no appreciable ordered arrangement 
around collagen fibrils three-dimensionally, as is the case in the wild-type mouse cornea. 
Also, the three distinct stromal regions (anterior, mid and posterior stroma) do not appear to 
differ significantly in their proteoglycan composition (Fig. 4.3).
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4.5 Discussion
The three-dimensional reconstructions presented here illustrate the relationships between 
collagen and proteoglycans in the C/*sr5-null mouse corneal stroma, where proteoglycan 
morphologies are significantly enlarged when compared to the wild-type. The ultrastructure 
reported in previous two-dimensional investigation is consistent with the observations from 
the reconstructions of each stromal region (Hayashida et al., 2006).
Studies on human corneas have shown oversulphated chondroitin sulphate/dermatan sulphate 
proteoglycans in macular corneal dystrophy (Nakazawa et al., 1984, Meek et al., 1989, Plaas 
et al., 2001), and if C/is/5-null mice corneas exhibit a similar phenotype, electron-dense 
proteoglycans with increased affinity for the cationic Cupromeronic blue dye would be 
expected on electron microscopy investigation. Indeed, this is the case and the three- 
dimensional images of enlarged proteoglycan filaments in the Chst5-nu\\ mouse cornea are 
striking. Previous research has shown that, through chondroitinase ABC digestion, the 
oversized proteoglycans are of the chondroitin sulphate/dermatan sulphate hybrid 
proteoglycan type (Hayashida et al., 2006). In this light, the observations made from the 
Chst5-null mouse cornea reconstructions suggest an important role for glycosaminoglycan 
sulphation in the packing and self-association of glycosaminoglycans and therefore, the 
determination of proteoglycan morphology.
Observations on proteoglycans from the Chst5-nu\\ three-dimensional reconstructions (fig. 
4.3) suggest that many more chondroitin sulphate/dermatan sulphate chains have the ability 
to pack together compared to those in wild-type mouse corneas. The extension of chondroitin 
sulphate/dermatan sulphate proteoglycans in the C/25/5-null mouse cornea, in some cases by 
over 500nm, could occur as a result of end-to-end aggregation or by elongation of single 
glycosaminoglycans, a process which is coupled with disaccharide sulphation at synthesis 
(Malstrom et al., 1975), or possibly both. In addition, lateral aggregation seems to take place 
since the size of ions used in staining (~lnm), and the width of individual glycan chains 
(<0.5nm) are insufficient (Scott, 1992) to account for the proteoglycan thicknesses observed, 
where enlarged proteoglycans display comparable diameters to collagen fibrils (Fig. 4.3(f), 
orange arrowhead; up to 29nm in thickness Fig. 4.4). This strongly implies that individual
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proteoglycans pack into complexes in the Chst5-null mouse cornea. In normal physiology, 
the aggregation potential of proteoglycans must therefore be limited in order to regulate 
proteoglycan dimensions throughout the stroma, which are relatively uniform (Parfitt et al., 
2010 - (Chapter Three)). Variations in the distribution of sulphation and the subsequent 
charge density appear to be the primary cause of increased proteoglycan aggregation in the 
C/7st5-null mouse cornea, and so it is probable that the positioning of sulphate esters regulates 
proteoglycan self-association in the wild-type cornea.
Synchrotron X-ray fibre diffraction experiments have indicated that the average spacing of 
collagen fibrils in the C/w/5-null cornea is not that dissimilar from the value in wild-type 
mice, though the lattice-like arrangement is disturbed (Hayashida et al., 2006). It is likely that 
an imbalance of the average negative charge on the proteoglycans would have an effect on 
their ability to attract water molecules and therefore, of regulating interfibrillar distances by 
osmotic swelling. Thus, the overall balance of electrostatic charge in the C/wri>-null mouse 
cornea seems to be maintained despite the complete removal of keratan sulphate proteoglycan 
sulphation. This further supports the hypothesis of a compensatory mechanism which results 
in an increased sulphation of the chondroitin sulphate/dermatan sulphate chains in the 
absence of sulphated keratan sulphate. Therefore, the oversulphation of chondroitin 
sulphate/dermatan sulphate glycosaminoglycans appears to facilitate further packing and self­
association of their chains, probably by the formation of more salt bridges with counter-ions. 
This idea is supported by the fact that self-association of dermatan sulphate has been shown 
to be promoted by the presence of Na+ ions (Fransson and Coster, 1979), so an increase in 
the charge density of proteoglycans would presumably lead to a greater influx and 
localisation of counter-ions, promoting further proteoglycan aggregation. Keratan sulphate, 
although non-sulphated, is still likely to be present (lumican core protein is detected in the 
Chst5-nu\\ mouse cornea (Hayashida et al., 2006)) and would be able to contribute to the 
regulation of interfibrillar spacing by drawing fibrils closer together through thermal motion 
(Knupp et al., 2009, Lewis et al., 2010). As well as a decrease in keratan sulphate 
proteoglycan hydration and the subsequent local osmotic swelling, self-association between 
non-sulphated keratan sulphate proteoglycans would still be expected if mediated by 
hydrogen bonds and/or hydrophobic forces. In conclusion, both types of proteoglycans could 
still maintain the ability to dynamically influence interfibrillar spacing and comeal fibril 
architecture necessary for tissue transparency despite their altered sulphation distribution.
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Fig. 4.5. (a and b) Schematic of proposed periodic aggregation of chondroitin sulphate/derm atan sulphate 
proteoglycans in the C/rs/5-null mouse corneal strom a and the disaccharide constituents, (a) orthogonal 
binding with protein cores and (b) w ithout. The near regu lar distances of orthogonal glycosaminoglycans 
in the reconstructions suggest periodic la teral aggregation of proteoglycans in the main body, (c) 
Potential helical associations between glycosam inoglycans. (d) Cross-section of oversized proteoglycan 
with regular protruding glycosaminoglycan branches.
The regular branching of proteoglycans in the mutant corneas with chondroitin 
sulphate/dermatan sulphate off-shoots indicates that periodicity likely exists in the 
aggregation of the chondroitin sulphate/dermatan sulphate proteoglycan main body (Fig. 
4.5(a) and (b)). It is currently unknown what molecules are involved in forming the branches 
to the main body of the stained proteoglycan filaments. The average distance between 
neighbouring quasi-orthogonal branches calculated here (46 ± lOnm) may not take into 
account the likelihood that not all binding sites may be occupied. Models can be envisaged, 
however, to explain the appearance of the proteoglycans in the reconstructions. For example, 
smaller chondroitin sulphate/dermatan sulphate proteoglycans, or other molecules could bind 
periodically and orthogonally along the chondroitin sulphate/dermatan sulphate body (Fig.
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4.5(a)). Alternatively, it is also possible that elongated glycosaminoglycans are forced to 
protrude out (Fig. 4.5(b)), due to the increased aggregation in the main proteoglycan 
complex. It cannot be excluded that glycosaminoglycans may also pack in a coiling 
conformation (Fig. 4.5(c)), similar to the situation in hyaluronic acid (Dea et al., 1973, Amott 
et al., 1983). Also in this case, the terminal ends of the proteoglycan chains would protrude 
out as in the model in fig. 4.5(b), or there could be interactions with other molecules as in fig. 
4.5(a). The result of either of these co-ordinated associations would give rise to the star-like 
appearance of oversized proteoglycans which we often see in cross-section (Fig. 4.5(d) and
4.1 (b and c), white arrow). In all cases it appears that glycosaminoglycan chains are 
physiologically able to interact and form macromolecular assemblies that are likely to be 
more robust than single chains. From this, it seems reasonable to postulate that similar 
interactions could occur in healthy corneas too, although with fewer molecules involved.
4.6 Conclusion
In conclusion, proteoglycans present in both the wild-type C57BL/6 and C/zsf5-null mouse 
corneas show no specific ordered arrangement around collagen fibrils. The removal of the 6- 
O-acetylglucosamine sulphotransferase enzyme responsible for transferring sulphate esters to 
keratan sulphate, results in chondroitin sulphate/dermatan sulphate proteoglycans with altered 
morphologies, which are significantly increased in both thickness and length. We suggest that 
altered sulphate ester distribution, and possibly disaccharide sequence differences, result in 
more favourable aggregation conditions that cause elongation as well as lateral and 
orthogonal aggregation of chondroitin sulphate/dermatan sulphate proteoglycans. The regular 
quasi-orthogonal glycosaminoglycan associations could be accounted for by periodic 
glycosaminoglycan aggregation. Sulphation, which influences both glycosaminoglycan 
elongation, epimerisation and the interactions with counter-ions and other 
glycosaminoglycans, is likely to be essential to the regulation of proteoglycan aggregation 
and therefore, the maintenance of corneal collagen fibril architecture
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5.1 Introduction to chapter
The transparent cornea exhibits a remarkable degree of organisation in its array of collagen 
fibrils when compared with other connective tissues. This ordered fibrillar arrangement is 
thought to be a consequence of dynamic regulation by sulphated proteoglycan 
macromolecules, as proposed in Chapters Three and Four.
To understand the importance of proteoglycans in corneal homeostasis, and specifically the 
major proteoglycan lumican, with its keratan sulphate glycosaminoglycan side-chains, the 
corneas of homozygous lumican-null juvenile mice were imaged in a transmission electron 
microscope and the three-dimensional arrangement of proteoglycans and collagen fibrils was 
reconstructed by electron tomography. From this, it was apparent that lumican impacts upon 
the regulation of normal collagen fibril assembly, and the presence of merged fibrils in the 
lumican-null mouse cornea indicates that these keratan sulphate proteoglycans contribute to 
the spatial regulation of neighbouring fibrils, most likely through their constituent 
glycosaminoglycan side-chains. Therefore, proteoglycans influence comeal transparency by 
maintaining a regular spatial distribution of collagen fibrils and thus, have an essential 
functional role in vision. Based on this, we propose a model to explain how proteoglycans 
regulate the ultrastructure of collagen fibrils in the cornea.
5.2 Introduction
Lumican is the major keratan sulphate proteoglycan in the comeal stroma and, along with 
decorin and biglycan, has been shown to limit collagen fibrillogenesis in vitro, as discussed in 
Chapter One. Similar to the other keratan sulphate proteoglycans in the cornea, lumican has 
2-3 glycosaminoglycan extensions of approximately 10-15kDa each, and a core protein of 
about 51kDa (Hassell et al., 1979, Midura and Hascall, 1989). Homozygous lumican-null
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mice have demonstrated the importance of lumican in the maintenance of the intricate 
collagen fibril architecture in the wild-type mouse cornea (Chakravarti et al., 1998), where 
lumican protein is present in an ascending gradient from anterior to posterior stroma 
(Chakravarti et al., 2000). As a consequence of the different distribution, fibril defects in 
lumican-null mutant corneas are prevalent in the posterior regions of the cornea. Moreover, 
keratan sulphate content in the lumican mutants decreases by 25% when compared to the 
wild-type mouse cornea (Chakravarti et al., 2000). The expression of keratocan is dependent 
on lumican (Carlson et al., 2005, Liu et al., 2010) and thus, lumican-null mice may also 
exhibit altered expression in other proteoglycan types. Even though chondroitin 
sulphate/dermatan sulphate proteoglycans account for the bulk of the mouse cornea's 
proteoglycan content, removal of lumican proteoglycans diminishes corneal transparency 
marginally. Therefore, observations made from lumican-null mouse corneas may reveal the 
modes of regulation that proteoglycans, through their glycosaminoglycan extensions, exert in 
order to maintain the short range order of collagen fibrils in the cornea.
In this investigation, we obtained three-dimensional reconstructions, at high magnification, of 
the homozygous lumican-null mouse comeal stroma to achieve a greater understanding as to 
the role of lumican, and proteoglycans in general, in regulating collagen interfibriHar spacing 
and fibril diameters, which are the two essential parameters in the development and 
maintenance of comeal transparency.
5.3 Materials and Methods
5.3.1 Sample Preparation for Electron Microscopy
Young adult (3 months old), wild-type (C57BL/6) and homozygous lumican-null mouse 
corneas were removed within 5 minutes post-mortem. Animals were treated under the ARVO 
Statement for the Use of Animals in Ophthalmic and Vision Research and local regulations at 
all times. Corneas were cut into halves and subjected to fixation in 2.5% glutaraldehyde in 
25mM sodium acetate (pH 5.7) with 0.05% Cuprolinic blue dye (wt/vol). Cuprolinic blue, a 
cationic dye utilised here at a critical electrolyte concentration of 0 .1M MgCl2, complexes
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with proteoglycans by interacting with anionic charges on both sulphate and carboxylate 
residues of the glycosaminoglycan chains. The specimens were next immersed in a 0.5% 
sodium tungstate solution to enhance the contrast of proteoglycans in the electron 
microscope. Samples were then subjected to ethanol washes increasing in concentration from 
70-100% to dehydrate the tissue and embedded in Araldite resin, through propylene oxide, 
for sectioning.
5.3.2 Enzyme Digestion
To determine the presence of specific proteoglycans in the lumican-null mouse corneas, 
certain glycosaminoglycan-cleaving enzymes were used. Corneas dissected in quarters were 
prefixed with 1 % paraformaldehyde and washed with 1 unit/ml tris/sodium acetate buffer (pH 
8), with one cornea remaining in the buffer as a control. To remove hybrid chondroitin 
sulphate/dermatan sulphate proteoglycans, one cornea was incubated in 2.5 unit/ml 
chondroitinase ABC (Sigma Aldrich) for 4h at 37°C, whereas keratan sulphate proteoglycans 
were degraded by treating another cornea with 1 unit/ml keratanase II (Sigma Aldrich), also 
for 4h at 37°C. To remove both types of proteoglycans, a combination of both enzymes was 
used. Samples were then fixed, proteoglycan-stained and embedded according to the protocol 
outlined above.
5.3.3 Electron Tomography
Embedded comeal tissue was cut into sections approximately lOOnm in thickness (gold 
interference) using a Reichert UCE ultra-microtome. Sections were collected on copper grids 
coated with a 0.38% polyetherimide support film, stained with 1% phosphotungstic acid for 2 
minutes followed by saturated uranyl acetate for 12 minutes and treated with colloidal gold 
solution (BBI, Cardiff, UK) on both faces of the grid. Single axis tilt series, -60° to +60°, of 
stromal lamellae in both longitudinal and transverse sections, and of each stromal region 
(anterior, mid and posterior stroma) were captured at 20kx magnification, in one degree 
increments, on a JEOL 1010 transmission electron microscope (80Kv) equipped with a Gatan 
ORIUS SC 1000 CCD camera. Each 121 image set was aligned using IMOD (Kremer et al., 
1996), and with reference to the position of gold fiducial markers (lOnm gold particles) on
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each image. A back-projected reconstruction was generated using EM3D (Ress et al., 2004), 
and its segmentation was performed through manual selection of contours in a region of 
interest, also carried out using EM3D.
5.3.4 Measurement o f Fibril Diameters
Collagen fibril diameters were measured using imageJ software (Abramoff, 2004) with the 
65nm collagen D-period used for internal calibration. Measurements were taken from fibrils 
(n=750) for each stromal region (anterior, mid, posterior).
5.4 Results
Electron microscopic investigations showed that the corneas of homozygous lumican-null 
mice are characterised by the presence o f enlarged and irregularly shaped collagen fibrils in 
the posterior stroma (Fig. 5.1. and Chakravarti et al., 2000). These abnormal fibrils are 
relatively rare, and although they vary in size and shape, their irregular appearance is 
consistent with them being the result o f neighbouring collagen fibrils that have fused laterally 
(Figs. 5.1(c) and 5.2.).
In some cases, multiple fibrils seem to fuse to give the appearance of a single fibril with an 
irregular contour (Fig. 5.2.). These merged fibrils are not apparent in the anterior stroma and 
their incidence increases towards the posterior region, in line with the findings of Chakravarti 
et al., 2000.
To identify the proteoglycans seen in the lumican-null mouse cornea, enzyme digestion using 
keratanase II (which cleaves keratan sulphate) and chondroitinase ABC (which removes 
chondroitin sulphate/dermatan sulphate glycosaminoglycans) was carried out (Fig. 5.3). 
Keratanase II treatment of both the lumican mutant (Fig. 5.3(b)) and C57BL/6 wild-type (Fig. 
5.3(f)) mouse cornea does not show any appreciable difference in proteoglycan density and 
morphology, indicative of a low population of keratan sulphate associated proteoglycans in
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the mouse cornea (Young et al., 2005, Hayashida et al., 2006). However, chondroitinase ABC 
treatment removes all apparent Cuprolinic blue stained proteoglycans in the lumican 
knockout mice (Fig. 5.3(c)), demonstrating the absence of sulphated keratan sulphate 
proteoglycans. In the wild-type mouse cornea, chondroitinase ABC digestion leaves a 
minimal amount of fine, fibril associated proteoglycans likely to be of the keratan sulphate 
variety (Fig. 5.3(g)). Digestion with both enzyme types results in the complete removal of 
Cuprolinic blue-stained proteoglycans in both the wild-type (Fig. 5.3(d)) and lumican-null 
mouse cornea (Fig. 5.3(h)).
Fig. 5.1. E lectron m icrograph of (a) w ild-type mouse (C57BL/6) corneal strom a and (b) posterior stroma 
of lum -/- mouse cornea. Lum ican knockout corneas a re  characterised  by the presence of oversized fibrils 
in the posterior strom a ((b) white a rrow head). Scale Bars = lOOnm
Three-dimensional reconstructions of the C57BL/6 wild-type mouse cornea reveal an 
apparent random proteoglycan organisation, where there is a non-specific rotational order
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around collagen fibrils with proteoglycans of differing dimensions seen to inter-connect 
neighbouring, and in some cases, next-nearest neighbour fibrils. Small interfibriHar (Fig. 
5.4(b), red arrowhead), and more curved proteoglycans (Fig. 5.4(b), green arrowhead) link 
nearest neighbours whereas next-nearest neighbour fibrils may be attached via an elongated 
third type of proteoglycan (Fig. 5.4(b), white arrowhead). The appearance of the collagen 
fibril arrangement in transverse section is characteristic of the cornea, with a lattice-like array 
comprised of fibrils with uniform spatial distribution and diameter.
•
•
W  JU l 
• _v
' % -
6> & QOO
Fig. 5.2. (top panels) Electron m icrographs o f collagen fibrils in transverse section in the posterior stroma 
of a lumican knockout mouse cornea. The contours o f these fibrils suggest tha t they arise from the fusion 
of regularly sized fibrils that have m erged in the absence of lumican proteoglycans, (bottom panels) A 
schematic representation of collagen fibrils (blue circles) coming together to form the aggregates seen in 
the top panels. Scale Bar = 20nm
Upon measurement of fibril diameters in the lumican mutant mouse corneal stroma, it is 
apparent that the fibril irregularities are confined to the posterior and mid-stromal regions, 
with a greater incidence occurring posteriorly. In the posterior region, collagen fibrils with 
diameters in the range of 55-65nm are relatively frequent which could possibly be accounted 
for by the presence of two or more laterally fused fibrils with diameters in the "normal" range 
of 25-35nm. This increase in fibril size is also apparent in the mid-stroma but on a lesser 
scale. The anterior stroma also has a larger distribution of fibril diameters compared to the 
wild-type mouse cornea, although no highly enlarged fibrils over 40nm were seen. In the mid 
stroma, the frequency plot (Fig. 5.5(c)) shows a less prominent bi-modal distribution than in
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the posterior stroma, although irregularly sized fibrils are present. The wider distribution in 
fibril diameters, and the fact that the distribution clearly appears to be bi-modal, is likely to 
explain the diminished transparency and increase in backscattered light in the posterior 
corneal stroma.
C57BL/6 Wild-Type Lumican-/-
Fig. 5.3. Electron m icrographs of w ild-type (left colum n) and homozygous lumican-null (right column) 
mouse corneal strom as showing C uprolin ic blue stained proteoglycans after incubation in buffer (a and 
b), chondroitinase ABC (c and d), kera tanase  II (e and  0  and both keratanase and chondroitinase ABC 
(g and h). K eratanase treatm en t shows the abundance  of chondroitin sulphate/derm atan sulphate 
proteoglycans in both wild-type (e) and lum ican-null corneas (0- Chondroitinase ABC digestion leaves a 
minimal am ount of small fdam entous proteoglycans in the wild-type (c), although none are seen in the 
m utant corneas (d) because of the lack o f the m a jo r keratan  sulphate proteoglycan, lumican. Enzyme 
digestion with both keratanase and chondro itinase ABC leaves no detectable proteoglycan component. 
Scale bar = lOOnm
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Fig. 5.4. Tomograms of collagen (blue) and proteoglycans (yellow) in the C57BL/6 wild-type mouse 
corneal stroma. Stereo-pairs of three-dim ensional reconstructions in (a) longitudinal and (b) transverse 
section. Proteoglycans do not exhibit any ro ta tional o rd e r around collagen fibrils and are seen to 
interconnect neighbouring fibrils (red a rrow head) as well as next-nearest neighbours (white arrowhead). 
Scale bar = 50nm
The three-dimensional reconstructions of the lumican-null mouse cornea show grossly 
enlarged fibrils with irregular contours in both the posterior and mid-stroma transverse 
sections, although their occurrence seems to be more frequent posteriorly (Fig. 5.6 and 
Chakravarti et al., 2000). These enlarged fibrils were not evident in the anterior lumican-null 
stroma. In longitudinal section, most collagen fibrils appear normal (Fig. 5.6(a,c,e)). 
However, some regions of the reconstructions reveal enlarged fibrils with evidence of an 
axially localised fusion of regularly sized fibrils. Interestingly, the collagen banding of each 
merging fibril appears to be in register (Fig. 5.7 red and green arrowheads). The merging of 
fibrils is not widespread, probably owing to the abundance of chondroitin sulphate/dermatan 
sulphate proteoglycans that are located between fibrils and which impede them from coming 
into contact and fusing. Proteoglycans, similar to what is observed in wild-type mouse 
corneas, do not exhibit any rotationally ordered arrangement. In addition, there appears to be 
a lack of the small interfibriHar proteoglycans which are likely to be of the keratan sulphate
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variety, as suggested by our enzyme digestion data (Fig. 5.3(c)). As a result, many next- 
nearest fibrils appear to be inter-connected by the larger chondroitin sulphate/dermatan 
sulphate filaments.
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Fig. 5.5. Frequency plots of collagen fibril d iam eters from (a) C57BL/6 wild-type mouse corneal strom a; 
(b) Anterior Lum -/- mouse corneal strom a; (c) M id-strom a Lum -/- mouse corneal strom a; (d) Posterior 
Lum -/- mouse corneal stroma. As the mid and posterio r strom a exhibit a bi-modal distribution for fibril 
diam eter, the mean is calculated for each mode; regu lar (blue) and irregular (red) sized fibrils.
5.5 Discussion
Using electron tomography we have visualised, in three-dimensions, the collagen- 
proteoglycan interactions in the homozygous lumican-null mouse corneal stroma. The 
proteoglycans of the lumican mutant cornea exhibit no rotational order around collagen
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fibrils, as is the case in other mammalian corneas (Lewis et al., 2010, Parfitt et al., 2010 - 
(Chapter Three)).
Fig. 5.6. Stereo-pairs of three-dimensional reconstructions of collagen (blue) and proteoglycans (yellow) 
in the lumican -/- mouse (a and b) anterior, (c and d) mid and (e and f) posterior corneal stroma. 
Longitudinal (a,c,e) and transverse (b,d,f) sections illustrate  the fibril defects of the posterior and mid 
strom a, where oversized fibrils exist (red arrow heads), (c) Successive slices through a tomogram of an 
oversized fibril in the posterior lumican-null mouse corneal strom a show four fibrils (bottom panel) 
merging to form a single fibril with irregular contours (Top panel). Scale bar = 50nm
In the absence of the major keratan sulphate proteoglycan lumican, neighbouring collagen 
fibrils in the mid and posterior stroma in the lumican-null mouse are seen occasionally fusing 
together to form enlarged fibrils with irregular contours. There is evidence, from studies of 
lumican-null mice which are older (7 months old) than those used in this investigation, of 
further enlargement and lateral fusion of fibrils in the mid and posterior stroma as time
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progresses. In 7.5 month old mice, the fused fibrils appear more abundant and exhibit more 
'cauliflower'-like morphologies with much larger diameters than those measured in this study, 
although this is expected as lumican expression is greater in the older mice (Chakravarti et 
al., 2000). It has been postulated that, even though mouse cornea is not as populated with 
sulphated keratan sulphate proteoglycans as other mammalian corneas (Scott and Bosworth, 
1990, Young et al., 2005), the dominance of the structural change in the posterior stroma is 
due to keratan sulphate proteoglycans exhibiting more structural influence in the deep stroma. 
Moreover, lumican removal is likely to affect the expression and distribution of other keratan 
sulphate proteoglycans (Carlson et al., 2005, Liu et al., 2010), as indicated by the lack of 
proteoglycans in the lumican-null mouse cornea when treated with chondroitinase ABC.
Fig. 5.7. Three-dimensional reconstruction of an irregularly  sized fibril in longitudinal section of the 
lumican-null mouse posterior corneal strom a. T hree collagen fibrils fuse locally to give the appearance of 
an enlarged fibril. In places (yellow arrow ), the fibrils a re  distinct and separate, suggesting that fibrils 
merge first at localised regions. Collagen banding correlation between the fibrils suggests that fibril 
fusion is possibly according to specific sites norm ally occupied by the proteoglycans. Scale bar = 50nm
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Proteoglycans contribute to the regulation of uniform collagen architecture in the cornea, 
restricting fibril diameters by preventing fibril fusion and by influencing interfibriHar spacing 
through opposing osmotic and thermal forces (Fig. 8). Type V collagen initiates and regulates 
the assembly of the fibrils themselves prior to deposition in the extra-cellular matrix by 
keratocytes (Hassell and Birk, 2010, Birk, 2001, Birk et al., 1990). Longitudinal 
reconstructions, where no appreciable defects are seen along the length of the fibril, suggest 
that enlargement of fibrils may occur, at least initially, at localised points, where 
neighbouring fibrils possibly coalesce at a single region and not extended axial regions 
spanning the fibril length. This view is supported by the reconstructed tissue volume that 
clearly shows three normal diameter fibrils merging into one. It is worth considering the 
possibility that the low concentration of lumican and other keratan sulphate proteoglycans in 
the healthy mouse comeal stroma (Scott and Bosworth, 1990, Young et al., 2005) might 
explain the low prevalence of oversized fibrils in the lumican deficient stroma, where a role 
in preventing fibril fusion is likely to be assumed by the more abundantly expressed 
chondroitin sulphate/dermatan sulphate proteoglycans. The enlarged, fused fibrils are 
irregularly scattered throughout the mid and posterior stroma in the lumican-null mouse 
cornea and the resultant anisotropy in fibril distribution and size caused by fusion affects light 
interference within the cornea. Assessment, by in vivo confocal microscopy, of backscattered 
light as an indicator of comeal transparency in lumican-null corneas, has disclosed that more 
light scattering occurs in the posterior stroma (Chakravarti et al., 2000), indicative of a 
reduction in transparency.
In consideration of the previously proposed model for the dynamic regulation of interfibriHar 
spacing (Knupp et al., 2009, Lewis et al., 2010, Parfitt et al., 2010 - (Chapter Three)), a loss 
of localised osmotic swelling pressure through the removal of sulphated proteoglycans, 
proposed to push fibrils apart to regulate their distribution in normal physiology, would be 
expected to allow for neighbouring fibrils to move closer and potentially come into contact 
with each other. Also, as there would be no lumican protein cores on the fibril, not only a 
potential source of steric hindrance would be removed, but potential sites for further lateral 
aggregation of fibrils may become available. This view is also supported by In vitro studies 
that have shown that protein cores, even without a glycosaminoglycan extension, are capable 
of limiting collagen fibrillogenesis (Rada et al., 1993), supporting the idea that protein core
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occupancy of collagen banding restricts lateral fusion. Moreover, the collagen banding of the 
merged fibrils appears to be in register along the length of the fibril, presumably allowing the 
forces that keep the collagen molecules together within a fibril to also act between separate 
fibrils. Although, it is unclear whether the fibrils are required to be register in order for fusion 
to occur. The removal of lumican is, therefore, likely to result in reduced osmotic pressure, 
the removal of a source of steric hindrance and also in the freeing of attachment sites on the 
collagen fibrils, all of which are possible factors in fibril fusion and enlargement, as seen in 
the posterior regions of the homozygous lumican-null mouse cornea.
The proteoglycans that remain in the lumican-null mouse corneas are likely to be mostly of 
the chondroitin sulphate/dermatan sulphate variety and are seen to frequently inter-connect 
more than two fibrils in a non-specific arrangement, maintaining collagen fibril spacing in the 
mutant cornea. With regards to the model proposed, if the abundant and more sulphated 
chondroitin sulphate/dermatan sulphate type of proteoglycans were to be removed, and 
consequently the osmotic pressure they generate, we predict a much greater incidence of 
lateral fusion would occur; primarily because of their prevalence and their proposed function, 
not dissimilar from keratan sulphate. This is indeed what is observed in the compound 
decorin/biglycan double-knockout mouse cornea (Zhang et al., 2009). No fused fibrils are 
observed in the corneas of Chst5-null mice however (Parfitt et al., 2011 - (Chapter Four)), 
and so it is likely that physical attachment of proteoglycans to fibrils is paramount to fibril 
separation and the prevention of fusion, whilst sulphation of glycosaminoglycans dictates the 
extent of localised osmotic pressure and the organised spatial distribution of fibrils. 
Therefore, our model is capable of explaining how proteoglycans can mediate the intricate 
comeal collagen fibril architecture by simultaneously regulating interfibriHar distances and 
fibril diameter to allow for fibril spatial flexibility and comeal transparency.
5.6 Conclusion
Three-dimensional reconstructions of collagen-proteoglycan interactions in the lumican-null 
mouse cornea imply that keratan sulphate proteoglycans regulate both fibril diameter and 
interfibriHar spacing by maintaining the separation between neighbouring fibrils. This is
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consistent with the view that proteoglycans are dynam ic mediators o f both fibril diameter and 
interfibriHar distance. It is possible that chondroitin sulphate/dermatan sulphate regulates 
collagen fibril architecture with the same mechanisms, and the removal o f these 
proteoglycans, as seen in the studies o f  decorin-biglycan knockouts, results in a severe 
phenotype in mouse cornea due to their abundance and ability to connect numerous fibrils in 
the mouse comeal stroma.
Fig. 5.8. Schematic representation of the proposed role of lumican in regulating collagen Fibril diam eter, 
m aintaining interfibriHar spacing and p reventing  fibrils from  fusing, (a) In healthy corneas, 
proteoglycans maintain fibril separation  m ainly via a com bination of the Donnan effect and therm al 
motion. The proteoglycan's highly anionic charge  density  a ttrac ts  positively charged ions, which in tu rn  
a ttrac t w ater molecules that cause an increase in local osmotic pressure and which "pushes" adjacent 
fibrils apart. At the same time, therm al motion o f the glycosaminoglycan chains causes a retraction of 
their term inal ends which are bound, via a protein  core, to collagen fibrils. An attractive force thus arises, 
the tendency of which is to bring fibrils closer together. The com bination of attractive and repulsive 
forces (black arrows) keep the fibrils a t optim al separations, (b) Proteoglycan motion is likely to cause 
movement of protein cores which a re  held in place by non-covalent interactions with fibrils. This is 
suggested by the presence of proteoglycans th a t lie along the fibril axis o r display skewed angles, along 
with a general lack of any ro tational sym m etry  o f the proteoglycans around the collagen fibrils. 
Movement of water, ions and nutrien ts th rough  the tissue (blue arrow s) and in-between fibrils cause the 
fibrils to move from their average position and a t tim es they get closer together. Fibrils are  prevented 
from fusing laterally by the com pressive resistance of proteoglycans imbibed with w ater and by the steric 
hindrance caused by their protein cores and glycosam inoglycan chains, (c and d) Localised removal of 
interfibriHar proteoglycans prevents dynam ic m ediation of interfibriH ar spacing and allows fibrils to 
come into contact and potentially fuse, most likely keeping their collagen banding in register as the three- 
dimensional reconstruction of a fused fibril suggests (Fig. 7).
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6.1 Introduction
The main aim of this project was to further our understanding of proteoglycan structure and 
function in the comeal stroma using the mouse cornea as a model system. By using mouse 
corneas, we have the opportunity of being able to analyse genetically manipulated specimens, 
alongside the advantage of using readily available tissue. Proteoglycan regulation of the 
organised collagen fibril architecture in the comeal stroma, the pre-requisite of comeal 
transparency, is not completely understood. Through observations on the relationships 
between proteoglycans and collagen fibrils in the wild-type, Chst5-null and lumican-null 
mouse cornea, we attempted to obtain a more clear definition of the role of proteoglycans in 
the cornea. Primarily, this was done by conventional transmission electron microscopy, 
electron tomography, and subsequent image analysis. To fully appreciate specific 
proteoglycan characteristics, investigation of proteoglycan morphometry and digestion by 
specific glycosaminoglycan-degrading enzymes complemented our microscopy studies.
A recent histological investigation into the mouse cornea (Young et al., 2005), outlaid the 
atypical ultrastructure of the mouse comeal stroma and suggested that further analysis would 
be required to fully understand the proteoglycan-knockout mice that are becoming common 
place in studies of proteoglycan function. Utilising electron tomography, we were able to 
visualise proteoglycan-collagen interactions three-dimensionally in the wild-type mouse 
cornea, which enabled us to propose a model of how collagen fibrils are spatially distributed 
with a remarkable degree of uniformity by the proteoglycans (Chapter Three). Three- 
dimensional reconstruction of C/zs/5-null mouse corneas, which exhibit proteoglycans with 
abnormal morphologies as a result of defective sulphate transfer, gave insights into 
proteoglycan packing and the flexibility of proteoglycan complexes (Chapter Four). Using 
the dynamic proteoglycan regulatory model proposed for the wild-type mouse cornea as a 
basis, we also analysed genetically modified mouse corneas (Lumican-null - Chapter Five) to 
help compound the idea that proteoglycans regulate both collagen fibril assembly and spatial 
distribution in the cornea. From this work, possible future avenues of research may include 
applying electron tomography to human corneas and even diseased corneas (i.e. keratoconus 
and macular corneal dystrophies) to test fully the hypothesis of dynamic proteoglycan- 
collagen architecture regulation, as put forward in this thesis. Further investigations using
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electron tomography may also include the characterisation o f keratocytes, the interface
between orthogonal lamellae, and also different developmental stages o f the comeal
extracellular matrix.
6.2 Discussion
Although much is understood about collagen fibril architecture in the cornea, and the 
implications of its regularity on the tissue's transparency (Maurice, 1957, Hart and Farrell, 
1969, Benedek, 1971, Farrell et al., 1973), little is known about how the fibrils are 
maintained in an ordered pseudo-hexagonal array that can cope with external stresses as well 
as the movement of water and nutrients through the stroma. Proteoglycans have been shown 
to be essential to controlling fibril assembly (Rada et al., 1993) and with the creation of 
proteoglycan-knockout mice, it has been observed, through electron microscopy (Chakravarti 
et al., 2000), and x-ray diffraction (Quantock et al., 2001, Meek et al., 2003), that 
proteoglycans contribute to the regulation of collagen fibril distribution and size. The exact 
modes of control that proteoglycans exert over the organised collagen fibril framework are 
still to be fully elucidated. However, electron tomography enables three-dimensional 
visualisation of macromolecular structures at relatively high resolution, allowing for a more 
clear interpretation as to proteoglycan interactions with collagen fibrils.
Our initial study was to determine proteoglycan dimensions and their organisation throughout 
the wild-type mouse cornea using electron tomography, as well as calculating the degree of 
collagen fibril order in the stroma through computing fibril radial distribution functions. 
From this, a simple model was proposed to explain how proteoglycans could effectively 
modulate the intricate collagen fibril organisation in the comeal stroma. Comparative analysis 
of the wild-type mouse cornea and reconstructions generated from genetically modified mice, 
granted further insights into proteoglycan structure and function.
6.2.1 Radial Distribution Functions/Proteoglycan dimensions
Comeal collagen fibrils, in a variety of species (Connon et al., 2000, Connon et al., 2004), 
maintain a short range order that is likely to be paramount to the tissue's transparency, as
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elucidated by calculating the radial distribution function of fibrils from electron micrographs. 
Radial distribution functions specify the probability of locating a fibril centre at a given 
distance, with respect to any reference fibril, and it can show whether or not fibrillar order 
extends over a long range. Several studies on mammalian corneas have reported a first peak 
within the 40 - 55nm range (Hart and Farrell, 1969, Cox et al., 1970, Freund et al., 1995), 
suggesting that neighbouring fibrils are positioned with remarkable regularity, whereas 
second peaks arise with a lower amplitude and over a greater range, indicating that order 
frequently diminishes after next-nearest neighbour fibrils. The less prominent second peak is 
a common occurrence in analysis of collagen fibril radial distributions and fibril order rarely 
appears to extend past 120nm (Hart and Farrell, 1969, Freund et al., 1995, Connon et al., 
2000, Cooper et al., 2006). There always appears to be short range ordering of collagen fibrils 
in the corneal stroma. This short range order is likely to be essential for the mutual 
interference of light entering the cornea as it is under half the wavelength of visible light. A 
significant increase in interfibriHar spacing, and the consequent decrease in fibril order, has 
been shown to have detrimental effects on comeal transparency and the formation of comeal 
haze (Meek et al., 2003, Bredrup et al., 2005, Beecher et al., 2006).
(nm)
Corneal Thickness 120 1000
!
550 450
Fibril Diameter 39.7 38.2 30.8 38.8
InterfibriHar Distance 64.6 ±6.5 56.8 ±4.5 55.3 ±4.0 58.8 ±4.5
RDF 1st peak 44 N/A 41.2 46.9
Keratan sulphate Population 
of Total Polyanion 18% 45% N/A 42%
*Taken from Scott and Bosworth (1990), Meek and Leonard (1993) and Freund et al (1995)
Table 6.1. Comparison of fibril and proteoglycan characteristics in mammalian corneas.
In the mouse comeal stroma, collagen fibril order does not appear to extend beyond next- 
nearest neighbours, defined by a diffuse second peak at ~90nm, whereas at ~44nm there is a 
distinct possibility of locating a neighbouring fibril, indicated by the first prominent peak. As 
a result, proteoglycans in the wild-type mouse cornea would probably physically connect
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both neighbouring and next-nearest neighbour collagen fibrils to be able to accurately define
their spatial order. As the second peak is less prominent, the probability o f locating a fibril at
this distance (~90nm) is lower than finding neighbouring fibrils at a 44nm separation.
Conventional electron microscopy of mouse comeal ultrastructure hinted to two distinct 
proteoglycan populations with different morphologies (Young et al., 2005, Hayashida et al., 
2006, Parfitt et al., 2010 - (Chapter Three)). However, analysis of proteoglycan morphology 
using two-dimensional images may give rise to possible inaccuracies, as detailed in an earlier 
study (Scott, 1992). From our measurements of proteoglycan dimensions using three- 
dimensional reconstructions of the mouse comeal stroma, next-nearest neighbour fibrils are 
interconnected infrequently by large proteoglycans approximately 122nm in length, whereas 
neighbouring fibrils are regularly interconnected axially by short interfibriHar proteoglycans 
(-31 +/- 4nm in length) and also by longer proteoglycans (-65 +/- 4nm in length) that can 
vary considerably in thickness (6 to 13nm in diameter). Young et al (2005) showed that the 
longer, sinuous proteoglycans are of the chondroitin sulphate/dermatan sulphate type whereas 
the small, interfibriHar proteoglycans are most likely keratan sulphate associated. The 
observed variation in thickness and length of the proteoglycans strongly implies that they 
may self-associate laterally or end-to-end to form complexes, likely to be more robust than 
single glycosaminoglycan chains. Also, there does not appear to be any qualitative 
differences in the distribution of these various proteoglycan types in the three distinct regions 
(anterior, mid and posterior) of the central comeal stroma.
6.2.2 Proteoglycan Self-association
Self-association of proteoglycans was first illustrated by Fransson et al (1970) and was shown 
to be facilitated by the sequence of disaccharides in the glycosaminoglycan chain; 
complementary, alternating disaccharides are more prone to aggregation, which can be also 
promoted by the presence of Na+, the degree of sulphation of the glycosaminoglycan 
backbone and iduronate-rich sequences (Fransson and Coster, 1979). Scott (2003) furthered 
this study by elucidating which proteoglycan types are more susceptible to aggregation and 
their relative individual elasticity, as well as postulating that anti-parallel associations may be 
possible through hydrogen or hydrophobic bonds.
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The radius of ions used in the staining of proteoglycans (i.e. Cu+ and W 042-) are no more 
than lnm in radius, and the width of an individual glycan chain is also likely to exceed no 
more than 0.5nm (Scott, 1992). Thus, the stain coating is unlikely to explain the thickness of 
proteoglycans observed in the wild-type mouse comeal stroma, which may frequently exceed 
lOnm. The variation in proteoglycan thickness and length, as well as the known thickness 
contribution from cationic stains, strongly implies that proteoglycans form complexes as 
opposed to single glycosaminoglycan chains connecting fibrils. It is possible that other bio­
molecules may facilitate the formation of proteoglycan complexes, although this is unclear as 
of yet. In order to understand whether proteoglycan self-association occurs in a co-ordinated 
manner, or whether artefacts are responsible for the measured thicknesses, an investigation of 
proteoglycan morphology in conditions of altered aggregation was required.
The existence of a mouse model for macular comeal dystrophy, where a gene (ChstS) that 
encodes a N-acetylglucosamine 6-0  sulphotransferase enzyme responsible for transferring 
sulphate esters to synthesising keratan sulphate is removed, allowed for the analysis of 
proteoglycan morphology in conditions of altered sulphation. As a consequence of keratan 
sulphate undersulphation, a compensatory oversulphation of chondroitin sulphate/dermatan 
sulphate proteoglycans is likely to have occurred. The resultant phenotype of Chst5 removal 
is abnormal chondroitin sulphate/dermatan sulphate proteoglycan morphology; proteoglycans 
increase dramatically in both thickness and length, and near-periodic radial off-shoots are 
present. Irregular proteoglycans up to 4x longer (~480nm in length) and twice as thick 
(~29nm in diameter) as the largest proteoglycan type prevalent in the wild-type mouse cornea 
are evident. This increase in magnitude is strongly indicative of furthered lateral and end-to- 
end aggregation, as well as orthogonal self-association (shown to be all of the chondroitin 
sulphate/dermatan sulphate variety (Hayashida et al., 2006)). The regularity of the orthogonal 
branches suggests that these proteoglycans may have aggregated in a co-ordinated manner, 
where specific regions are able to exhibit off-shoots, although not all sites may be occupied. 
It is therefore postulated that proteoglycan complex formation, most likely in a co-ordinated 
fashion, is a key aspect of normal proteoglycan functionality in the wild-type mouse cornea 
that occurs to a lesser and more controlled extent than the oversized proteoglycans in the 
C7?s/5-null mouse cornea.
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As glycosaminoglycan sulphation occurs concomitantly with chain elongation and 
epimerisation, any disruption at proteoglycan biosynthesis could potentially affect the length 
of the glycosaminoglycan and the distribution of disaccharides within the side-chain. It has 
been reported that (Malstrom et al., 1975, Fransson and Coster, 1979) sulphation at synthesis 
has a bearing on the sequence of disaccharides and the ratio of iduronate:glucuronate through 
epimerisation of glucuronate. Any alterations in the sequence of disaccharides could therefore 
lead to favourable aggregation conditions and potentially the increased self-association 
observed in the CTw/5-null mouse corneas. We hypothesise that proteoglycan oversulphation 
and the subsequent increase in counter-ion attraction, as well as potential disaccharide 
sequence differences, leads to increased self-association as opposed to heightened mutual 
repulsion which may be expected from the increased negative charge density.
In physiological conditions, proteoglycan aggregation must therefore be regulated in order to 
produce discrete complexes that are relatively uniform in their dimensions and distribution 
throughout the stroma, as depicted in the wild-type morphometry studies (Chapter 3), with 
C/w/5-null corneas highlighting the importance of sulphation in the determination of 
proteoglycan morphology. Interestingly, the enlarged proteoglycans in the ChstS-null mouse 
cornea also exhibit remarkable flexibility, with the ability to bend around fibrils in many 
cases and although they are extremely oversized and oversulphated, the fibril distribution is 
not greatly affected as the overall hydrophilic charge within the stroma is likely to be 
maintained.
6.2.3 Proteoglycan Organisation
In the three-dimensional reconstructions of wild-type, Chst5-null and lumican-null mouse 
corneas, it is apparent that the proteoglycans show no specific ordered, symmetrical 
arrangement around collagen fibrils - supporting the idea that proteoglycans have a dynamic 
influence on the maintenance of collagen fibril architecture. This is also apparent in bovine 
corneas (Lewis et al., 2010). In both mouse and cow, proteoglycans often display skewed 
angles and in some cases lie along the fibril axis, whilst some interconnect neighbouring 
fibrils as interfibriHar bridges at regular axial positions, in a "ladder-like" manner. This is in 
disagreement with previous models which postulate that proteoglycans exist in a six-fold
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symmetrical arrangement (Farrell and Hart, 1969, Muller et al., 2004), connecting next- 
nearest neighbours to hold fibrils in a near-perfect lattice-like configuration; even though a 
precise lattice is not required for corneal transparency. Our findings point to a more "fluid" 
system whereby fibril positions are not fixed and possibly, neither are proteoglycan self­
associations and proteoglycan-collagen fibril interaction.
X-ray diffraction analysis reveals that a crystalline lattice is not a requirement for 
transparency (Goodfellow et al., 1978) and although it is unclear as to the effects of electron 
microscopy preparation on the preservation of the proteoglycans' native state; a dynamic, 
adaptable system would be expected to be more conducive to fibril flexibility in the corneal 
stroma, where water, ions and nutrients could circulate without affecting the tissue's 
biophysical properties; namely transparency and corneal curvature. A dynamic system would 
also limit structural damage from external stresses and allow for cell migratory processes and 
the transport of important bio-molecules.
6.2.4 Dynamic Proteoglycan Regulation o f  Collagen Fibril Architecture
From our electron tomography study of lumican-null mouse corneas, it is apparent that 
proteoglycans, particularly lumican, are responsible for the separation, and consequently the 
prevention of fusion, of neighbouring fibrils through their interconnection at regular axial 
intervals. As lumican is not as abundant as chondroitin sulphate/dermatan sulphate associated 
proteoglycans in the mouse cornea, only few fused fibrils are observed in the lumican-null 
mouse cornea, although other research (Chakravarti et al., 2000) suggests the prevalence of 
fibril defects may increase with age. The dramatic increase in fibril aggregates in 
decorin/biglycan knockout mouse corneas (Zhang et al., 2009) further supports a role for 
proteoglycans in the prevention of fibril fusion and the maintenance of neighbouring fibril 
separation. Moreover, when proteoglycans are introduced in vitro to collagen type I fibrils, 
lateral association of fibrils is limited (Rada et al., 1993). Here, we propose a model to 
explain how proteoglycans maintain the organised fibril assembly in the cornea based on our 
findings from the wild-type and homozygous lumican null mouse cornea (Chapter 5).
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Table. 6.2. The role of proteoglycans in the regulation of corneal collagen fibril architecture and the 
effects of altered proteoglycan biosynthesis, (a) Proteoglycans (keratan sulphate = green, chondroitin 
sulphate/dermatan sulphate = black), considered to pack as complexes in an anti-parallel, co-ordinated 
fashion, regulate interfibriHar spacing through a balance of opposing forces (black arrows). In some 
cases, proteoglycans lie along the fibril axis which suggests that they have the ability to move according to 
the requirements of the tissue and to maintain dynamic regulation of fibril organisation, (b) In the wild- 
type mouse cornea, fibrils are positioned in a pseudo-hexagonal lattice that allows for light transmission 
through the cornea. Corneal proteoglycans do not exhibit any rotational symmetry around collagen 
fibrils and are able to interconnect neighbouring and less frequently, next-nearest neighbour fibrils, (c) 
Upon defective sulphate transfer to keratan sulphate glycosaminoglycans, chondroitin sulphate/dermatan 
sulphate proteoglycans become oversulphated and exhibit ir regu la r  morphologies in the CAv/5-null mouse 
cornea. Smaller chondroitin su lphate/derm atan sulphate proteoglycans bind periodically and 
orthogonally along the enlarged chondroitin sulphate /derm atan  sulphate body or possibly, elongated 
glycosaminoglycans are forced to p ro trude  out due to the increased aggregation in the main proteoglycan 
complex. Glycosaminoglycans may also pack in a coiling conformation, as suggested for the normal 
proteoglycans in (a) and similar to the case of hyaluronan (Arnott et al., 1983). Collagen organisation 
remains relatively intact as the overall hydrophilic charge likely stays similar to that of the wild-type 
mouse corneal stroma, (d) When lumican, the m ajor keratan sulphate proteoglycan of the cornea, is 
removed, collagen fibrils fuse laterally. This suggests that proteoglycans actively separate fibrils to 
prevent their fusion. Fusion of fibrils, and their  subsequent lateral aggregation, would affect fibril 
diameter and the spatial distribution of collagen in the cornea, in turn  this would affect the transparency 
of the cornea.
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Highly anionic proteoglycans are able to attract counter-ions, and because of the Donnan 
effect, water molecules hydrate the proteoglycan complexes forming a compression resistant 
bio-gel. Water entering the stroma leads to osmotic pressure/turgor in the interfibriHar space 
and give rise to forces that repel neighbouring fibrils. Thus, proteoglycans are essential 
players in corneal swelling and their removal causes reduced water influx (Hedbys, 1961). 
The localised water intake gives rise to osmotic pressure forces in the area surrounding 
proteoglycans and between fibrils which would be expected to push them apart, causing an 
increase in interfibriHar spacing. The extent of proteoglycan sulphation would therefore be 
expected to be an important factor contributing to the level of counter-ions and osmotic 
pressure generated within an area, as a result of the anionic charge density from sulphate 
esters.
To restrict interfibriHar space expanding excessively from osmotic pressure, proteoglycans 
would be expected to pull fibrils together with an opposite force. The physical attachment of 
protein cores to fibrils would be expected to prevent fibrils from being positioned too far 
apart and from coming into immediate proximity to each other, maintaining fibrils at a given 
distance according to glycosaminoglycan chain length. Furthermore, thermal motion of 
glycosaminoglycans would retract the terminal ends of the proteoglycans, which are non- 
covalently bound to collagen fibrils through their protein constituent, and therefore, attached 
fibrils would experience an attractive force as a result. Constant bombardment of 
glycosaminoglycans by molecules and ions would be expected to also facilitate the retraction 
of the proteoglycan terminal ends. As a result o f this, fibrils would be expected to constantly 
move from their average position and potentially come closer together. Therefore, 
proteoglycans prevent the fibrils from coming into contact through a balance of these forces 
and the attachment of protein cores to specific binding sites on fibrils, and thus, fibril fusion 
is prevented and average positions are maintained, enabling light transmission through the 
cornea.
The extent to which either force is exerted, and whether fibrils are pushed apart or pulled 
closer together, would be dependent on a variety of factors that affect proteoglycan 
characteristics. These could include disaccharide sequence, sulphation patterns and the 
consequent charge density, relative content of iduronateiglucuronate, chain length, and also
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the extent of self-association (chain width). The glycosaminoglycan chain length and extent 
of aggregation, shown previously to be reliant on the degree of disaccharide sulphation, 
would likely determine fibril separation distances and the robustness of attachment. The 
amount of each of the different proteoglycans in the stroma, and also the counter-ions 
present, affect the drawing and retention of water in the stroma (Hedbys, 1961), and so it is 
likely that the concentrations of individual proteoglycan types are regulated in homeostasis to 
achieve optimal control of fibril assembly and architecture. This is supported by the 
compensatory mechanisms that occur when proteoglycans are altered at the genetic level 
(Carlson et al., 2005), and also the varying proteoglycan compositions observed in corneas 
from different species that exhibit varying degrees of thickness (Scott and Bosworth, 1990).
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Appendices
CB Cuprolinic Blue
CCD Charged Coupled Device
CS Chondroitin Sulphate
DS Dermatan Sulphate
ECM Extra-cellular Matrix
g Gram
GAG Glycosaminoglycan
KS Keratan Sulphate
Mg Milligram
MgCl2 Magnesium Chloride
ml Millilitre
nm Nanometre
PEI Polyetherimide
PG Proteoglycan
TEM Transmission Electron Microscope
pm Micrometre
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Materials
Araldite Monomer CY212
BDMA Accelerator
Chloroform
1 Onm Colloidal Gold
0.05% Cuprolinic Blue (0.0 lg)
DDSA Hardener
EM slot grids (2mm x 1 mm)
EMKMR2 Glass-cutter
Ethanol (50%, 70%, 90%, 100%)
Ethylene Dichloride (1,2 -  Dicholoroethane)
Glass
2.5% Glutaraldehyde (2ml)
JEM1010 TEM
Kodak MegaPlus 1.4/digital CCD camera
0.1M Magnesium Chloride
Microscope Slides
1 % Phospho-tungstate Acid
Polyetherimide granules
Propylene Oxide
25mM Sodium Acetate (20ml, pH5.7)
Supplier
Agar Scientific 
Agar Scientific 
Sigma-Aldrich 
BB International 
BDH
Agar Scientific
TAAB
Leica
Sigma-Aldrich 
Sigma-Aldrich 
Leica
Agar Scientific
Jeol
Gatan
TAAB
TAAB
TAAB
Goodfellow
Agar Scientific
Aldrich
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0.5% Sodium Tungstate (Aq.) 
Ultracut Microtome 
2% Uranyl Acetate
TAAB
Reichart-Jung
BDH
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Appendix One
Measurement of proteoglycan dimensions and collagen fibril diameter and distribution 
in the mouse corneal stroma.
Collagen fibril diameter and interfibrillar distance were calculated from transverse section 
micrographs with a known pixel size of 0.33nm. The collagen fibril D-period (~65nm in 
cornea) and gold fiducial markers (lOnm) were used for internal calibration. All 
measurements were made using ImageJ software.
Anterior Mouse Corneal Stroma
Collagen Fibril Diameters Interfibrillar Spacing
Pixels Diameter (nm) Pixels IF Distance (nm)
AVG = 30.8 ± 1.9 AVG = 48.8 ± 4.5
90 29.7 141 46.53
93 30.69 174 57.42
99 32.67 126 41.58
94 31.02 141 46.53
99 32.67 146 48.18
93 30.69 162 53.46
87 28.71 153 50.49
90 29.7 127 41.91
90 29.7 144 47.52
99 32.67 150 49.5
84 27.72 132 43.56
99 32.67 150 49.5
90 29.7 144 47.52
87 28.71 162 53.46
105 34.65 150 49.5
90 29.7 141 46.53
84 27.72 154 50.82
87 28.71 144 47.52
102 33.66 144 47.52
96 31.68 174 57.42
96 31.68 150 49.5
84 27.72 162 53.46
94 31.02 150 49.5
84 27.72 132 43.56
90 29.7 141 46.53
93 30.69 126 41.58
93 30.69 174 57.42
99 32.67 154 50.82
96 31.68 141 46.53
96 31.68 132 43.56
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87 28.71 144 47.52
84 27.72 162 53.46
99 32.67 153 50.49
96 31.68 144 47.52
94 31.02 174 57.42
93 30.69 171 56.43
99 32.67 147 48.51
102 33.66 154 50.82
105 34.65 162 53.46
90 29.7 132 43.56
96 31.68 144 47.52
94 31.02 150 49.5
90 29.7 141 46.53
Mid Mouse Comeal Stroma
Collagen Fibril Diameters Interfibrillar Spacing
Pixels Diameter (nm) Pixels IF Distance (nm)
AVG = 32.0 ± 2.8 AVG = 49.1 ± 3.9
104 34.32 120 39.6
88 29.04 136 44.88
100 33 170 56.1
100 33 145 47.85
112 36.96 150 49.5
84 27.72 140 46.2
88 29.04 162 53.46
112 36.96 132 43.56
112 36.96 154 50.82
108 35.64 144 47.52
88 29.04 141 46.53
96 31.68 160 52.8
92 30.36 141 46.53
88 29.04 156 51.48
96 31.68 152 50.16
88 29.04 148 48.84
100 33 141 46.53
112 36.96 126 41.58
102 33.66 144 47.52
100 33 156 51.48
112 36.96 178 58.74
116 38.28 134 44.22
92 30.36 144 47.52
91 30.03 141 46.53
94 31.02 144 47.52
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100 33 150 49.5
92 30.36 132 43.56
93 30.69 138 45.54
98 32.34 165 54.45
o o 33 144 47.52
92 30.36 153 50.49
96 31.68 131 43.23
99 32.67 133 43.89
92 30.36 145 47.85
88 29.04 148 48.84
101 33.33 160 52.8
86 28.38 172 56.76
102 33.66 156 51.48
84 27.72 142 46.86
92 30.36 144 47.52
86 28.38 156 51.48
106 34.98 141 46.53
105 34.65 152 50.16
91 30.03 157 51.81
96 31.68 153 50.49
98 32.34 148 48.84
100 33 166 54.78
92 30.36 145 47.85
88 29.04 165 54.45
86 28.38 150 49.5
100 33 144 47.52
Posterior Mouse Comeal Stroma
Collagen Fibril Diameters Interfibrillar Spacing
Pixels Diameter (nm) Pixels IF Distance (nm)
AVG = 28.9 ± 1.6 AVG = 51.9 ±5.7
84 27.72 150 49.5
90 29.7 136 44.88
82 27.06 144 47.52
88 29.04 153 50.49
92 30.36 138 45.54
88 29.04 134 44.22
82 27.06 120 39.6
77 25.41 186 61.38
82 27.06 178 58.74
83 27.39 156 51.48
83 27.39 152 50.16
93 30.69 140 46.2
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29.7
27.06
144
162
47.52
53.46
28.38 158 52.14
30.36 158 52.14
29.04 142 46.86
31.02 184 60.72
31.68 168 55.44
27.06 129 42.57
29.04 180 59.4
30.36 177 58.41
29.7 127 41.91
31.68 176 58.08
29.04 183 60.39
27.72 172 56.76
28.05 142 46.86
28.05 154 50.82
27.06 162 53.46
30.36 140 46.2
31.02 149 49.17
29.04 175 57.75
29.7 164 54.12
29.7 154 50.82
27.72 144 47.52
28.38 175 57.75
29.7 168 55.44
29.04 178 58.74
27.06 128 42.24
25.41 144 47.52
26.4 167 55.11
30.36 182 60.06
28.38 155 51.15
27.06 154 50.82
29.04 167 55.11
31.68 184 60.72
30.36
29.7
30.36
29.04
32.34
156
144
153
177
164
51.48
47.52
50.49
58.41
54.12
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Three-dimensional reconstruction o f the w ild-type mouse corneal stroma
Anterior stroma in longitudinal section
Anterior stroma in transverse section
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Measurement of proteoglycan dimensions
Proteoglycans were only measured if their whole morphology was contained within the 
reconstruction and also lying in the same plane as the surface of the plastic section. Again, 
ImageJ was used for measurements.
Anterior Mouse Corneal Stroma
Proteoglycan Dimensions
Pixels Thickness (nm) Pixels Length (nm)
20 6.6 210 69.3
32 10.56 197 65.01
18 5.94 192 63.36
28 9.24 202 66.66
32 10.56 200 66
18 5.94 103 33.99
30 9.9 218 71.94
22 7.26 212 69.96
36 11.88 218 71.94
16 5.28 92 30.36
11 3.63 94 31.02
26 8.58 320 105.6
26 8.58 387 127.71
16 5.28 95 31.35
14 4.62 97 32.01
28 9.24 182 60.06
32 10.56 384 126.72
13 4.29 85 28.05
16 5.28 87 28.71
Mid Mouse Comeal Stroma
Proteoglycan Dimensions
Pixels Thickness (nm) Pixels Length (nm)
34 11.22 194 64.02
19 6.27 128 42.24
18 5.94 181 59.73
14 4.62 91 30.03
18 5.94 86 28.38
33 10.89 193 63.69
38 12.541 182 60.06
34 11.22 394 130.02
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13 4.29 85 28.05
12 3.96 96 31.68
15 4.95 91 30.03
28 9.24 184 60.72
33 10.89 198 65.34
21 6.93 115 37.95
16 5.28 89 29.37
30 9.9 185 61.05
18 5.94 98 32.34
24 7.92 194 64.02
Posterior Mouse Corneal Stroma
Proteoglycan Dimensions
Pixels Thickness (nm) Pixels Length (nm)
30 9.9 215 70.95
34 11.22 194 64.02
13 4.29 84 27.72
32 10.56 188 62.04
24 7.92 202 66.66
32 10.56 192 63.36
18 5.94 97 32.01
12 3.96 87 28.71
34 11.22 371 122.43
18 5.94 108 35.64
20 6.6 187 61.71
32 10.56 178 58.74
12 3.96 89 29.37
11 3.63 97 32.01
12 3.96 91 30.03
28 9.24 190 62.7
Radial Distribution Functions were calculated out using in-house software after relative 
positions of cross-section fibrils were plotted and normalised.
Radial Distribution Function of Collagen Fibrils in the Mouse Comeal Stroma
g(r)
Centre-to-
Centre
Distance
(nm) Anterior Mid-Stroma Posterior
Overall Stroma 
Average
0 0 0 0 0
2.75 0 0^ 0 0
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5.5 0 0 0 0
8.25 0 0 0 0
11 0 0 0 0
13.75 0 0 0 0
16.5 0 0 0.006154 0.002051
19.25 0.005333 0.013333 0.016 0.011556
22 0.016471 0.028235 0.077647 0.040784
24.75 0.092632 0.088421 0.107368 0.09614
27.5 0.152381 0.19619 0.205714 0.184762
30.25 0.330435 0.37913 0.342609 0.350725
33 0.7456 0.7744 0.6512 0.723733
35.75 1.124444 0.965926 0.811852 0.967407
38.5 1.38069 1.343448 0.855172 1.193103
41.25 1.505806 1.298065 0.814194 1.206022
44 1.669091 1.392727 0.996364 1.352727
46.75 1.389714 1.112 0.835429 1.112381
49.5 1.152432 1.08973 0.851892 1.031351
52.25 0.961026 0.982564 0.785641 0.909744
55 0.900488 0.83122 0.844878 0.858862
57.75 0.773023 0.645581 0.698605 0.705736
60.5 0.801778 0.756444 0.698667 0.752296
63.25 0.773617 0.710638 0.655319 0.713191
66 0.795102 0.737959 0.72898 0.754014
68.75 0.781961 0.75451 0.660392 0.732288
71.5 0.833962 0.798491 0.700377 0.77761
74.25 0.856727 0.84 0.701818 0.799515
77 0.945263 0.89193 0.801404 0.879532
79.75 0.942373 0.834576 0.68 0.818983
82.5 1.028852 0.912787 0.704918 0.882186
85.25 1.012063 0.891429 0.63619 0.846561
88 1.006769 0.954462 0.741538 0.900923
90.75 0.97194 0.896119 0.727164 0.865075
93.5 1.018551 0.936232 0.710725 0.888502
96.25 0.953239 0.851831 0.699718 0.83493
99 0.966027 0.90137 0.730959 0.866119
101.75 0.931733 0.8176 0.7232 0.824178
104.5 0.895584 0.812987 0.710649 0.806407
107.25 0.921519 0.827342 0.761013 0.836624
110 0.840494 0.840988 0.731358 0.80428
112.75 0.906024 0.765301 0.70506 0.792129
115.5 0.889412 0.864471 0.700706 0.818196
118.25 0.922299 0.825287 0.666667 0.804751
121 0.950562 0.896629 0.716404 0.854532
123.75 0.939341 0.897143 0.720879 0.852454
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126.5 0.887312 0.87871 0.687742 0.817921
129.25 0.941474 0.859368 0.647158 0.816
132 0.961237 0.880412 0.760825 0.867491
134.75 0.924444 0.837576 0.731717 0.831246
137.5 0.937426 0.857426 0.732277 0.842376
140.25 0.911068 0.83534 0.699417 0.815275
143 0.944762 0.875048 0.719619 0.846476
145.75 0.866168 0.824299 0.672523 0.787664
148.5 0.93578 0.787523 0.709725 0.811009
151.25 0.904505 0.78018 0.711712 0.798799
154 0.932743 0.838938 0.689204 0.820295
156.75 0.897391 0.804522 1" 0.67687 0.792928
159.5 0.911111 0.874872 0.690598 0.825527
162.25 0.923361 0.814118 0.65916 0.79888
Appendix Two
Measurement of proteoglycan dimensions
Measurement of proteoglycan dimensions in the C to5-null mouse cornea were restricted to 
those wholly contained and lying in the plane o f the plastic section.
Proteoglycan Dimensions in the Anterior Chst5-nu\\ A ouse Comeal Stroma
Branched Proteoglycans Proteoglycan Branches Unbranched Proteoglycans
Thickness
(nm) Length (nm)
Thickness
(nm)
Length
(nm)
Thickness
(nm)
Length
(nm)
21 349 9 67 10 60
17 226 10 60 7 57
20 170 11 62 8 69
29 184 9 75 8 59
15 270 14 69 9 70
11 57 12 115
10 64 8 60
10 52
7 66
9 68
8 61
Proteoglycan Dimensions in the Mid Chst5-n\xW Mouse Comeal Stroma
Branched Proteoglycans Proteoglycan Branches Unbranched Proteoglycans
Thickness
(nm) Length (nm)
Thickness
(nm)
Length
(nm)
Thickness
(nm)
Length
(nm)
18 320 11 56 8 68
19 208 9 56 7 65
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20 223 7 50 8 60
10 64 10 62
7 60
Proteoglycan Dimensions in the Posterior C/w/5-null Mouse Corneal Stroma
Branched Proteoglycans Proteoglycan Branches Unbranched Proteoglycans
Thickness
(nm) Length (nm)
Thickness
(nm)
Length
(nm)
Thickness
(nm)
Length
(nm)
18 238 9 69 8 72
24 173 8 66 8 76
18 460 9 70 9 71
18 314 9 70 11 110
19 240 8 56
8 72
9 66
8 72
Three-dimensional reconstruction of the Chst5-nu\\ mouse corneal stroma
Posterior stroma in longitudinal section
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Posterior stroma in transverse section
Appendix Three
Three-dimensional reconstruction of the lumican-null mouse corneal stroma
Posterior stroma in longitudinal section
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Posterior stroma in transverse section
irregular fused fibril in the posterior stroma of the lumican-null mouse corneal stroma
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Enzymatic digestion through the strom a of (left panel) the wild-type mouse cornea and 
(right panel) lumican-null mouse cornea.
No obvious qualitative differences were observed through the stroma and in the different 
stromal regions and so only the mid-stroma was used (Chapter Five).
C57BL/6 Wild-type Lumican-null
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